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The primary aim of this thesis was to classify the nature of the clonal expansion of 
cells that gives rise to bovine and murine mammary epithelia. It is generally 
assumed that the mammary gland is derived from the outgrowth of mammary-
determined stem cell progeny, and that this expansion produces a mixture of 
cellular clones throughout the gland. Molecular techniques that enable the 
'visualization' of the size and distribution of these clones will lead to a better 
appreciation of mammary gland development and architecture. 
In female mammals, the simplest 'mark' of clonality is provided by the 
inactivation of one or the other of the two X chromosomes. This event occurs 
early in embryogenesis and gives rise to stem cells that propagate this mark in 
progeny cells throughout the life of the animal. Two approaches, that utilized X-
inactivation as a mark of clonality, were investigated, 1) naturally occurring X-
linked gene polymorphisms in cattle, and 2) artificially introduced X-linked 
transgenes in mice. 
The first part of this thesis deals with the isolation and utilization of polymorphic 
markers on the bovine X-chromosome as markers of clonality. Such expressed 
genetic markers are essential if one is to distinguish which of the two X-
chromosomes is active in a given cell. Two X-linked bovine genes, glucose-6-
phosphate dehydrogenase (g6pd) and the X-inactive specific transcript (Xist) were 
selected for sequencing and SNP detection. As no specific sequence data was 
available for these genes, a bovine lambda genomic DNA library was screened. 
The G6PD clone selected from a lambda library was shown to be a pseudogene 
and therefore not useful for the present study. Another clone, that hybridized with 
an Xist gene probe, was shown to actually represent a bovine Huntingtin-
Associated Protein 1 like (HapJ-like) pseudogene, making it of no utility in this 
study. However, screening of regions of exon 1 of the Xist gene by direct PCR 
and sequencing, led to the discovery of an informative G+--+ T single nucleotide 
polymorphism (SNP). The variation, which was found in frequencies of 0.8 and 
0.2 for 'G' and 'T' variants respectively (32% of females are heterozygous), was 
used in a number of different ways in order to assess the clonal profile of small 
Ill 
'blocks' of the gland (S30 mm3). In these preliminary experiments, RT-PCR 
analysis of Xist expression patterns within each of the small blocks (each 
comprising around 3 X 107 cells) showed general heterogeneity but the 
experiments were not conclusive. Limitations of the experimental methods used 
are discussed and suggestions of alternative approaches, that will offer higher 
resolution, are presented. 
A second experimental approach, involving mice with a reporter transgene 
construct introduced into the X-chromosome (H253), was also used. The 
transgene consisted of 14 tandem repeats of a lacZ nuclear-localized reporter gene 
coupled with a mouse 3-hydroxyl-3-methylglutaryl coenzyme A reductase 
(hmgcr) promoter (Tam and Tan, 1992). A number of researchers had already 
utilized this transgenic model, and had confirmed that the cellular patterns of lacZ 
expression reflected actual X-inactivation patterns in a number of tissues. While 
carrying out initial investigations to ascertain the utility of this reporter system in 
investigations of the mammary gland it was discovered that the usual description 
of hmgcr as a 'house-keeping' gene is somewhat of a misnomer, as some tissues 
in the mouse show very strong patterns of lacZ expression while others gave 
minimal, or no, detectable expression. Furthermore, transgene expression was 
observed to increase during pregnancy and it was concluded that this effect was 
almost certainly a response to increased estrogen levels at this time. 
Whole mount analysis of five mouse mammary glands from transgenic animals 
revealed heterogeneous patterns of lacZ staining, indicating that mammary 
epithelia is generally polyclonal. In total, 42% of terminal buds and alveoli 
displayed a single lacZ staining pattern. Analysis of these staining patterns in 
duct termini indicated that the majority of individual alveoli are derived from two 
or three division competent (stem) cells. 
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Chapter 1 begins with a brief introduction and concludes with a literature 
review comprising: 
1) A review of general mammary development, with particular emphasis 
on the importance of the Terminal End Bud (TEB) in murine and 
similar structures in ruminants. 
2) The current understanding of mechanisms of cellular clonality. 
3) A review of established knowledge of mammary ductal clonality. 
4) Details of existing approaches for measurement of cellular clones. 
5) Proposed experimental approaches for the study of cellular clonality in 
the bovine and murine glands. 
Chapter 2 describes general methods and materials used during this project. More 
specific details of methods used can be found within the relevant results chapters. 
Chapter 3, the first results chapter, describes the detection of bovine Single 
Nucleotide Polymorphisms (SNPs) by DNA sequencing and analysis of X-linked 
genes. The second results chapter, Chapter 4, describes the development of an 
RT-PCR/RFLP approach to allow the visualization of the contribution of different 
stem cell clones to the mammary gland. In Chapter 5, experiments used to 
determine the suitability of an animal model (a lacZ transgenic mouse) for studies 
of cellular clonality in the murine mammary gland are presented. Chapter 6 
details application of the techniques developed in Chapter 5, showing how the 
animal model is used to visualize clonal events within mammary tissue and to 
allow the prediction of precursor cell numbers contributing to individual terminal 
ductal structures. 
Finally, in Chapter 7, a discussion of the relevance and importance of the findings 





1.1 General introduction 
Literature Review 
of Mammary 
Mammary organogenesis follows a developmental program that occurs 
predominantly postnatally (Horseman, 1999). This special feature of the 
mammary gland makes it possible to observe changes in branching 
morphogenesis in adult tissue and to correlate these changes to different 
physiological events. In contrast, most other glandular tissues (for example, 
salivary glands) undergo branching morphogenesis that is near completion at 
birth, therefore making these tissues far less amenable to such study. 
In vugm animals, ductal growth and lateral branching occurs to fill the 
mesenchymal space; in pregnant animals, further growth, with differentiation of 
milk-producing glandular components, occurs. At parturition the gland has been 
organised to allow for milk secretion and its efficient transfer to suckling young. 
After weaning, the gland undergoes radical restructuring, involution, to return it to 
an anatomical state similar to that of the virgin animal. Subsequent pregnancy 
requires the outgrowth of residual mammary tissue to produce a large mammary 
ductal network. Experimental characterisation of these stages of epithelial cell 
growth and reduction is essential for maximising profitability from dairy animals 
(Ellis, 1998). 
Mammary epithelial tissue expansion occurs by proliferation from a pool of 
dedicated stem cells, with progeny of each of these stem cells forming small 
populations ('clones') of cells in the adult gland. This thesis examines the size 
and distribution of these stem cell clones within bovine and murine mammary 
glands by detecting randomly inactivated X-linked marker genes. 
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1.2 Stem cell theory 
1.2.1 Introduction 
The existence of stem cells, defined as cells that remain in the tissue and retain the 
ability to proliferate throughout life, was first suggested in 1901 (Adami, 1901). 
The stem cell has since been further defined as: an undifferentiated cell type, able 
to divide both symmetrically and asymmetrically, which is responsible for cellular 
replacement in a tissue. Stem cells must be able to switch between these different 
roles throughout life (Potten, 1986; Potten et al., 1997). Consensus opinion now 
considers that such cells represent a very small part of any tissue population and 
are likely to exercise their proliferative function through division of intermediate 
cells, the so-called transiently activated (TA) cells (Potten and Morris, 1988). 
Self-renewal and production of a more differentiated progeny TA cell (so-called 
asymmetrical division) is described in the 1976 Oakberg-Huckins model of stem 
cell behaviour (Figure 1.1 ), which was based on studies of renewal of tritiated 




Non-dividing, maturing simple 
transit cell population 
Figure 1.1 The Oakburg-Huckins model of stem cell growth. The stem cell divides to produce 
more terminally differentiated cells, the transit cells, although this is not at the expense of stem cell 
numbers as such cells are able to self-renew to preserve their numbers (adapted from Potten, 
1986). 
Gilbert and Lajtha ( 1965) proposed distinct stem cell growth behaviours for each 
of three broad tissue types identified, that is: 1) essentially nonreplacing - female 
germ-line, CNS and muscle; 2) nonrenewing but with regenerative capacity -
liver, kidney, CT and apocrine glandular tissue; and 3) continually replacing 
tissues - haemopoietic, surface epithelia, the male germ line and holocrine 
glandular epithelia. 
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2. Symmetrical division 
Figure 1.2 A summary of stem cell behaviour. SC= stem cell, TA= transiently activated cell, TD 
= terminally differentiated cell. Stem cells can divide I) Asymmetrically to produce more 
differentiated progeny while self-renewing; or 2) Symmetrically to yield two parent-type stem 
cells. (Drawn from data in Potten (1986). 
Division during normal growth is asymmetrical, which maintains numbers of 
proliferation capable cells. Stem cells are also capable of symmetrical division, 
particularly in response to disease or where massive accumulation of tissue is 
required quickly (Potten and Morris, 1988). For example, during mammary gland 
growth at pregnancy (see Figure 1.2, part 2). Therefore, stem cell division 
behaviour is dependent on tissue/niche location and developmental timing. 
1.2.2 Stem cell hierarchies in Mouse gut: 'perpetual' regeneration 
Few tissues have been subjected to rigorous study of the stem cell kinetics 
involved in their growth. An exception is mouse intestine, where cellular 
proliferation in the crypt-villus of the gut wall epithelia has been extensively 
studied (Potten, 1986). Such structures, and the ordered nature of the clusters or 
patches in which they form, provide models of self-renewing stem cells that 
produce a tissue 'subunit' through a series of increasingly differentiated daughter 
cells. The fact that each hierarchy is contained within a well defined space (the 
crypt), and that descendents of the hypothesized stem cells move out of the crypt 
in a well-organized fashion, facilitates observation throughout the depth of the 
crypt (Hermiston and Gordon, 1995). 
The crypt-villus comprises a deep well-shaped pit, the crypt of Lieberktihn, with 
walls extending steeply to terminate at the apex of the villus. Studies of adult 
phenotypes have shown that an anulus of between 4 and 16 cells (the presumed 
stem cells), is located about four or five cells from the base of the crypt. In 
cellular kinetics studies, these cells have been found to exhibit slow cell cycle 
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times relative to other crypt cells (Potten et al., 1997; Wright and Alison, 1984). 
Stem cell division results in a gradient of differentiation, with the most 
differentiated cells found at both the top and the bottom of the crypt. Cells 
moving down the axis differentiate into a paneth cell (involved in immunity and 
found at the base of the crypt) phenotype, while cells moving out of the crypt 
accumulate other markers of differentiation as they become increasingly 
terminally differentiated (Potten, 1986) (Figure 1.3). This stem cell activity 
produces four principal cell lineages, all of which differentiate to fulfil a terminal 
function as they move vertically up the crypt. In the mouse intestinal epithelium, 
they are eventually sloughed off by exfoliation at the tip of the villus (Hermiston 
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Figure 1.3. The mouse intestinal crypt-villus as a model of stem cell contribution to an organ 
structure. While it is thought that an anulus of stem cells (S) is located at an average depth of 4 
cells from the base of the crypt, actual stem cells and their immediate progeny (lSC, 2SC, 3SC), 
that may have limited stem cell clonogenic capabilities, are found scattered throughout the lower 
and middle regions of the crypt. These cells produce the functional daughter cells, 1-4, that 
display increasing degrees of differentiation commitment as they enter the 'functional-zone', that 
is, the villus, as can be seen with differentiation markers applied to such populations. (Modified 
from Potten et al., 1997). 
In neonate chimeric animals crypts of mixed origin have been found, and this 
indicates polyclonality. However, this pattern is lost after a few weeks, 
presumably because of a "purificiation" by a predominance of progeny of a single 
anchored stem cell and its descendents in the crypt (Schmidt et al., 1988). 
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Two theories of population and maintenance of the intestinal crypt by the stem 
cells have been suggested. In the first, the stem cell pedigree concept (SCPC), 
one master stem cell maintains the entire crypt through a population of daughter 
stem cells (Schmidt et al., 1988). The second theory postulates that crypt 
population occurs via a small population of identical stem cells that arise 
simultaneously during gut morphogenesis (Hermiston and Gordon, 1995). 
In support of the SCPC, stem cell organization within the crypt-villus has been 
suggested to result from a single primary progenitor that produces two lineages of 
progeny. The first, the enteroendocrine lineage, produces factors to stimulate the 
other lineage, the enterocyte lineage, by means of a enteric neural interface (Mills 
and Gordon, 2001). 
1.2.3 Implications for studies of mammary clonality 
As detailed above, mouse gut epithelial cellular populations have anatomical 
features that make them useful for study of epithelial cellular hierarchies/clonality 
in surface epithelia. However, as suggested by Gilbert and Lajtha (1965), 
glandular apocrine systems, because they do not require perpetual regeneration, 
are unlikely to show the exact same patterns of growth as seen in the 
mouse intestine. 
Nevertheless, the production of an entire organ from a small number of 
progenitors is a presumed function of all stem cell populations in epithelial 
organs. Mills and Gordon (2001) imply that cellular growth patterns similar to 
that described in the crypt-villus system may exist in other organs, including the 
mammary gland, where single progenitors produce several different cell types 
(detailed below). Furthermore, it is thought that the crypt-villus model represents 
a standard model for the growth of all epithelial systems (Zajicek, 1995). 
1.3 Organization and growth of mammary epithelia 
The formation of the adult mammary gland, with ectodermal epithelia infiltrating 
a mesodermal fat pad to produce a ductal-alveolar 'tree', produces the cellular 
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structures to support lactogenesis. Several factors, including endocrine regulation, 
spatiotemporal control of cell division and death (apoptosis), regulated turnover of 
ECM components, cell-cell interactions, migration and differentiation, act to 
influence this development (Gumbiner, 1992). 
The mammary gland is an extensively arborized epithelium with a fractal 
geometry (Guarini and Onofri, 1993) embedded within a fatty stroma. The adult 
gland comprises two cellular compartments, that is, the mesenchyme of fatty 
stroma invaded by blood vessels and nerves, and the milk-producing epithelial 
component, comprising ducts and lobules. A basement membrane of type IV 
collagen, laminin and glycosaminoglycans, separates these two tissue 
compartments. The epithelial compartment consists of three mature cell types, the 
myoepithelia, the ductal epithelia and the alveolar epithelia, all of which are 
distinguishable using epithelial specific cell markers (reviewed in Rudland, 1993). 
The mammary ductal system has one or more layers of cuboidal epithelial cells, 
many of which border a lumen that is continuous throughout the gland. As noted 
above, these cuboidal cells are typically surrounded by a layer of elongate 
myoepithelial cells. 
Classically, morphological features have been used to distinguish ductal and 
secretory epithelia from myoepithelia. The two mammary epithelia are 
distinguishable because ductal epithelia exhibits apical microvilli and specialized 
junctional complexes (as well as desmosomes) whereas myoepithelial cells 
typically exhibit smooth muscle-like myofilaments, pinocytotic vesicles and 
basement membrane on their basal surface (Rudland, 1987). 
1.4 Mammogenesis - embryo to puberty 
1.4.1 General features of rodent and ruminant embryonic 
mammary development 
The seminal event in mouse mammary gland formation is lateral to midline 
ectoderm proliferation, resulting in the formation of a mammary band (or streak). 
In mouse embryos, this band is seen between d 10 and d 11 of the -21 day murine 
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gestation (Sakakura et al., 1987) whereas, in bovine, it is observed between d75 
and d85 of a 280-day gestation (Ellis, 1998), that is, relatively earlier than in the 
mouse. Outgrowth of this band produces the mammary line that comprises a line 
of stratified cells representing three layers of epithelium - the surface epitrichium, 
the stratum intermedium and the malphigian layer or stratum germinatarium - as 
reviewed in Ellis ( 1998). After local thickening, the mammary 'hillock' and bud -
mammae precursors - are observed. The mammary bud was originally thought to 
be the product of epithelial proliferation. However, its formation is now attributed 
to epithelial reorganization (Propper, 1978). Mammary bud formation coincides 
with mammary line degeneration. 
The next step in development is proliferation of the mammary bud epithelia to 
form the primary sprout and teats. In ruminants, these result from the 
proliferation of the associated mesenchyme. Secondary sprouts soon emerge from 
the primary structure and, in rodents, both sprout structures (initially solid cords 
of cells) canalise soon after their formation to form open ductal structures. The 
mechanism of canalization is unclear, although in rodents it is assumed that cells 
at the centre of the cords either move outwards or die by apoptosis. This creates a 
hollow precursor ductal structure (Hogg et al., 1983 ). At birth, the mouse gland 
consists of branching hollow tubes that open at the nipple. 
Further embryonic mammary development is achieved by growth of epithelial 
elements into a primary undifferentiated embryonic mesodermal fat pad. Most of 
the fat pad precursors, primarily adipose tissue, fibroblasts, nerves and blood 
vessels, develop posterior to the mammary bud; however, compared to the other 
components, fibroblasts develop in close association with the mammary bud 
proper (Sakakura et al., 1982). 
1.4.2 Mammary development: birth to puberty 
Isometric mammary gland growth, that is, proportional with increased animal 
size, occurs between birth and the onset of puberty at around 3 wks (reviewed in 
Sinha and Tucker, 1966). 
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1.4.3 Mammary development: puberty to involution 
Late in puberty the immature gland grows rapidly to form a ductal system that 
extends to the borders of the fat pad. Between 3 and 12 weeks of age, this 
allometric growth is seen as intense mitotic activity at the mammary end buds, 
that have a specialized advancing edge for fatty stroma penetration (Silberstein 
and Daniel, 1982). Prolactin and progesterone are important inducers of lobular 
budding during this last stage of irreversible gland growth (Horseman, 1999) 
(Figure 1.4 ). This phase of growth is also dependent on the action of estrogen and 
growth hormone, probably through the action of insulin-like growth factor I (IGF-
1), which acts to induce rapid ductal growth with extensive proliferation in the 
TEB - discussed below (Horseman, 1999). 
During pregnancy the glandular epithelia undergoes extensive proliferation in 
response to prolactin, placental lactogens, progesterone and local growth factors 
(Horseman, 1999). 
At parturition, levels of progesterone, estrogen, and placental lactogens, decrease 
sharply so that lactogenesis can proceed. Eventual involution occurs following 
milk stasis, in a signal transducer and activator of transcription (STAT)-regulated 
mechanism that involves a decrease in STATS activity and up-regulation of 
ST AT3 expression (Philp et al., 1996). 
Oxytocin 
ER 
·~ ... • Lac:tallon v r r I 
Newborn Puberty Pregnancy Partur1Uon 
Figure 1.4. Diagram representing progressive steps in mouse mammary development under the 
influence of various hormones (receptor expression and transcription factor involvement is also 
indicated). ER - estrogen receptor, PRL - Prolactin, PRLR - prolactin receptor, inhibin BB, 
C/EBPB, ST AT5a - signal transducer and activator of transcription 5a, PR - progesterone 
receptor, A-myb, cyclin D 1, CSF-1 - colony stimulating factor 1, LAR, Mf3 and oxytocin 
Involution, not pictured here, occurs after lactation ceases and involves upregulation of STAT3 
and downregulation of STATS (redrawn from Hennighausen and Robinson, 1998). 
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The post-involution gland resembles the virgin gland morphologically. However, 
it has been shown to harbour a novel population of epithelial cells, located around 
the terminal end ducts, which survive apoptosis. This was discovered using 
measurements of longevity of cells expressing a Rosa-lacZ reporter construct 
activated by a second transgene (W AP-Cre) during lactogenesis II. These cells 
were also shown to be involved in glandular regrowth during subsequent 
pregnancy (Wagner et al., 2002). 
1.4.4 Human mammary development 
Embryonic mammary development in humans is well characterized. Ectodermal 
thickening produces two lines (extending from the axilla to the groin) by the sixth 
week of embryonic development. Gland formation occurs by the development of 
more than 20 separate ectodermal cords that grow into the underlying mesoderm. 
At birth the gland consists of a primary lactiferous duct that branches into three to 
five secondary ducts that end in TEBs (reviewed in Sell and Pierce, 1994). Before 
the onset of puberty, proliferation of these simple branched ducts occurs. 
Monopodial (from the sides of existing ducts), and dichotomous (at the growing 
tips) branching at the termini of the primary ducts and of lateral end buds, also 
occurs around this time. This allows for the differentiation into small alveolar 
buds that undergo expansion at puberty to form terminal ductal lobular 
units (TDLU). 
During pregnancy the TDLU differentiate rapidly to form alveolar lobules, some 
consisting of upwards of 200 ductules (Russo and Russo, 1987). Distension of 
these alveolar lobules produces the secretory alveoli seen to increase during the 
lactation phase. Post-lactational changes include alveolar involution but, overall, 
the "post-lactation" gland remains in a more differentiated state than that seen 
before pregnancy (reviewed in Rudland 1993). 
Pockets of primitive epithelia exist within adult human glands. It has been 
suggested that these cells may represent either, virginal lobules that have 
remained refractory to endocrine stimulation or, reserves for the replacement of 
degenerating or exhausted glandular tissue (reviewed in Rudland 1993) as shown 
for similar cell populations in the mouse gland (Wagner et al., 2002). 
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1.4.5 Ruminant mammary development 
In cows, a 15-fold increase in the amount of DNA (that is, a cell number 'index') 
in the gland has been measured between 2-3 months of age, with the remaining 
prepubertal period characterized by linear growth (Sinha and Tucker, 1969). This 
is in contrast to the isometric growth seen in the rodent gland in the comparable 
period, that is, the bovine mammary gland grows allometrically (faster relative to 
general growth) between 3 and 9 months. However, between 9 months of age 
and the onset of pregnancy, the bovine mammary glandular epithelium is again 
observed t<;> undergo isometric growth. 
1.5 Comparing ruminant and mouse postnatal gland 
morphogenesis 
Parenchymal morphogenesis in the ruminant mammary gland is thought to 
proceed in a distinct mechanism from that seen in the mouse gland (Hovey et al., 
1999) and this is particularly evident in histological observations (Ellis, 1998). 
Ruminant gland development is, however, similar to that of the human gland with 
ductal elongation by epithelial proliferation of terminal buds in TDLU (Russo and 
Russo, 1987). 
There are significant species differences in the general structure of the mammary 
gland. Perhaps the most significant is that, while the virgin mouse has mainly 
primary and secondary ducts, a few end buds and few alveoli, the bovine 
mammary gland ( and the mammary gland of mammals with a luteal phase in their 
estrous cycle) has a far more developed ductal and alveolar structure. 
The mammary structure of newborn ruminants has a single primary duct 
extending from each teat. The base of this duct undergoes enlargement to produce 
a cavernous cistern while distal regions of the duct branch to form secondary and 
tertiary ducts. These secondary branches undergo further branching to form 
lobular clusters of ductules, similar to the TDLU seen in human glands (Hovey et 
al., 1999). Hence, the bovine gland lacks TEBs; and ductal proliferation and 
advance is achieved via highly arborescent ductal structures embedded within a 
dense fibrous stroma (Ellis, 1998). 
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The mechanism of ductal lumen formation also differs greatly between ruminants 
and rodents. In the mouse, lumen formation occurs by apoptosis of anterior body 
cells within the TEB and is simultaneous with TEB penetration of the fat pad. 
Lumen formation in ruminants, where ductal apoptosis is rare (Molenaar et al., 
1996), is thought to occur by the coordinated and simultaneous separation of 
already formed (closed) ducts within an entire TDLU. The duct aperture size 
seems to be limited by constraints imposed by both neighbouring TDLU, that are 
undergoing similar separation, and by the surrounding dense connective tissue 
(Ellis, 1998). Expression of both Netrin-1 and its receptor, neogenin, has been 
shown to be important in the partitioning of mouse cap cells (discussed below) 
from the lumenal space, with elimination of either gene resulting in a disorganized 
TEB (Srinivasan et al., 2003); the importance of this adhesion interaction in 
bovine lumen formation has not yet been examined. 
Studies of ruminant mammogenesis, approached through examination of mouse 
models must, therefore, consider the fundamental, and sometimes dramatic, 
differences that exist between the two species. 
1.5.1 Rodent and ruminant gland structural comparison 
Different requirements for glandular support are thought to account for many of 
the anatomical differences observed in rodent and ruminant mammary glands. In 
ruminants, ductal growth is seen in "veins" throughout the network of fibroblasts 
within connective tissue (CT). These "veins" penetrate the adipose tissues of the 
mesenchyme, forming septa of rope-like cords. In contrast, ductal growth in the 
mouse occurs with the ducts directly abutting the adipose tissue. Hovey (1999) 
suggests that, in the ruminant, the extensive network of CT coupled with major 
ligaments provides structural support for the entire gland, a feature that is not 
required in the mouse, where the flattened glands lie directly adjacent to the 
underside of the animal. A table showing anatomical and developmental 
differences between the murine, bovine and human glands is presented 












Mammary streak in 
embryo at d10-11. 
Around d20, fat pad is 
seen. A collection of 
hollow branching ductal 
tubes opening at 
the nipple 
Simple branched anlage 
of ductal components 
Between 3-12 wks 
allometric growth is 
seen. Ductal elongation 
continues to form 
sparsely branched ductal 
network 
Development continues 
and ducts fill the entire 
mammary fat pad 
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Ruminant 
Mammary streak is 
first seen around d80. 
At birth a single 
primary duct extends 
from the teat 
Base of the primary 
duct enlarges to form a 
gland cistern while 
distal regions divide to 





Clusters of ductules 
arising from larger 
ducts are formed. 
Pronounced lobule 




7-8 wks post 
conception. Wks 12-
16: groups of cells 
begin · to branch, 
forming primitive milk 
ducts late in 
pregnancy 
Proliferation of simple 




3-4 years of growth 
form mature structure 
comprising 15-20 
lobes {TDLU) that 
meet the nipple via 
milk ducts. Similar to 
structures seen in 
ruminants 
Allometric growth is A limited amount of 
maintained for the first ductal branching 
few estrous cycles occurs 
Extensive branching and Allometric 
alveoli formation occurs returns 
growth Terminal ductal 
regions differentiate 
rapidly to form 
alveolar lobules 
to give secretory 
potential 
Terminal differentiation 




by extensive apoptosis, 
returns the entire gland 
back to state of the 
mature virgin 











alveoli that allow for 
milk production 
Alveolar involution 
Table 1.1. A table of comparisons between developmental and anatomical features of ruminant, 
human and rodent mammary glands. Sources: Tucker ( 1987), Sell and Pierce ( 1994 ), 
Hovey ( 1999). 
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1.6 Endocrine regulation of mammary growth -
stromal contribution 
The importance of the stroma in directing epithelial branching morphogenesis has 
been demonstrated by tissue transplantation experiments, in particular those 
involving transplantation of salivary and mammary epithelia (interchanged 
between their native stromal environments). It has been shown that, regardless of 
the origin of the epithelial transplant, growth matched that expected for the 
associated stromal type present. This clearly showed that stroma had a major 
controlling affect on epithelial branching and general duct growth (Sakakura et 
al., 1976; Sakakura et al., 1987). The mechanism whereby undifferentiated 
epidermal cells are directed to differentiate and form mammary epithelia is 
thought to involve hormonal signals in a mesenchymal-epithelial communication. 
This communication has been implicated as having a significant influence during 
fetal glandular development (Cunha, 1994; Cunha and Hom, 1996). 
Significantly, the size of the fat pad or, specifically, the amount of adipose in the 
fat pad, determines the number of epithelial cells found in the gland and, 
therefore, has a direct correlation with the potential for milk production (Hovey et 
al., 1999). 
The hormonal milieu involved in directing mammary development is complicated. 
For normal fetal mammary development there is a requirement for the metabolic 
hormones (insulin, growth hormone, the thyroid hormones, and glucocorticoids) 
and others such as the insulin-like growth factors: IGF-1 (Kleinburg, 1998) and 
IGF-11 (Manni et al., l 994 ), as well as fetal growth hormone (FGF) (Barraclough 
et al., 1990). This highlights the importance of mesenchymal-ectodermal 
communication in normal gland formation and maintenance (discussed below). 
In the mouse, estrogen encourages ductal growth and TEB formation from ducts 
while progesterone causes the differentiation of alveolar structures. Implant 
experiments have shown that estrogen acts, both locally and systemically, to 
regulate epithelial growth via stromal epithelial interactions and/or growth factor 
production (Haslam, 1988). Associated experiments have shown that estrogen-
responsiveness required the presence of stromal cells (Haslam, 1988) and that the 
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majority of TEBs and ductal epithelial cells lacked estrogen receptors (Zeps et al., 
I 998). Locally, the basal 'B cells', which are considered to be mammary stem 
cells, in the resting gland differentiate into 'Clear' A cells under the influence of 
estrogen (Chepko and Smith, 1998). 
Negative mediation of ductal growth is thought to occur via the action of a 
number of factors, including transforming growth factor-~ isoforms (TGF-8). 
Experiments using slow release implants releasing TGF-~ 1 showed inhibition of 
ductal growth in a murine model - observed as reduced thymidine labelling 
(Silberstein and Daniel, 1987). A similar inhibitory affect has been observed in 
experiments in ruminants (Woodward et al., 1995). 
A model describing the contribution of various stromal, ovarian and pituitary-
derived hormones to the progression of epithelial invasion of the fat pad has been 
presented by Hovey ( 1999) (see Figure 1.5). 
Ovarian steroids Mammogenic hormones 
0 0 0 0 0 0 
Epithelium 
Figure 1.5. A schematic showing hormonal control of mammary epithelial growth. Three levels of 
regulation, from the pituitary, ovaries and the stroma itself are implicated in the regulation of 
mammary epithelial growth. GF - growth factors, BM - basement membrane (redrawn from 
Hovey et al., 1999). 
In summary, hypophyseal and ovarian hormones, coupled with local stromal 
hormones, interact in murine mammogenesis. Similar endocrine regulation is 
thought to be responsible for ruminant mammogenesis (Ellis, 1998). Studies of 
branching morphogenesis of the mammary cell line 1-7 HB2 have demonstrated 
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the importance of the fibroblast-derived morphogenic growth factors, including 
hepatocyte growth factor/scatter factor HSF/SF and various other fibroblast 
derived growth factors (Berdichevsky et al., 1994), in this process. Furthermore, 
a role for matrix metalloproteinases (MMPs) has been demonstrated in collagen 
gel culture studies, where inhibitors of MMPs eliminated branching 
morphogenesis but did not directly affect epithelial proliferation (Simian et al., 
2001). 
1. 7 The Terminal End Bud {TEB) 
The TEB is the generator of new epithelial tissue for mammary ductal formation 
and progression. The tip, flank and neck regions of the TEB are covered in an 
epithelial monolayer of 'cap' cells. These are stem cells that characteristically 
lack specialized features (such as intercellular junctions). Ductal penetration and 
the formation of a myoepithelial 'sleeve' around the duct, is effected by apical cap 
cell proliferation, while ductal elongation results from the formation of ductal 
epithelia achieved by the proliferation of 'body cells' within the luminal region of 
the TEB beneath the cap cell zone (Williams and Daniel, 1983). TEB structures 
are functional until the end of puberty, when the ductal network approaches the 
edges of the fat pad, at which time they are permanently replaced by terminal end 
ducts (TED) and alveolar buds (Topper and Freeman, 1980; Williams and Daniel, 
1983). 
The stem cell characteristics of cap cells has been demonstrated by histochemical 
and immunohistochemical staining that shows weak staining for markers of 
differentiation in cap cells and in a subset of body cells. Specific 
immunocytochemical staining for epithelia, using monoclonal antibodies (MAbs) 
to MFGM, anti-EMA and peanut lectin (PNL), produces a graded staining pattern 
with the loosely-packed apical peripheral cells showing weak staining that 
becomes stronger closer to the centre of the TEB. Myoepithelia specific markers, 
including antibodies to keratin, PKK2 and LP34, smooth muscle actin, myosin 
and vimentin (Rudland, 1991 ), stain the apical cells similarly to the epithelial 
markers described above. Staining becomes more intense in these peripheral cells 
more posterior to the apex of the TEB, and finally shows maximal intensity at the 
myoepithelia of the subtending duct of the TEB (Rudland, 199 l ). The cap cells at 
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the apex of the TEB stain positive, although weakly, for both myoepithelial and 






Figure 1.6. Schematic of a TEB in mouse mammary showing specific staining for myoepithelia 
and epithelia. Epithelial specific markers (MAbs to MFGM, anti-EMA and PNL) and 
myoepithelial specific markers (histochemical staining of Smooth muscle actin and BM proteins) 
(Rudland, 1993) reveal the relative location of different epithelia formed in the advancing duct by 
intensive mitosis of the cap cells. Although these apical peripheral cap cells stain weakly to 
moderately for both sets of markers, the epithelial specific markers stain the cortical cells most 
intensely while the myoepithelial markers stain peripheral cells with a gradual increasing intensity 
towards the subtending ductal myoepithelia (Lochter, 1998). (Drawn from sources in Lochter, 
1998; Rudland, 1993). 
Primary culture assays, involving immunomagnetic separation of epithelial and 
myoepithelial lineages, showed that while pure cultures of myoepithelial cells did 
not interconvert to ductal/secretory type epithelia, a portion of these cells did 
differentiate into myoepithelia cell types (Pechoux et al., 1999). This 
demonstrates that the two lineages share a common progenitor stem cell, and that 
the epithelial type is more plastic than the myoepithelial type, presumably because 
myoepithelia represents a more terminally differentiated cell type. 
Direct evidence for the existence of mammary stem cells in the TEB includes 
chemical carcinogen studies that revealed a correlation between the presence of 
TEB and predisposition to cancer in the mammary gland. The effective 
carcinogenicity of chemical carcinogens (for example, 7, 12-
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dimethylbenz[a]anthracene [DMBA] and N-nitrosomethylurea) in rodents 
decreases 50 days postpuberty. In humans this developmental stage coincides 
with a natural decrease in TEBs (as they differentiate into alveolar bundles and 
terminal ducts) in the gland (Russo and Russo, 1978). McGregor (1977) found 
that prepubertal and adolescent women, ages characterized by high amounts of 
I 
breast ductal formation, were the group most susceptible to radiation-induced 
breast carcinoma in Hiroshima and Nagasaki. 
1.7.1 Apoptosis in the TEB 
Apoptosis plays a critical role in ductal growth phase. In a study of apoptosis 
within the TEB during growth, Humphreys ( 1996) demonstrated that while only 
7.9% of the rapidly dividing proliferative cap cells were undergoing apoptotic 
processes, up to 15% of cells in the three layers of body cells immediately 
adjacent to the lumen were apoptotic. Therefore, levels of apoptosis during 
development are higher than that observed during either involution or pregnancy, 
with 4% and 5% of cells in the TEB affected in each state, respectively (Li et al., 
1996; Quarrie et al., 1995). Moreover, other developing tissues typically display 
far lower levels of apoptosis than that observed in the TEB; kidney displays 3% 
(Coles et al., 1993), and optic nerve 0.25% (Barres et al., 1992) apoptotic cells 
during normal development. Humphreys ( 1996) states that the significance of 
these relative levels of involvement must be viewed against the normally low 
background levels of apoptosis in quiescent cells ( of only 0.1 to 1 % ). 
In embryogenesis, rodent gastrulation is thought to be regulated by an apoptotic 
signal from the endoderm that communicates with cells within the developing 
embryo to cause cavitation. Cells that are anchored to the basement membrane 
escape the apoptotic response to this signal (Coucouvanis and Martin, 1995). 
Considering this work, Humphreys ( 1996) suggests that positional sensing, 
relative to both the TEB and to its environment, is critical to apoptotic signalling 
within the TEB and that tubular morphogenesis may occur by a mechanism 
similar to that seen in the early embryo. 
Patterns of apoptosis m the ruminant mammary gland are thought to be 
substantially different from those in the rodent mammary gland. Molenaar ( 1996) 
reported low numbers of apoptotic cells in virgin ewe mammary glands and 
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emphasised that the observed numbers of apoptotic cells were much lower than 
that seen in comparable murine glands. Ellis (1998) suggests that this observation 
may reflect interspecies differences in lumen formation mechanics, as outlined in 
the gland comparison above (Table 1.1 ). 
In summary, the terminal end bud is a dynamic structure via which ductal 
extension occurs by coordinated processes of proliferation and apoptosis. 
1.8 Ductal branching of parenchyma 
Branching parenchymal morphogenesis in the mouse has been divided into three 
distinct processes. First, the entire gland is populated by increased linear ductal 
length. Next, dichotomous branching occurs to expand the parenchymal area. 
And, finally, the growth of collateral duct segments fills any remaining areas 
(Ormerod and Rudland, 1984). Ellis (1998) stressed the importance of massive 
amounts of epithelial proliferation to provide the 'building blocks' for such 
growth, and this behaviour is examined below in a review of mammary stem 
cell biology. 
1.9 A model of mammary development by epithelial 
outgrowth - stem cell candidates 
1.9.1 Stem cells and division competence in 
mammary development 
As in most mammalian tissues, a fine balance of cell death and proliferation in the 
mammary epithelial population is crucial for normal growth. Studies of the 
human gland showed that multiple rounds of oestrus do not lead to a huge 
accumulation of mammary tissue (Ferguson and Anderson, 1981 ). This implies 
that the activity of mammary stem cells, that is, those cells capable of responding 
to critical developmental timepoints by producing new epithelial cells, is balanced 
by apoptosis. Indeed, it is known that apoptosis removes much of the excess 
epithelial population produced during menses (Potten and Loeffler, 1990). 
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Triated thymidine ([3H]dThd) labelling of virgin female rats (by intra-peritoneal 
injection), allows detection of actively dividing (DNA synthesizing) cells and has 
identified a population of cells (the cap cells) in mammary terminal end buds that 
produce separate lineages for luminal and possibly myoepithelial cells (Dulbecco 
et al., 1982). This implies that stem cells are responsible for ductal elongation 
into the fat pad. The ubiquity of these stem cells in the gland was indicated by 
transplantation studies where it was shown that cells taken from any part of the 
mammary gland could repopulate the epithelia-free fat pad (Smith and Medina 
1988). This represents clear evidence for the existence of a ubiquitous population 
of 'resting' cells that have the potential to act as stem cells within the mammary 
epithelial cell population. 
Smith and Medina (1988a) have characterized the 'repopulating ability' of 
mammary epithelial components using a combination of autoradiographic, 
immunohistochemical and various morphological criteria, in conjunction with 
transplantation experiments involving different portions of the murine mammary 
gland. Mammary stem cells were defined as 'uncommitted mammary cells' that 
have the potential to divide by mitosis to produce committed cell progeny without 
the total loss of their own uncommitted status. The work showed that indigenous 
mammary epithelia become division-defunct after a finite number of cell 
divisions. The same authors found 'pale staining' mammary cells that: 1) were 
present at all stages of development, 2) divided soon after being placed in culture, 
3) were connected by desmosomes and hemidesmosomes to their neighbouring 
cells. This was important as it indicated that they were not simply "wandering 
lymphocytes", and 4) produced daughter cells that functionally differentiate in the 
presence of lactogenic hormones. Therefore, the cells displayed the 
characteristics expected of stem cells (Smith and Medina, 1988a). 
Christov (1993) used bromodeoxyuridine (BrdU) labelling in virgin BALB/C 
mice to identify three division-competent cells in each gland that contributed to 
epithelial growth. Smith (1996) observed that, in the progeny of a pool of 5 X 103 
transplanted p-galactosidase expressing mammary epithelial cells, lobular, ductal 
and combined lobulo-ductal populations could be observed in an epithelial-free fat 
pad. These experiments suggest that, while some division-competent mammary 
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stem cells are committed to ductal growth and some to lobular growth, a third cell 
type, which is able to produce both ductal and lobular progeny, may exist. 
A more precise identification of these stem cells was carried out by Christov 
( 1993) who used the presence of condensed chromosomes, as markers of division 
competence, to establish a model of epithelial cell hierarchies in the murine 
mammary gland. This model describes three division-competent epithelial cell 
populations and states that the Small Light Cell (SLC) - synonymous with the cap 
cell, the suspected mammary stem cell - differentiates into the terminally 
differentiated mammary cells (both secretory and myoepithelial) after passing 
through two precursor stages. SLC were seen to lose their division competence as 
they acquired signs of differentiation (such as lipid droplets and desmosomes). 
These SLC represent about 3% of the total mammary epithelial population and are 
characterized by naked chromosomes, that is, chromosomes that lack extensive 
transcriptional machinery. These cells do not exhibit secretory potential due, in 
part, to absence of luminal contact (Chepko and Smith, 1997). 
According to the proposed model, a subset of the Undifferentiated Large Light 
Cells (ULLC) secondary progenitor cells eventually differentiate into 
Differentiated Large Light Cells (DLLC) and finally to functional secretory 
epithelia while the remaining ULLC differentiate into pre-myoepithelial cells for 
ultimate terminal differentiation into functional myoepithelia (Figure 1.7). 
The proposed model for the production of functional differentiated cells in the 
mouse is supplemented by results obtained in [3H]dThd studies of human breast 
tissue. Such studies indicate that basal clear cells (the human SLC analogs) divide 
frequently, and that the myoepithelia originates from a precursor within the 
mammary epithelium after a number of cellular divisions of the precursor cell 
(Joshi et al., 1986). 
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Figure 1.7. Schematic of suggested hierarchies of division competent stem cell to functionally 
differentiated cell in mammary tissue. SLC - small light cells, ULLC - undifferentiated large light 
cell , DLLC - differentiated large light cell. DSC - differentiated secretory cell (Adapted from 
Chepko and Smith, 1997). 
This work is confirmed by other [3H]dThd studies. Zeps (1996) found that, while 
50% of mouse mammary cells were labelled after three injections, most of this 
signal was lost after two weeks (by halving kinetics) but a small portion of cells 
(varying regionally between 1 in 50 and 1 in 1000 cells) retained a [3H]dThd 
signal. The authors suggest that this population of cells represents the slowly 
dividing functional mammary precursors that were first described by Potten and 
Loeffler ( 1990). 
The primary progenitor (SLC) cells, proposed in the Chepko and Smith model, 
were shown to be capable of multiple cellular divisions before becoming 
committed to a particular differentiation pathway. These division-competent (and 
differentiation-committed) primary progenitor SLC divide by cytokinesis 
(perpendicular or parallel to the basement membrane) to produce secondary 
progenitor ULLC. Typically, perpendicular division is symmetrical and produces 
two secretion committed ULLC (or two SLC). In contrast, parallel division is 
asymmetrical and produces both a pre-myoepithelial cell and a progenitor ULLC. 
The outcome of these divisions seems to hinge on the orientation of the cleavage 
furrow and the timing of division (Figure 1.8). 
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Figure 1.8. Possible stem cell division strategies in mammary organogenesis - predicted by the 
model described by Chepko and Smith ( l 997). A) Symmetric division of a stem cell (SC; blue) 
occurs to produce two identical SC (green) in the population of a tissue compartment, B) 
Asymmetric division of a SC to give a more terminally differentiated daughter cell or TA cell 
(yellow) and another SC, and finally C) symmetrical division to give two TA cells with exhaustion 
of stem cell potential. Each of these division strategies are thought to occur during 
mammary organogenesis. 
Cells resembling SLCs and LLCs have been described in human (Ferguson, 
1985), bovine (Nickerson et al., 1982), and in ovine mammary tissue (Ellis et al., 
1995). The fact that these undifferentiated cells are found in a number of species 
lends support to the notion that they possibly exist as stem cells in the 
mammary gland. 
Recently, three distinct progenitor populations - luminal-restricted, myoepithelial-
restricted and bipotent - have been identified in human mammary tissue (Stingl et 
al., 2001 ). The authors used single cell culture system to show that a portion of 
cells in the human mammary gland population were bipotent and capable of 
generating each of the other lineages (luminal and myoepithelia) in culture. 
Furthermore, they proposed that each of the cell types observed in the human 
population may be directly analogous to the cells observed in the mouse 
mammary, as has been proposed previously (Kordon and Smith, 1998; Smith and 
Medina, 1988a). 
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1.10 Clonality studies 
Cellular clonality, the phenomena of proliferation by a subset of tissue-type 
determined stem cells that ultimately populates a tissue compartment within a 
mammalian organ, has been examined by a number of experimental strategies. 
Inactive X chromosome based techniques are the most widely used methods for 
the study of cellular clonality. Other experimental approaches to the assessment 
of clonal structures include cytogenetic analysis, tracking somatic mutants in vivo, 
and retroviral integration (reviewed in Wainscoat and Fey, 1990). X chromosome 
inactivation based assays have aso been used in tumour clonality studies where 
they are used to distinguish clonal tumour tissue from normal (presumed 
polyclonal) tissue in adjacent tissues (Busque et al., 1996). 
1.10.1 Types of clonality assays 
There are two primary methods employed to observe clonality in the tissues of 
female eutherian mammals, that is: 1) examination of pre-existing variation (for 
example differences between alleles) on the X chromosome, and 2) examination 
of introduced variation. The latter includes the observation of tissues within 
chimeric and transgenic animals, as well as animals manipulated by retroviral-
mediated introduction of cellular markers. 
1.10.1.1 Protein histochemistry method 
The protein or histochemical method, developed by Fialkow (1973), is used in 
vitro (gel-based) analysis of glucose-6-phosphate dehydrogenase (G6PD) 
isozymes to distinguish particular patterns of X chromosome inactivation 
throughout a tissue. While a simple technique, because of the infrequency of the 
G6PD variant - with only 1 % of the Caucasian and 30% of the African population 
informative (Beutler et al., 1967) - its application is limited to just a small subset 
of the general population. 
1.10.1.2 DNA and RNA based methods 
DNA and RNA based methods rely on naturally occurring allelic differences in X-
linked genes. Vogelstein ( 1985), devised an RFLP strategy based on the detection 
of a variable number tandem repeat (VNTR) m the hypoxanthine 
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phosphoribosyltransferase (HPRT) gene for the assessment of clonality in human 
tumours. This technique makes use of the fact that the inactive X chromosome is 
modified by methylation whereas the active chromosome remains unmethylated. 
By using methylation-sensitive restriction endonucleases, the paternal and 
maternal chromosomes can be distinguished. 
Since their first description by Vogelstein (1985), polymorphisms within the 
human androgen receptor (HUMARA) gene have been widely used as cellular 
clonality markers. This gene exhibits an 11-31 unit VNTR. In order to assess 
clonality using this loci, regions of interest are first micro-dissected from tissue 
sections on glass microscope slides and the DNA extracted and digested using a 
methylation-sensitive restriction enzyme (usually Hpa II). Next, the region 
containing the VNTR is amplified by PCR and the products electrophoresed by 
polyacrylamide gel electrophoresis (PAGE). A densitometric analysis of the 
bands is performed and the relative amounts of each allele determined (Figure 
1.9). This assay is widely used because the majority (86%) of individuals are 
heterozygous for the VNTR (Gale et al., 1996). 
1 Differentially methylated X-linked VNTR element 
2 Digest DNA with methylation-sensitive restriction enzyme and PCR amplify 
VNTR region with flanking primers 
: .. ~ .-~\~--:-
3 [-A 7 -c I 
Figure l.9. Showing cellular clonality measurement by discrimination of an X-linked Variable 
Number Tandem Repeat (VNTR). I) Different choice of methylated inactive (Xi) and 
unmethylated active (X.) X chromosomes in two different cells within the same tissue, 2) x. is 
unmethylated and, therefore, digested with a methylation-sensitive restriction enzyme (such as 
Hpa II). PCR is carried out to amplify the intact Xi VNTR region which, because it is methylated, 
remains undigested. 3) The resultant PCR products are electrophoresed on an acrylamide gel in 
order to discriminate the products by size. Monoclonality is evident when one band is seen while 
polyclonality is assumed when two bands are observed in a single lane. 
The X-linked phosphoglycerate kinase (pgk) gene has often been used in X-
inactivation assays. PGK has 8 Hpa II sites located close to a Bst XI restriction 
Chapter One Literature Review 25 
enzyme polymorphism (PM) at the 5' of the gene. Assays based on the pgk gene 
allow for the analysis of very small (::::::100) populations of cells (Gilliland et al., 
1991). 
1.10.1.4 Retroviral incorporation 
Engelhardt ( 1995) used retroviral incorporation as a marker of cell lineages 
involved in sub-mucosa] salivary gland development (in constructs comprising 
lacZ, or alkaline phosphatase, under the control of cytomegalovirus [CMV] 
enhancer). These methods allowed the resolution of X-inactivation profiles and, 
therefore, clonality within a transfected tissue. Such studies have limited 
informative regions m a tissue due to the small areas infected by an 
introduced retrovirus. 
1.10.1.5 General chimeric animal studies 
Manipulation of mouse blastocysts can also yield useful animal models within 
which clonality can be examined. Specifically, the examination of a combination 
of two lineages of cells throughout a chimeric animal provides investigators with 
a tool by which to examine the clonal profile of a tissue. A requirement for such 
studies is that cells derived from each parental lineage can be distinguished by 
histochemical techniques. 
By utilizing mice that are chimeric for electrophoretic variants of NADP-
dependent isocitrate dehydrogenase, the developmental history of skeletal muscle 
myotubes was shown to be via cell fusion rather than by acytokinesis (Mintz and 
Baker, 1967). Furthermore, coat colour markers have been used to show that skin 
epithelia has its origin in 64 randomly arranged progenitor cells which 'stream' 
from the neural crest to populate the nascent skin epithelial zone (Wolpert and 
Gingell, 1970). 
The timing of paternal chromosome inactivation in extraembryonic tissue has 
been studied using an elegant assay with chimeric mice produced by the injection 
into blastocysts (of a sandy coat coloured strain) of cells exhibiting an X-linked 
translocation (Cattanach's translocation) 3 or 4 days post-coitum. An 
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examination of the resulting coat colour patterns revealed that X-inactivation had 
not taken place by embryonic d4 (Gardner and Lyon, 1971). 
The experiments described above show the utility of chimeric animals in clonality 
assays. Similarly, one would expect transgenic animals that are heterozygous for 
an X-linked marker gene (and accordingly displaying mosaic patterns of 
expression throughout a model animal) to be equally informative. 
1.10.1.6 Limitations of existing techniques for clonality assessment 
X chromosome based clonality assessment takes advantage of the inactive-X 
choice mosaicism throughout an animal. As the choice of inactive X chromosome 
is random and early (occurring in the committed stem cell), and because daughter 
cells from a single stem cell maintain the same inactive X chromosome as their 
parent cell, different populations (clones) of cells in female animals have either X 
chromosome inactivated, that is, are mosaic for chromosome choice. This random 
choosing results in different clones within a tissue that each exhibit a particular 
inactive X chromosome. 
The single most important requirement in an X-based clonality assay is that each 
parental chromosome, that is, paternally-derived X (Xp) and maternally-derived X 
(Xm), can be distinguished. As detailed above (section 1.10.1 ), this can be 
achieved either through examination of the methylation (inactivation) status of 
variable length loci on the chromosome, by distinguishing differential expression 
of variable regions (at the transcript level), or by examining isozymes of proteins 
produced by the expression of genes containing polymorphisms. 
In the STR ( or VNTR) clonality assessment method ( described in section 
1.10.1.2), monoclonality for either allele is assumed when a single product is 
observed after electrophoresis and polyclonality when double bands (that is, both 
allele amplification products) are seen (Figure 1.9). A prerequisite for such 
experiments is that both parental alleles have been genotyped and that the animal 
under study is heterozygous for the polymorphism examined. 
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This technique, while elegant in its simplicity, has several failings. The most 
important is the potential for sampling error caused by the inclusion of non-target 
cells in the tissue isolated for DNA extraction. In the literature, such introduced 
error is seen in contrasting assessments of clonality of human mammary tissue, 
such as that detailed in the human mammary clonality studies below, where 
measurements of the clonality of the same tissue type give different 
clonal profiles. 
Another failing of existing approaches is that such techniques are exclusively in 
vitro and, therefore, provide little direct anatomical framework by which to 
determine the significance of clonal regions within a tissue. Accordingly, Garcia 
et al. (2000) has identified in situ assessment as being a crucial 'next step' 
required for further understanding of tumour cellular clonality. 
For the present study a novel alternative approach, that examines an X-linked 
single nucleotide polymorphism (SNP) in heterozygous animals as a means of 
discriminating allelic differences, and therefore of determining clonality within 
tissue niche, was designed and applied. As detailed in Chapter 3, the bovine 
experiments used a polymorphism of the bovine X-inactive Specific Transcript 
(XIS]). Accordingly, details of XIST, its expression and transcriptional 
regulation, and its involvement in establishing the inactive X chromosome are 
discussed below. 
1.11 X-inactive Specific Transcript (X/57) 
1.11.1 Inactivation of an X chromosome as a mechanism for 
dosage compensation 
In observations of mature nerve cells in female cats, Barr ( 1949) observed a well 
developed 'nucleolar satellite' that was almost always absent in male animals. 
This morphological marker was found to be a reliable indicator of sex which, the 
author determined, could be readily ascertained from observation of any suitably 
stained tissue section, where the condensed chromosomal body (Barr body) was 
seen on the inner cell membrane. 
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In her seminal work, Lyon ( 1961) proposed that random inactivation of one X 
chromosome in the stem cells of female mammals is responsible for dosage 
compensation of X-linked genes between the sexes. This inactivation effect 
would produce a mosaicism of inactive X chromosome choice throughout 
an animal. 
According to the Lyon hypothesis, X inactivation involves random inactivation of 
one X chromosome in the stem cell, and this inactivation decision is maintained 
throughout a stem cell clone (that is, a stem cell and its daughter cells). This 
effect, known as Lyonization, produces a heterochromatinized, hypoacetylated, 
hypermethylated and condensed chromosome that is almost exclusively 
transcriptionally inactive (Lyon, 1961, 1992). 
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Figure I.IO. A diagram showing l) the approximate location of the Xist gene on the mouse X 
chromosome, 2) a graphic of the murine XIC and 3) a schematic representation of the Xist gene 
itself. The gene was initially thought to include 6 exons encoding a 15 kb transcript (Brockdorff et 
al., 1992) but was described in 1999 as comprising 7 exons (I-VII) with 7 possible 
polyadenylation signals (A0 ) having a transcription product of 17.4 kb (Hong et al. , 1999). An 
eighth exon in the mouse has also been putatively identified but was not included in the diagram 
due to lack of experimental proof of its existence (Chureau et al. , 2002). Finally, 4) the recently 
sequenced bovine XIC, a 233 kb Bacterial Artificial Chromosome (BAC), including the two genes 
discovered in this region (Xist and Jpx) is included for comparison. (This figure was drawn from 
the three sources referenced within the caption: Brockdorff et al., 1992; Chureau et al. , 2002; 
Hong et al., 1999). 
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Such chromosome-wide inactivation is mediated by the X-inactive Specific 
Transcript (Xist) (Figure 1.10). During X-inactivation, Xist is expressed only 
from the chromosome destined for inactivation, and the gene product (RNA) coats 
the same chromosome in a cis-acting manner that contributes to the silencing of X 
chromosome gene expression. 
1.11.2 Timing and nature of X-inactivation 
X inactivation timing studies have measured the relative amounts of X-linked 
gene products produced at different embryonic stages in male and female 
heterozygous mice. Kratzer and Gartler (1978) used mouse litters (with an 
approximate male to female ratio of l: 1) to show bimodality of hypoxanthine 
guanine phosphoribosyltransferase (HGPRn activity until the eight cell morula 
stage. This was followed by X inactivation, indicated by a gradual movement to 
unimodal activity (that is, single gene expression), occurring at blastulation. 
Tissue-specific differences in the onset of X-inactivation are known to occur in 
mouse extraembryonic tissues. Observations of female mouse embryos that are 
heterozygous for Cattanach's translocation (In7;X) indicated that mouse 
extraembryonic tissues show an inactivation bias for the paternal X chromosome 
(Takagi and Sasaki, 1975). Experiments with mouse embryos lacking paternal X 
chromosome showed that one of the two 'maternal-type' X chromosomes was 
inactivated in extraembryonic tissues (Rastan et al. 1980). This suggests that 
while the choice mechanism of an inactive chromosome in this tissue normally 
selects the paternal chromosome for inactivation, the presence of this 
chromosome is not an absolute requirement for successful inactivation and 
chromosome counting. 
Xist expression has been detected at very early stages in embryonic development. 
Avner (2000) used RT-PCR to show the presence of Xist mRNA at day 4 of 
embryonic development. This correlates with non-random X-inactivation in 
extraembryonic tissues, that is, preferential extraembryonic paternal X 
inactivation, which is completed by 3.5--4.5 days post conception (dpc). The 
same authors also showed that Xist expression was maternally imprinted until the 
blastocyst stage, at which time expression became random (Avner et al., 2000). 
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1.11.3 Levels of XIST/Xist transcript 
Quantitative RT-PCR has shown that, in the kidney of both the adult mouse and 
the 7 .5 dpc mouse embryo, there are less than 2 X 103 Xist transcripts per cell 
(Buzin et al., 1994 ). Such low expression levels are intriguing as they indicate 
that the Xist transcript is not expressed in sufficient quantities to coat the entire X 
chromosome (the mouse X chromosome is approximately 1.5 X 108 bp so at least 
7000 15 kb transcript copies would be required for complete linear coverage). 
This low copy number suggested that Xist expression may be the consequence of 
X chromosome inactivation rather than being an integral part of its causative 
mechanism (Brockdorff et al., 1992; Brown et al., 1992). Subsequently, however, 
this theory has been disproved by experiments with Xist knock-out animals that 
demonstrated that Xist is crucial to normal X chromosome inactivation 
(Marahrens et al., 1997; Penny et al., 1996). 
1.11.4 XISTI Xist mode of action 
The Xist transcript associates with and coats the inactive X chromosome, and it 
has been suspected that the transcript may interact via certain consensus 
sequences along its length (Clemson et al., 1996). There are several features of 
the Xist transcript that suggest functional domains within its sequence. Both the 
human and mouse XIST/Xist cDNAs are long (19.3 and 17.8kb respectively, Hong 
et al., 1999; Hong et al., 2000) and no evidence for conserved open reading 
frames (ORF) within the gene has been found (human - Brown et al., 1992; mouse 
- Brockdorff et al., 1992). Furthermore, peptide nucleic acid (PNA) studies that 
eliminated normal Xist transcript function in mouse cell culture, have 
demonstrated that the target Xist transcript contains sites whose disruption results 
in loss of X-inactivation. While having no effect on steady state levels of Xist in 
treated cells, the addition of one particular PNA (as a PNA-transportan conjugate) 
resulted in the complete loss of X inactivation. The binding site of the effective 
PNA-transportan was found in 'region C' (antisense PNA sequence: 
aaattccatgactctagaa), the third of four repetitive stretches corresponding to a 
region at the 5' end of exon 1 of the gene (Beletskii et al., 2001). Binding of the 
PNA-transportan within region C was shown to eliminate histone mH2A 
association with the inactive X chromosome, and caused the loss of localized Xist 
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RNA and the loss of an observable Barr body. This study was the first to 
demonstrate that the Xist transcript is organized into functional domains. 
Immunoprecipitation experiments have shown that the Xist transcript associates 
specifically with hypoacetylated chromatin, often co-localizing with the 
hypoacetylated histone H4 at the promoters of X-inactivated genes. This suggests 
that the transcript acts directly in silencing X-linked genes (Gilbert et al., 2000). 
1.11.5 Nonrandom X chromosome inactivation and skewing 
Clonality experiments assume fidelity of X inactivation, that is, that X 
chromosome inactivation has taken place randomly throughout all tissues. 
However, some experimental evidence suggests that this pattern may not always 
be present. Busque ( 1996) tested X-inactivation ratios of 295 human females 
using a human androgen receptor gene (HUMARA) based assay on blood cells and 
found that significantly increased skewing of chromosomal choice was correlated 
with advancing age. Some 37 .9% of individuals aged 60 years and older showed 
chromosome-choice skewing, while only 8.6% of neonates exhibited some degree 
of skewing. In this same study, the total pool of blood stem cell progenitor 
number was calculated to be between 8 and 16 cells. This estimate, reached by 
stoichiometric calculation using skewed inactivation patterns in neonates, agrees 
with those for other tissues and suggests that X chromosome inactivation occurs at 
an early stage in embryogenesis before determination (Fialkow, 1973). 
Analyses of organ morphogenesis using X-linked markers for inactivation are 
more informative if the size of the stem cell pool present at the time of 
inactivation is known. Estimates of the size of this progenitor population have 
been made. Puck ( 1992) examined skewing in neonatal mice and estimated that a 
pool of between 10 and 20 cells were present at the time of inactivation, while 
Montiero ( 1998), using simulation studies, estimated that between 4 and 16 cells 
were present at the time of X chromosome inactivation. Both of these suggestions 
reflect the findings of X-inactivation timing experiments (Kratzer and Gartler, 
1978), where bimodal expression of the X-linked gene hgprt was shown to occur 
until the 8-cell (morula) stage. 
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Ohno ( 1967) predicted that each adult tissue in mammals must have arisen from a 
small number of progenitors (reviewed in Migeon, 1998). Accordingly, 
inactivation events (even if truly random) acting on this small population of cells 
may lead to stochastic variation resulting in unequal distributions of inactivation 
choice. In this scenario, it is stochastic selection, not non-random X chromosome 
inactivation, which produces the uneven ratio of inactive X chromosomes. 
1.12 Using Single Nucleotide Polymorphisms 
(SNPs) to measure clonal regions 
An alternative to the methods discussed above is to detect and distinguish SNPs in 
transcripts from X-linked genes as a direct measure of chromosome activity. As 
individual clones of cells express the same allelic variant of an SNP, this method 
would allow a measurement of the size, and relative contribution, of such cell 
populations (clones) in a tissue. 
Single Nucleotide Polymorphisms (SNPs) are naturally occurrmg single base 
changes in DNA sequence that result in polymorphic alleles at a particular loci. 
SNPs, most of which are presumed to be functionally silent, are defined as a 
frequent and naturally occurring single nucleotide sequence variation (Weaver and 
Hedrick, 1997). 
With the recent completion of the first major phase of the human genome 
sequencing project, a partial description of SNPs found in humans (that is, from 
the limited number of individuals sequenced in the project) has been made 
available. With some 1.42 million SNPs mapped in the human genome (by The 
SNP Consortium and The International Human Genome Sequencing Consortium), 
such polymorphic variation represents the majority of known human sequence 
variation (the remainder being due to rearrangements, repeat length polymorphism 
and insertion/deletion events) (Sachidanandam et al., 2001). The identification 
and characterization of SNPs has been accelerated by the completion of the 
working draft of the human genome and huge financial investment by 
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pharmaceutical companies, whose particular interest is in disease-gene 
linked SNPs. 
While only 4.2% of polymorphisms fell within exons, 85% of all exons were 
within 5 kb of an SNP (Sachidanandam et al., 2001). The human X chromosome 
exhibits a low frequency of SNPs, with only 1 SNP per 3.77 kb compared with the 
genome-wide average frequency of 1 SNP per 1.9 kb. Only one other 
chromosome, the Y chromosome, has a lower SNP frequency ( one SNP per 
5.19 kb). 
The exploitation of single nucleotide polymorphisms as markers of different X-
linked alleles has the advantage over other clonality measurement approaches in 
that it is not complicated by variable methylation that could affect DNA-based 
methods. X chromosome inactivation assays based on SNP discrimination have 
used G6PD (Beutler and Kuhl, 1990), lduronate-2-sulfatase (IDS) (Wilson et al., 
1993) and palmitoylated membrane protein (p55) (Luhovy et al., 1995a) gene -
all in in vitro experiments. Heterozygotes for these SNPs occur at frequencies of 
27%, 41 % and 48% respectively. In practice such SNPs could be distinguished 
by 'marker cocktails', with approximately 90% of females informative when 
using a combination of PGK and HUMARA DNA analysis and 68% informative 
for IDS, p55 and G6PD SNPs (Gale, 1999). 
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1.13 Studies of mammary clonality 
1.13.1 Terminology 
A cellular clone ("clone") represents a family of cells deriving from a common 
progenitor, that is, a single stem cell and its daughter cells. So, "clonality" is a 
broad term that refers to the number and organization of clones involved in the 
formation and maintenance of the particular tissue being examined. A "patch" is 
a group of cells that share a common genotype contiguous at the moment of 
consideration (Nesbitt, 1974). 
1.13.2 History 
The first attempts at elucidation of the clonality of mammary tissue involved 
assessment of X-linked enzyme histochemical activity of the housekeeping gene 
g6pd (Thomas et al., 1988). Cells from normal (C3H) animals were introduced to 
blastocysts of GPDX animals, to produce chimeric mice (C3H-GPDX) that were 
mosaic for G6PD isoforms. Thomas (1988) examined dl5 lactation C3H-GPDX 
chimeric animals for G6PD expression (lactation had been previously identified 
as an enhancer of g6pd expression in rats (Richards and Hilf, 1972) and non-
lactating animals were shown not to be informative). Heterozygotes showed the 
expected dual population of G6PD variants with most individual acinar 
exclusively showing one or the other parental type. Some acinar and all ducts 
display a mosaic (or mixed) parental lineage, suggesting a polyclonal origin. 
Furthermore, the distribution of patches in the mammary tissue appeared non-
random, which indicated that 'coherent clonal growth' was producing a relatively 
large patch size for each parental-type inactive X in lactating breast tissue. 
The in situ results suggested a polyclonal origin for the majority of the larger 
ducts, with only some smaller ducts and most individual alveoli displaying a 
"monophenotypic" (homogeneous) staining pattern (Thomas et al., 1988). These 
experiments also showed that, for the marker measured, physiological state 
mediates gene expression. Moreover, it was demonstrated that X-linked gene 
products could be exploited in the wholemount measurement of mammary cellular 
clonality. Most importantly, the experiments showed that cell mingling and 
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clonal growth occurred during histogenesis, and resulted in demonstrable cellular 
clones in the mouse gland. 
1.13.3 Stem cell number in the mouse mammary 
Kordon ( 1998) transplanted mouse mammary tumour virus (MMTV) infected 
epithelial cells into epithelial-free mouse fat pads and estimated that a single stem 
cell is theoretically able to produce 1012 to 1013 multipotent offspring (that is, 11 
doublings through 4 transplants were observed) before reaching senescence. 
Smith ( 1996) estimated that there are around 2500 stem cells in the adult mouse 
inguinal mammary gland. The authors also showed that, in Czech II mice, any 
portion of the mammary gland was sufficient to produce an entire functional gland 
after transplantation into a cleared (epithelia-free) mammary fat pad. 
Other studies have shown that between 0.2 and 0.45% mammary epithelial cells 
exhibit the ability to efflux Hoechst 33342 dye, a behaviour that is considered a 
universal stem cell marker (Alvi et al., 2002). Limiting dilution cell transplant 
experiments, where these undifferentiated 'side population' cells were introduced 
to cleared mammary fat pad, showed that such cells functioned to generate 
epithelial structures. 
1.13.4 Calculating tissue progenitor cell number 
Observations of ratios of each of the two possible X-inactivation choices (Xp- or 
Xm-derived inactive X chromosome) in an adult tissue can be used to estimate 
numbers of precursor cells that have contributed to that tissue. Typically, such 
approaches make use of the fact that determinative events of early embryo 
development are random binominal sampling events and, therefore, that statistical 
analyses of differentiated mosaic tissues can give information on these 
determinative events themselves (Nesbitt, 1971). Such analyses are performed by 
analysis of variation (ANCOV A analysis) in mosaic compostion between mosaic 
individuals, and within individual tissues in mosaic animals. These statistical 
manipulations provide data regarding both the number of cells present in the 
embryo at the time of inactivation (n1) and the number of primordial precursors 
that were present in each tissue (n2) (McMahon et al., 1983; Nesbitt, 1971; Stone, 
1983). 
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A more direct method of assessment, which can be applied to the assessment of 
clonality in individual structures, has been demonstrated. Stone (2002) produced 
an estimate of progenitor cell numbers in individual taste-buds by determining the 
relative amounts of blue to non-staining cells after lacZ histochemistry of tissues 
from a hemizygous H253 transgenic animal (using the method detailed in Chapter 
6, section 6.3.3). 
There has been some doubt cast on the accuracy of such methods as, in order to 
perform the analysis, two assumptions, namely: 1) that cells are completely mixed 
at 'sampling', and 2) that proliferation occurs equally from all progenitors, must 
be made (Mead et al., 1987). In practice, these assumptions are difficult to test. 
1.13.5 Cellular clonality in the human mammary gland 
It is generally accepted that cancers arise after a set of mutations accumulate 
within a stem cell and that these mutations cause unchecked proliferation 
(reviewed for bowel cancer in Fearon and Vogelstein, 1990). Because, it would 
be unlikely that identical mutation patterns would occur in adjacent cells, leading 
to the formation of a homogenous tumour, individual tumours are assumed 
monoclonal (that is, originating from a single cell), while hyperplasic outgrowth is 
considered a polyclonal process comprising cells that are still responsive to both 
endogenous and exogenous stimuli (Noguchi et al., 1994a). It would be valuable 
to assess complete tumours for clonality to determine the relative contribution of 
their constituent cellular clone/s. 
There are conflicting reports regarding the clonality of breast carcinoma. In 
contrasting studies, Smith (1971) used G6PD variants to show that mammary 
carcinomas were monoclonal, while Fialkow (1976), also using isozyme analysis, 
concluded that mammary carcinomas were polyclonal. Noguchi (1994a) 
suggested that such discrepancies may be due to the inadvertent inclusion of 
stromal tissue with the parenchymal tissue analysed. 
Noguchi et al. ( 1992) reassessed the clonality of human mammary carcinoma 
using RFLP analysis of PGK variants. A monoclonal pattern was the 
predominant pattern observed in the tumours examined. This was in contrast with 
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the polyclonal patterns of clonality observed in normal breast tissue. The authors 
used this method to determine that predominantly intraductal carcinoma 
(specifically when found dispersed throughout the breast) was monoclonal 
(Noguchi et al., 1994a). 
Recent re-evaluations cast doubt on the findings of Noguchi et al. (1992) and 
produced a different measurement of patterns of clonality in human mammary 
tissue. Using a HUMARA assay, Tsai et al. (1996) found that entire lobules and 
large ducts in normal human mammary were monoclonal. While the patch size 
was found to be between 0.08 and 0.45 mm2, measurements of homogeneous 
expression of one HUMARA variant in an entire block from a human reduction 
mastectomy (from a HUMARA heterozygote), demonstrated that the amount of 
tissue derived from a particular stem cell (that is, the patch or clone size) may, in 
some circumstances, be quite large. In further support of this evidence for large 
clone size in human breast tissue, G6PD histochemical studies of breast tissue 
from Sardinian women heterozygous for a temperature sensitive G6PD variant 
showed suspected monoclonality within all 111 small ducts and 57 lobules 
examined (Novelli et al., 2003). 
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1.14 Aims and hypotheses 
It has been suggested that the clonal mechanics of all epithelial tissue systems 
resemble those observed in the intestinal crypt-villus (Zajicek, 1995). If so, then 
one would expect individual mammary ducts to display a profile of clonality that 
is roughly similar to that found in mouse large intestine. As explained above 
(section 1.2.2), mouse gut progenitor stem cells are located near the base of the 
intestinal crypts. The progeny from these cells become more differentiated as 
they move towards the villi apex; where they ultimately undergo natural cell death 
and sloughing. Mouse mammogenesis differs in some important mechanistic 
aspects as it involves the TEB penetrating the fat pad with intense mitotic division 
by stem cells (cap cells) at the tip of the duct. Accordingly, progeny of these 
progenitor cells form end bud components, which ultimately contribute to the 
mammary ducts and alveoli. 
A A/f.TfRJOfl BlJD. 
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Figure 1.11. Diagrams showing A) mouse mammary buds and B) a ruminant mammary bud, 
originally from Turner (1930). The ruminant bud is characterized by clear separation from the 
surrounding mesenchyme while, in contrast, the mouse mammary bud directly abuts the 
mesenchyme. 
It is presumed that the entire population of stem cells that contribute to this 
ductal/alveolar epithelium are found within the mammary bud (Figure 1.11 ). 
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Because of the assumed large number of such stem cells in this structure and, 
assuming an equal mitotic contribution from these cells, it was predicted that early 
outgrowth would form polyclonal mammary sprouts. Further ductal extension 
could result from either: 1) a large population of stem cells contributing randomly 
to new lateral branches by chance orientation to a branch point after penetration of 
the primary epithelial duct through the fat pad. This would produce a 
heterogeneous mixture of small cellular clones throughout the gland or, 2) stem 
cells being deposited as 'reservoirs' along the ductal basement membrane during 
growth. Hence, with ductal extension, there would be a reduction in total stem 
cell numbers available for contribution to new ductal outgrowth. This may lead to 
skewing where large terminal regions of the gland are produced from single stem 
cell progeny or, 3) a very early selection of one stem cell in the mammary bud for 
all subsequent ductal formation, resulting m an almost completely 
monoclonal gland. 
This thesis had the following aims: 
• To develop methods for measuring the size of individual stem cell clones 
in animal models 
• To classify the distribution of individual stem cell clones in murine and 
bovine mammary epithelia using in situ and in vitro techniques, and to 
propose a model of cellular clonality in the mammary gland. 
• To compare observations from each model animal, bovine and murine, to 
draw new conclusions as to the suitability of each animal for the study of 
human breast disease. 
• To test the hypotheses that: 1) mammary tissue is predominantly 
polyclonal, that is, does not display extensive regions of homogeneity for 
X-linked markers (which would indicate monoclonality), 2) homogeneous 
expression of X-linked markers is limited to ductal termini, and 3) cellular 
clonality patterns m munne and bovine mammary tissue 
are fundamentally similar. 
To achieve these aims, and to test the hypotheses, a series of experiments were 
designed to determine patterns of clone size and distribution in mammary tissue. 
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These experiments assume that branching decisions occur along the ductal axis 
where stem cell progeny contribute to new ductal structures and that these 
structures can be measured using in vitro experiments or wholemount (and/or thin 
section) tissue preparations. 
Initially, an in vitro method using X-linked SNPs was applied to distinguish 
alleles of selected X-linked bovine genes and, therefore, the cellular clone profile 
of the tissue. This approach assumes that the stem cells contributing to a gland all 
display a random choice of an inactive X chromosome; so that females that are 
heterozygous for the expressed X-linked polymorphism will be mosaic for each 
allele throughout the gland. The bovine house-keeping gene X-inactive specific 
transcript (X/ST) was screened for polymorphism and an expressed SNP was 
identified. RT-PCR/RFLP analysis was used to measure the expressed SNP allele 
ratio in heterozygous animals and, hence, to determine if the gland progenitor 
pool is small; which would result in an over-representation of one allele 
(assuming no chromosome selection causes a skewed ratio) in 30 mm3 blocks of 
tissue (representing around 3 X 107 cells). 
It was decided that study of a transgenic mouse model would be the best way to 
examine cellular clonality in the murine gland. A mouse with an X-linked 
transgenic modification (H253), a transgene construct that includes the bacterial 
lacZ gene, was chosen for use in the study. Entire whole mount glands from 
hemizygous female mice were stained using a histochemical reaction that detected 
the trans gene product (bacterial ~-galactosidase ). Examination of patch size and 
distribution, in whole mount preparations and in thin sections, revealed the 
clonality of the entire mammary ductal network in individual glands. These data 
were used to make conclusions about the numbers of progenitor stem cells that 
contribute to individual TEB/alveoli. 
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Chapter Two 
General Materials and Methods 
2.1 Screening Lambda bovine genomic DNA library 
2.1.1 Preparing host strain for lambda sensitivity 
A loop of an XLl-blue MRA (P2) host strain glycerol stock was streaked onto an 
LB-agar plate and incubated overnight at 37°C. An individual colony was then 
used to inoculate 5 ml of LB media (see appendix) supplemented with 0.2% (w/v) 
maltose. The media was cultured in a shaking incubator until OD600 0.5 was 
reached (assuming that 1 OD600 = 5 X 108 cells/ml, this represents a cell 
concentration of 2.5 X 108 cells/ml). This culture was then supplemented with 
MgS04 to a final concentration of 1 OmM and incubated for an additional 5 min 
before transfection with the lambda virus. 
2.1.2 Titre of pre-made Lambda bovine DNA library 
A lab stock of a proprietary lambda bovine genomic DNA library (Stratagene cat. 
# 945701), created using DNA extracted from the liver of a cow (of undisclosed 
breed), was titred to determine phage concentration. This library consists of 
fragments of the B. taurus genome (between 9 and 23 kb) within DASH® II 
lambda library vector arms (Figure 2.1) and was constructed by ligation of 
partially digested BamHI fragments of the B. taurus genomic sequences into 
BamHI digested DASH® II lambda library arms. 
The phage titre was assumed to be approximately 1 X 104 phage forming units per 
µl (pfu/µl). A 2 µl aliquot of the library phage was used to infect 2 ml of host 
strain (OD600=0.5) prepared as detailed above. After 20 min incubation at 37°C a 
series of aliquots (200 µl, 20 µl and 2 µl) were each added to 5 ml of lambda top 
agarose (50°C), aliquoted into 10 ml falcon tubes and thoroughly mixed by 
inversion. Immediately following mixing, each of the phage-infected host strain 
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suspensions was poured onto separate pre-poured LB-agar plates (10 cm X 10 cm) 
and an even distribution of media ensured by tilting. 
Lambda B. taurus genomic library 
A 
B 
Xba I Sa I I Not J T3 promoter fcoR I Bani I Hfnd I I I Sac I Xho l Xba 1 
++ + J. + J. I + J. J. 
s · ·TCTAGA GAGCT GTCGAC GCGGC CGC ~AATTAACCCTCACTAAAGGGAAC GAATTC G~ATCC AlGCTT GAGCTC CTtGAG AAATTC rcfAGA -3 ' 
Xba I Xho l Su I Hfnd I 11 Ball!H I f coR I T7 promo ter No t I Sal I Xba l 
s · ·GCTAGA +GAATTT ·bcGAG tAGCTC lAGCTT lGATCC tune frcGCCCTATAGTGAGTCGTATTAC GGC CGC GTlGAC AGtrc rcfAGA-3 ' 
C 
Xba I Sa 1 I Not I T3 promoter fcoR I Bani 
s · ·TCTAGA +GAGCT trcGAC t cGGCCGC !GAATTAACCCTCACT.1,AAGGGAAC Gl...rrc G!ATCC" 
Ba/Mi I fcoR I T7 promoter Not I Sa 1 I Xba I 
! GArcc JAATTC AcGCCCTATAGTGAGTCGTATTAC iGGccGc GTlGAC AG!rc rcfAGA · 3· 
Initial digest sites In library construction 
Not I sites for eventual Insert removal 
- 8 . taurus genomic DNA Insert (9-23 kb) 
Figure 2.1. A diagram of the DAS He II lambda library vector showing A) unmodified commercial 
DASH® II lambda vector, B) the vectors Multiple Cloning Site (MCS) and C) a representation of 
Stratagene # 945701 B. taurus genomic DNA library (drawn from manufacturer product 
information sheets with modification). 
After the top agarose had solidified the plates were incubated overnight at 37°C. 
The next day, plaques on each plate were counted to determine the concentration 
of pfu. The phage titre for the bovine genomic DNA library used was determined 
to be 1.4 X 104 pfu/µl. 
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2.1.3 Library screen: transfection of host strain 
XL 1-blue MRA {P2) 
To infect the host strain with lambda, a 10 µl aliquot of the phage library (1.4 X 
105 pfu/µl) was inoculated into 2 ml of host strain prepared as detailed above and 
allowed to transfect for 20 min, after which time 35 ml of LB top agarose (50°C) 
was added and mixed thoroughly by inversion. Next, a pre-poured 22.5 cm 
square LB-agar plate was warmed to 37°C and the top agarose/infected host strain 
poured, spread by tilting and allowed to solidify. Finally, the plates were placed 
in a 37°C incubator overnight to allow for plaque formation. 
2.1.4 Plaque lifts 
After the overnight incubation described above, the plates were chilled at 4 °C for 
3 h to decrease the likelihood of top agarose peeling during the plaque lift. Sheets 
of Hybond™-N+ membrane were gently laid onto the top agarose, so that all 
plaque-bearing portions were completely covered. A syringe needle was used to 
punch holes through both the Hybond membrane (Amersham) and the underlying 
agarose and agar layers. These reference holes were later used to position 
autoradiographs, membranes and plates, so that plaques that corresponded to a 
strong probe hybridization signal on the membrane could be individually selected 
from residual viral plaques on the top agarose layer on the plate. To avoid 
contamination between membranes, needles were flamed for 5 sec before each 
reference hole was punched. 
The first of each of the duplicate membranes used for plaque lifting on each plate 
was laid down for 1 min. Subsequent membranes (usually one duplicate set were 
produced per plate) were laid down for a longer period(> 2 min) in an attempt to 
ensure that approximately equal numbers of phage were transferred in each lift. 
After the appropriate application time, the filters were carefully lifted from the 
plate with a single and even motion (using two forceps). The duplicate 
membranes were placed (plaque-side up) onto a near-saturated filter paper 
containing denaturing solution (0.5 M NaOH, 1.5 M NaCl) for two minutes, and 
the membranes placed onto neutralising solution (0.5 M Tris/1.5 M NaCl) 
saturated filter paper for 5 min. Following these treatments, the membranes were 
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transferred onto dry filter paper, dried in an 80°C oven for 5 min, and the DNA 
from the plaques cross-linked to the membranes by exposure to 120 mJ of UV 
light (at 254 nm) using a BLX-254 crosslinker (GibcoBRL). The membranes 
were stored in plastic bags at -20°C until use in hybridization experiments. 
2.1.5 Phage-library Probe preparation 
PCR products were labelled using Rediprime™ kit (Amersham) chemistry 
according to the manufacturer's instructions. Briefly, 20 ng of gel-purified PCR 
product was placed in a 0.6 ml microfuge tube and the solution volume brought to 
45 µI by the addition of TE (pH 8). The sample was denatured at 96°C for 5 min 
and the solution allowed to cool briefly, after which it was added directly to the 
Rediprime reagents in a 1.7 ml tube (the proprietary reagent mixture includes 
Kienow, dNTPs, and random hexamer primers). The solution was mixed 
thoroughly by gentle finger-flicking after the addition of 5 µl (50 µ Ci) of Redivue 
a-[32P]dCTP (Amersham). The labelling reaction was then allowed to continue at 
37°C for 30 min and then the labelled probe stored on ice until required. 
2.1.6 Probe Hybridization to plaque lifts 
The library membranes lifted from the primary screen plates were placed into 
hybridization tubes (Hybaid HB-OV-BXL, 7.25 cm Internal Diameter, 30 cm 
Length) and prehybridized for 2 h in Church and Gilbert hybridization solution 
(see Appendix 5) at 64 °C. Ten ml of fresh Church and Gilbert hybridization 
solution was poured into a 50 ml tube and the labelled probe, denatured by the 
addition of 15 µI of 4M NaOH (final concentration -1 M), added directly to 
the solution. 
This solution was added to the Hybaid™ tubes containing the prehybridized 
membranes and the probe hybridized overnight at 64 °C, with rotation, in a 
Hybaid™ oven (Midi Dual 14). After hybridization the probe solution was 
collected into a Falcon tube and stored at 4 °C. The membrane was washed with 
3X SSC, 0.1 % SDS for 10 min, then with O.IX SSC, 0.1 % SOS for a further 5 
min. The membranes were removed from the Hybaid™ tubes and washed in a 
tray for another 5 min in the same solution. When the counts had decreased 
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sufficiently (as assessed by Geiger counter), the washed membranes were sealed 
in plastic bags and immediately placed in an autoradiography cassette for 
overnight exposure to autoradiographic film (XR-OMAT, Kodak). 
2.1.7 Selecting positive clones 
Plaques that gave a good hybridization signal were identified on their original LB 
plates by reorienting the membrane with the autoradiograph and the LB plate. 
Plaques were collected by inserting the large bore end of a pipette tip through the 
upper (agarose) layer of the plating media and selecting the region of media that 
included the plaque of interest. This agarose plug was placed into 1 ml of SM 
buffer (see Appendix 5) and allowed to elute for 1 h at room temperature on a flat-
bed shaker. Due to the proximity of plaques on the plates, most of the clones 
selected in primary screens were mixed with their non-target neighbours; 
consequently secondary, tertiary (and sometimes quaternary) screens were 
performed to ensure the isolation of a pure lambda clone. 
2.1.8 Amplifying Lambda phage - DNA extraction 
A 100 µI inoculum of an overnight culture of XLl-blue MRA (P2) host strain 
(supplemented with 10 mM MgCh) was inoculated into 15ml of LB media and 
grown to OD600=0.5. Phage aliquots of 150 µI were inoculated into 800 µI 
aliquots of these plating cells, which were then incubated at 37°C for 20 min. 
After this incubation the infected host strain (-950 µI) was added directly to 100 
ml of NZY broth (Appendix 5) and incubated for 16-20 h with shaking. Next, 1 
ml of chloroform was added and each of the cultures shaken for a further 5 min to 
Iyse any remaining bacterial cells. The vessels were placed in the 4 °C cold-room 
for 30 min to allow the chloroform to settle, then the aqueous phase elements 
(phage and bacterial debris) were poured into 50 ml Beckman centrifuge tubes. 
The tubes were balanced and centrifuged for 10 min at 10 000 rpm ( 10 000 RCF) 
at 4°C using a Beckman JA20. l rotor. The supernatant was collected and the 
pellet discarded. This centrifugation was repeated once to ensure that the cellular 
debris had been completely removed. Filtered 1.25% glycerine was added to a 
final ratio of 0.01 % by volume. After thorough mixing the samples were 
centrifuged at 20 000 rpm (40 000 RCF) in a Beckman JA20. l rotor for 2.5 h. 
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The supernatant was discarded and the pellets, representing identical and largely 
intact phage, were pooled into the same 1.5 ml eppendorf tube and re-suspended 
in 400 µl of TE buffer (pH 8). DNAse and RNAse were added, to final 
concentrations of 37.5 µg/ml and 12.5 µg/ml respectively, and the tubes incubated 
at 37°C for 10 min. Following this incubation, 20 µl of 10% SDS (0.5% final 
concentration) was added, mixed into the sample by vigorous flicking of the tube 
and an incubation carried out at 60°C for 5 min. Finally, the suspended DNA 
was purified by three extractions in Tris-buffered phenol (AR grade) and two 
extractions in chloroform. 
After these purification steps the DNA was precipitated by the addition of a 1/101h 
volume of 3 M sodium acetate (pH 5.2) and two volumes of ethanol. After five 
min at RT the DNA was pelleted by a 10 min centrifugation at 13 000 rpm (12 
000 g) in a Heraeus (Biofuge Pico) bench-top centrifuge. The pellet was washed 
once with 70% ethanol, air-dried and resuspended in 100 µl of TE buffer (pH 8). 
2.1.9 Removal of arms from the lambda clone 
The DASH II lambda vector used in the construction of the library has Natl sites 
within the multiple cloning site (MCS) which flank its bovine DNA insert (Figure 
2.2). For each candidate clone, a 3 µl (-750 ng) sample of the extracted Lambda 
DNA was digested overnight at 37°C in 20 µl of IX 'H' digestion buffer with 10 
U of Natl (Boehringer). Following this digestion, the fragments were ethanol 
precipitated, washed in 70% ethanol and the DNA resuspended in 50 µl of TE 
buffer (pH 8). 
gel electrophoresis. 
The restriction pattern was analysed by 1 % TBE 
The gel was placed on a mylar sheet and bands corresponding to the insert DNA 
of the lambda vector, that is, bands of lower molecular weight than those 
corresponding to the lambda arms, were excised from the gel using #10 scalpel 
blades. For a number of clones, Natl digestion gave more than three bands, 
indicating that the restriction endonuclease cuts within the insert itself (in such 
cases these bands were collected separately). 
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The DNA fragments within each of the gel slices were extracted using a Qiaex II 
Gel extraction kit (Qiagen cat #20021) according to the manufacturer's 
instructions. Briefly this required incubation of a gel slice for 10 min at 50°C in 
'QXI buffer' with I µ1/ml 'Qiaex II DNA binding solution' resin. Following 
centrifugation and serial washing steps, the DNA was eluted into 20 µI of TE 
buffer (pH 8). After purification, this extract was used directly as a cloning insert. 
2.1.10 Cloning of insert DNA into phagemid Bluescript KS+ 
Cloning of the insert from the selected lambda clone was carried out using a 
pBluescript II KS+ (pBS KS+) cloning vector (a 2961 bp vector; Stratagene cat.# 
212207) with XL I-blue host strain. For each cloning experiment 200 ng of vector 
(in 10 µI) was made linear by digestion with 10 U each of the restriction enzymes 
Natl (gclggccgc) and Sall (gltcgac) in the Boehringer digestion buffer 'H'. These 
enzymes both cut once within the pBS KS+ multiple cloning site (MCS). 
Following digestion the vector was precipitated with two volumes of ethanol, 
washed in 70% ethanol, and the vector pellet resuspended in 4 µI of 
deionised water. 
The insert DNA, digested from lambda with Natl as described above, was ligated 
into the pBluescript KS+ vector using 1 U T4 DNA ligase in a 10 h reaction at 
l6°C in T4 DNA ligase buffer. Vector to insert 5' end ratios of 1:1, 1:2 and 1:3 
were trialled for each ligation experiment. 
After ligation of the insert to the appropriate docking Natl 5' sticky end overhang, 
the linear vector-insert fragment was purified and the remaining sticky ends were 
blunted in a 10 µl reaction with 1 U Kienow in the presence of 5 mM dNTPs. 
The blunt-ended fragment was again purified by precipitation and another ligation 
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Figure 2.2. Diagram showing I) the cloning strategy used in library clone purification and 2) 
annotated cloning vector Multiple Cloning Site (MCS) sequence. After excision of the bovine 
genomic DNA insert from the arms of the lambda library vector the bovine fragment was la) 
sticky-end ligated on a pBS KS+ vector and I b) blunt end filled and ligated onto the 
complementary end of the vector under construction. I c) Finally the vector was purified and 
aliquots used directly for transfonnation of the host strain used (XLl-blue) (see below) and after a 
short incubation plated onto LB agar supplemented with ampicillin. The vector preparation is 
detailed by a diagram of the vector Multiple Cloning Site (MCS) (2). The diagram shows Noll and 
San states post insertion, with the San site modified by end-filling (drawn from Stratagene product 
infonnation sheets). 
2.1.11 Preparation of competent host strain 
Host strains used in cloning experiments were prepared immediately before they 
were required, as such cells give an improved transformation frequency compared 
to competent cells stored for longer periods of time at -80°C. 
A 0.1 ml aliquot of XL I -blue host strain from a 10 ml overnight liquid culture ( 10 
ml of LB broth inoculated with cells from a single colony cultured on an LB plate 
at 3 7°C overnight, then sealed and stored at 4 °C for up to a week before use) was 
used to inoculate 9.9 ml (final ratio: 1 part in 100 parts) of LB broth. The strain 
was cultured until OD600 :::::: 0.4, indicating that cells were in the exponen\ial/loj 
phase of growth. 
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One ml aliquots of the host strain culture were centrifuged for 15 secs in 1.5 ml 
tubes, the supernatant was discarded and the pellet resuspended in 100 µl of cold 
IX TSS (see appendix 5). The cells were stored at 4°C, for no more than 1 h, 
until required in transformation. 
2.1.12 Transformation 
Transformations of total plasmids produced from the above ligations were 
performed using a heat-shock protocol. Between l and 3 µl of the ligation 
reaction mixture was pipetted into each 100 µl aliquot of host strain in lX TSS 
(prepared as above) on ice. After 30 min the tubes were placed into a 42°C water 
bath for 1.5 min, and then immediately into an ice bucket for 5 min. One ml of 
LB broth (without antibiotic) was added and the tubes incubated at 37°C for 30 
min (to allow the newly transformed cells to express plasmid encoded antibiotic 
resistance factors before being plated out). After the tubes were centrifuged for 
20 sec at 11 000 rpm and the supernatant discarded, the cells were finally 
resuspended in 50 µl LB supplemented with 10 mg/ml ampicillin. 
2.1.13 Plating and selection 
A 20 µl aliquot of each transformation, produced as described above, was plated 
onto LB agar (supplemented with 100 µg/ml ampicillin, 0.5 mM IPTG and 40 
µg/ml X-gal) and distributed evenly over the plate using a sterile glass spreader. 
The plates were allowed to partially dry in a laminar flow hood for 10 min, then 
incubated overnight at 37°C and assessed for potential insert-positive clones by 
eye. White colonies (that is, those potentially exhibiting an insert disrupting the 
vector lacZ gene) were selected using a sterile toothpick and streaked across a 
square on a grid labelled LB-Amp agar plate. The toothpick was then immersed 
into 1 ml of LB broth AMP media for 10 sec. Both the liquid media and these 
'selection' plates were incubated overnight at 37°C, the former with shaking. Re-
streaked plates were again assessed for the presence of white colonies and the 
inoculated LB broth tubes that corresponded to positive (white) streaked colonies, 
subjected to a plasmid extraction as below. 
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2.1.14 Alkaline lysis plasmid extraction 
For initial clone screening purposes a rapid alkaline lysis technique, essentially as 
detailed by Cormack and Somssich ( 1997), was used. In brief this involved 
centrifuging 1 ml overnight cultures of candidate clone-containing XLl host cells 
for 30 sec at 10 000 rpm ( 12000 g), removal of supernatant, and re-suspension of 
the cellular pellet in 0.2 ml of Solution II (I% SDS, 0.2 N NaOH). After gentle 
mixing for a few minutes, 0.2 ml of Solution III (3M potassium acetate pH 5.5) 
was added and the samples were mixed by inversion. Next, the samples were 
centrifuged at 13 000 rpm (12 000 g) for 2 min to remove cellular debris and the 
supernatant collected and transferred into clean 1.5 ml plastic tubes. An equal 
volume of 100% isopropanol was added and, after thorough mixing, the samples 
were centrifuged for an additional 2 min to pellet the plasmid DNA. The 
supernatant was discarded and the pellet air-dried for 10 min. The pellets were 
resuspended in 50 µl of TE buffer with IO µg/ml of DNAase-free RNAase A 
(Sigma) at 37°C for IO min. Finally, a phenol/chloroform extraction was 
performed to remove the RNase and the plasmid was resuspended in TE buffer. 
2.2 Other protocols used 
2.2.1 DNA sequencing 
Sequencing reactions were carried out using 1A reaction volumes (with a final 
volume of 5 µl) using a protocol provided by The University of Waikato DNA 
Sequencing Facility. The reaction consisted of 2 µl of Bigdye IffM (Applied 
Biosystems 377), 1 µl of primer (0.8 pmol/µl; 20mers were usually used), 0.5 µl 
of template (100 ng of plasmid; or 1-10 ng of PCR product) and 1.5 µl of 
deionised water. The cycling conditions used were: 18 to 25 extensions using an 
MJ Research PTC-IOO thermocycler (MJ Research, Inc) program of 96°C/lO sec 
and 60°C/4 min. Products were purified by precipitation, in a final concentration 
of 0.12 mM sodium acetate (pH 4.6) in 2 volumes of ethanol, for 20 min at RT. 
The precipitated DNA was collected by centrifugation for 30 min at 13 000 rpm. 
The pellet was washed in 200 µl of 70% ethanol, the tube centrifuged for another 
1 O min, the ethanol discarded and the pellet dried at 80°C for a few seconds in a 
thermo-cycler. The samples were supplied in this form directly to the sequencing 
facility for electrophoresis. 
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2.2.2 RNA extraction from bovine and murine tissues 
RNA was extracted using Trizol™ (Stratagene) reagent according to the 
manufacturer's instructions with minor modifications. Briefly, this involved 
placing a piece of frozen tissue (50-120 mg) into a folded sheet of mylar plastic 
sheet, smashing the tissue using a light hammer and tipping the resulting powder 
into a 1 ml aliquot of Trizol™ in a 1.7 ml tube. The tube was then capped and 
shaken to mix the contents and to ensure a consistent homogenate. After 
incubation for 20 min at RT, 0.2 ml of chloroform was added and, following 
thorough mixing by vortexing, the samples were centrifuged at 13 000 rpm for 1 O 
min at 4 °C and the aqueous phase collected. Isopropanol (0.5 ml) was added and 
the samples mixed and stored at 4°C for 30 min. Finally the samples were 
centrifuged for 10 min at 13 000 rpm and the resultant pellet washed in 1 ml of 
75% ethanol, air-dried and, after re-suspension in 50 µl of DEPC-treated 
deionised H20, stored at -80°C. 
2.2.3 DNA extraction from bovine milk for mass SNP screening 
For the extractions, 50 ml milk samples were collected either directly from an 
animal, or from retail milk (Anchor™ Milk). The milk sample was centrifuged 
for 5 min at 3 500 rpm (2 200 g), and the top 45 ml of supernatant (and the upper 
fat layer) discarded. The remaining 5 ml was transferred to a 10 ml tube and after 
the addition of 5 ml of TE buffer (pH 7 .5, 4 °C) the tube was inverted a few times 
to ensure mixing and then centrifuged at 500 rpm (45 g) for 5 min. Next, the 
upper 9 ml was removed by aspiration and discarded and the remaining 1 ml of 
solution carefully removed (avoiding disruption to the debris pellet). This 1 ml of 
solution was transferred to a 1.5 ml tube and centrifuged for 15 sec at 13 000 rpm 
(12 000 g) and the majority of the supernatant discarded (leaving about 200 µl of 
solution). Following the addition of 1 ml of TE buffer (as above) to this 200 µl 
solution and centrifugation for 15 sec at 13 000 rpm, the supernatant was again 
discarded, this time retaining only the lowest 100 µI of solution (that is, the 
fraction containing the debris-free somatic cells). Finally, 100 µI of Proteinase K 
buffer (see Appendix 5) - supplemented with 40 µg of Proteinase K - was added 
and the solution mixed by pipetting through a medium bore tip. The cell protein 
components were digested by incubation at 55°C for 2 h. Genomic DNA was 
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obtained by standard phenol/chloroform extractions and ethanol precipitation. 
The numbers of cells present in the original milk sample were estimated using the 
method shown in Appendix 6 (pers. comm. R.J. Wilkins, The University 
of Waikato). 
2.2.4 End-labelling oligonucleotide probes for use in RT-
PCR/RFLP experiments 
Deoxyoligonucleotide probe (20 pmol of 5' ends) was brought to a volume of 
17 µI by the addition of deionised water. End-labelling was carried out in a 20 µl 
volume with 1 µl (10 U) T4 polynucleotide kinase (PNK; Roche), 2 µl of lOX 
PNK buffer and 1 µl of Redivue [y33P]dATP (10 µ Ci; Amersham), for 30 min at 
37°C. The reaction was stopped by the addition of 1 µl of 2 M EDT A (final 
concentration of 0.2 M EDT A) and the tubes stored in an ice-bath before direct 
addition to the hybridization solution. 
2.2.5 Hybridization 
UV cross-linked membranes were pre-hybridized in 5 ml of Church and Gilbert 
hybridization buffer (see Appendix 5) for 2 h before the direct addition of 20 pmol 
of labelled oligonucleotide probe. Hybridization was carried out for between 6 
and 12 h, then the excess probe was removed by washing in 2X SSC/0.1 % SDS 
for 10 min at the hybridization temperature. Finally, the membranes were dried 
and exposed to autoradiographic film overnight (or to a Fuji phosphorimaging 
plate 2 h to overnight). 
2.2.6 General PCR strategy 
PCR was carried out as detailed in the individual results chapters. Typically, 
annealing was carried out at a temperature 5°C lower than the average of the 
primer Tm· Where this approach failed to yield products, annealing temperature 
was lowered and/or cycle number increased in an attempt to amplify the difficult 
target molecule. 
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2.2. 7 Developing autoradiographs 
Autoradiographs were taken from their cassettes in the dark and placed in a fresh 
developer (Kodak) until hybridization-positive regions were well-developed 
(usually after -2 min). The film was lifted from the developer solution, allowed 
to drain briefly and placed in a fixative solution until the cloudiness on the surface 
of the film had cleared. The film was then washed thoroughly in tap water and 
allowed to drip dry. 
2.3 Image acquisition: 
2.3.1 BAS-1800 II Phosphorimager (Fuji) 
Phosphorimaging with the BAS-1800 uses 'photostimulable phosphor layer 
(BaFX:Eu)' coated imaging plates (23 X 25 cm). These phosphor plates store 
charge from radioactive isotopes and this charge is later read by a laser-coupled 
photomultiplier tube within the instrument. The distributor claims that the system 
offers 10 to 100 times the sensitivity of film based autoradiography and hence 
increases membrane throughput times as well as allowing direct image capture to 
a computer for image quantification. 
A Fuji BAS-180011 phosphorimager was used for much of the autoradiographic 
'development'. For the development of blots probed with 32P-labelled probes, 
membranes were dried in a 37°C oven, placed in a plastic bag, and then taped, 
signal-side up, to the positioning grid within a BAS cassette. Next, a phosphor 
plate that had been cleared of residual signal by exposure to light for 20 min, was 
placed into the cassette with the dry membranes. The cassette was laid flat for the 
required exposure time - usually 2 h, although this was dependent on approximate 
signal intensity on the membrane, measured using a Geiger counter. 
Following exposure the plates were removed and placed face up into a BAS-1800 
reader instrument and an image read using the associated software package 'BAS 
- Image Read'. The resultant image was cropped and its contrast/brightness 
adjusted with 'BAS - Image Gauge' software. 
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2.3.2 Photographic image acquisition 
2.3.2.1 Nikon Coolpix995 
Low magnification images were collected using a Nikon Coolpix995 via a 
modified 1 Ox eyepiece attachment. Wholemount images between 1 OOx and 200x 
magnification were collected in 'manual mode' as TIFF images (setting: 'Hi': 
without compression) and full size ('3:2') to ensure maximum resolution upon 
subsequent image manipulation and enlargement. 
2.3.2.2 Zeiss AxioHR digital camera 
Both higher magnification and/or resolution images for the in situ hybridization 
(Chapter 4) and histochemical (chapter 5) studies were collected using a Zeiss 
Axiocam HR on a fluorescent microscope with digital imaging software 
capability. Images were collected at magnifications between 1 Ox (for 
wholemount glands) and 400x (for in situ hybridization results). As above, 
images were saved as TIFF images for later assessment and manipulation. 
2.3.2.3 Agarose gel images 
Ethidium bromide (EtBr) stained agarose gels were observed using a TFX-35M 
transilluminator (LifeTech) and images collected using a Cohu™ CCD camera 
with Scion 'Image' frame capture software. 
2.4 Histology 
2.4.1 APES treatment of glass slides 
In order to treat slides to allow cross-linking adherence of tissue sections, pre-
cleaned glass slides (Semi-frosted; Erie Scientific) were soaked for 60 sec in 1 % 
3-aminopropyltriethoxy-silane (APES), rinsed in running tap water, and washed 
3 X 10 min in DEPC H20. The slides were subsequently allowed to air-dry, and 
were stored in an airtight container until required. 
2.4.2 Fixation of animal tissues 
The bovine tissues used in this study were fixed in a freshly prepared 4% 
paraformaldehyde solution. This was made by dissolving 4 g 
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of paraformaldehyde in 66.5 ml of DEPC-high quality water at 60°C with 3 drops 
of 2M NaOH added to assist dissolving. Finally, 33 ml of 3X PBS (final lx) was 
added and pH adjusted to 7.4 with I M HCI after the solution had cooled. 
2.4.3 Paraffin-embedding murine and bovine mammary tissues 
Paraformaldehyde fixed bovine mammary glands were cut into thin (-4 mm thick) 
tissue blocks before processing, whereas fixed mouse glands were processed 
whole. The tissues were treated for I h each in 30%, 50%, 70%, 90% ethanol and 
for 3 X I h in I 00% ethanol (final in absolute -98% ETOH). After dehydration, 
the tissues were cleared in xylene for 3 X lh and placed in histology cassettes. 
The cassettes were submerged in baths of molten paraffin wax at 58°C for 3 X I 
h. Next, the tissue cassettes were taken from the final paraffin bath and the tissue 
block removed and placed into a metal pouring mould (pre-filled with molten 
paraffin wax). The plastic cassette insert was placed over the top of the mould, 
ensuring that the liquid wax covered it, and the mould placed on an ice-cooled 
tray for 20 min. Next, the moulds were placed in a beaker into which cold tap-
water was run for 20 min. The moulds were finally cooled in a fridge at 4 °C for 
20 min, after which time the paraffin blocks were removed from the moulds. The 
excess wax was trimmed in preparation for microtome sectioning. 
2.4.4 Microtome sectioning 
Serial thin sections ( I 0-15 µm) were produced using a microtome blade at a 6 
degree angle to the block. These sections were floated in a water bath and 
collected onto coated glass slides. Finally, the slides were dried overnight in a 
4i'c oven. 
2.4.5 Frozen sections 
Blocks of tissue from sampled glands were frozen in liquid N2 immediately after 
dissection. Before sectioning, the tissues were mounted onto a block using OCT 
(Tissue-Tek™) mounting solution. Frozen sections (10 µm) were produced, 
lifted onto silane-coated slides and allowed to air-dry for I h. The slides were 
then fixed in 4% paraformaldehyde for 5 min, and dried in an ethanol series (70% 
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5 min, then l 00%) after which they were stored at 4 °C in 100% ethanol before use 
(up to l month). 
2.4.6 Mouse mammary wholemounts 
The lacZ histochemically-stained mammary tissues were dehydrated in an ethanol 
series and cleared in acetone for 30 min. After clearing, the wholemounts were 
re-hydrated, stained overnight in carmine alum and dehydrated in an ethanol 
series to l 00% ETOH. Following this dehydration, the mounts were soaked in 
xylol for l h (or until cleared) and then mounted with a xylene-based mounting 
media (D.P.X) using another glass slide as a cover-slip. 
2.5 Ethics and ERMA approvals 
The bovine tissue used in this study was sourced from animals at a research 
abattoir. As they were not slaughtered specifically for use in the experiments 
described in this thesis, no special ethics approval was required for this work. The 
transgenic animal tissues used in the murine studies were from culled animals 
bred for an unrelated study conducted at another facility. This study had the 
appropriate approval (Agresearch Ruakura AEC number 3499). 
Cloning of bovine DNA fragments was carried out with approval from ERMA. 
The internal biological safety committee approval reference number is: 
GMOOO/UOW 1. 
2.6 Oligonucleotides used in this study 
The oligonucleotides used as primers or probes in the present study are listed in 
Table 2.1 






BXist.Rev .2.1 CCAGCATTAGCCACGGGGTAGGT 





Bov .Xist.Prom.Rev CCCAACACTTTTCCAACCATATAA 
XIF ATTGTGGTATCATGAGGTGGGAAA 
Bov.XFI .back TTTTGAACACTCTAACAAAGCAGA 
XF2.2 TCAGAAAGGGTGGTAGAATCGG 
XRI CGAGGTGCTATGCTAACTCAT 
Bov .PM.specific.ALU! GGTGCCGTGGCCGAAGCCCTAGC 
X2R.outer TCAAAAATCCGACCCCAGCATTAG 







For amplifyin2 a probe for screenin2 of the l library for G6PD: 
Bov .G6PD.Probe.F RGTGTTGAARTGATCTCAGAGGT 
Bov .G6PD.Probe.R TTCTCYMGMTCAATCTKGTGCAGC 
Bov .G6PD.2ndF ATGCAGAACCACCTMCTGCAGATG 
Bov .G6PD.2ndR TAGGTAAGGTCCAGCTCCGACTCCT 
For sequencin2 the pXIST l library insert: 
pXIST-T7-2 CCTCTCTGTAGCGAAGCTCCTATC 

















For sequencin2 the pG6PD l library insert: 
pG6PD.m 13.2 GTACAAGCTGGATTTAGAAGAGGC 
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pG6PD.Rev.2 ACCAAGATGATGACCAAGAAGCCT 
pG6PD.B.M 13.3 CTAAAGAGCCTCTTGATGAGGCTG 
pG6PD.C.Rev .2 TGAATGGCAGTCTCCGTGGCATT 
pG6PD.B.M 13.4 TGCCAAAGAATTGATGCTTTCAA 







For bovine G6PD exon 10 screen 
Bov .Ex 10.screen.F CCAAAGCCTGCTGTGTCCATCC 
Bov .Ex 1 O.screen.R CAGGGTGTCACCAAGGTGCTGA 
For bovine G6PD Exon 11 screen 
pG6PD.B.screen.F CCACACTGCTCCTTCTCTGTAG 
pG6PD.B.screen.R AGGCTGCCCTTTCCGCCACG 
pG6PD.B.Ex 11.Screen.F GCACCTTGGTGACACCCTGT 











GAPDH Forward ACTCACTCAAGATTGTCAGCAATG 
GAPDH Reverse GTCATGAGCCCTTCCACAATGCCA 
For mouse RT-PCR: 
HMGCoA Reverse CACCGCGTTATCGTCAGGATGAT 
HMGCoA Forward CCCTGGGAAGTTATTGTGGGAACA 
GFP reverse CTGCTTGTCGGGCCATGATATAGAC 
GFP forward CTTCAAGGACGACGGCAACTACAA 
Lacz reverse CGTTTCGTCAGTATCCCCGTTTA 
Lacz forward GCAAAGACCAGACCGTTCATACAG 
HMGCoA probe reverse CTTCGTCCAGACCCAAGGAAACC 
Lacz probe forward TCGCTCGCCACTTCAACATC 
Table 2.1. Oligonucleotides used in this study. 
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Chapter Three 
Screening Bovine X-linked 
Genes for Polymorphism 
3.1 Introduction 
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One of the aims of this thesis was to measure the size and distribution of cellular 
clones in bovine mammary tissue. To achieve this, a marker that discriminates 
between neighbouring cellular clones is required and, for this purpose, most 
studies use polymorphic alleles of X-linked genes. 
X-linked gene polymorphisms have been used for analysis of the cellular clonal 
profile in studies of a number of tissues and disease states. For example, glucose-
6-phosphate dehydrogenase (G6PD) polymorphisms in myeloproliferative 
disorders (Luhovy et al., 1995), hypoxanthine phosphoribosyltransferase (HPRD 
polymorphisms in haematological samples (Browett et al., 1988), and human 
androgen receptor (HUMARA) polymorphisms in studies of thyroid gland clonal 
composition (Jovanovic et al., 2003). PCR-based in vitro analysis of the mosaic 
expression of these markers showed that the clonal profile of a tissue could be 
found by simply determining the presence of the different alleles by 
polyacrylamide gel electrophoresis (PAGE) (also reviewed in Chapter One). 
At the beginning of this study there was little available genome sequence data for 
X-linked bovine genes. Accordingly, it was thought necessary to screen a 
genomic library for bovine homologues of known X-linked genes. The candidate 
genes chosen were: 
I) G6PD: An X-linked housekeeping gene used previously in studies of 
cellular clonality in human specimens (Peng et al., 2000). The human G6PD 
gene is known to be reasonably polymorphic, especially for SNPs, with 18 SNPs 
reported in human G6PD (Genbank: NM_000402). It was assumed that the 
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bovine homologue will also display a high level of variation thereby making it a 
good candidate for this study. 
2) X inactive-specific transcript X/ST: Bovine XIST was thought likely to 
contain useful polymorphism for two primary reasons. Firstly, there was 
previously published polymorphism for the human XIST gene (Rupert et al., 
1995), and secondly, evolutionary studies had shown that the gene lacked 
conserved coding potential (Hendrich et al., 1993). Both of these findings 
indicated that XIST sequence constraints were not likely to be rigid. Fluorescence 
in situ hybridization (FISH) studies had shown that the XIST transcript localized 
to a single X chromosome in cis in female somatic cells (Duthie et al., 1999), 
meaning that it would provide a focal nuclear-localized marker of X inactivation 
pattern and therefore the origin of particular groups of cells derived from the same 
progenitor (that is, an individual clone). 
It was thought that the best markers of clonality for use in this study were single 
nucleotide polymorphisms (SNPs). SNPs give an advantage over variable number 
tandem repeat (VNTR) polymorphisms in this work as they can be readily 
detected by both PCR-based and eventually by in situ methods. Going (2003) 
anticipates that such in situ methods applied to study of the human breast will 
reveal clonal profiles in normal and diseased tissues without the potential for 
contamination from neighbouring tissues (discussed in Chapter 4). 
This Chapter describes: I) the isolation of putative G6PD and XIST clones from a 
bovine genomic DNA A library, and 2) the direct sequencing of bovine X/STusing 
consensus primers designed from known XIST/Xist gene sequences. The 
annotation of the G6PD and the XIST clones identified in the library screening is 
described in appendices A.2.1 and A.2.2, respectively. The XIST sequence 
obtained by direct sequencing was subjected to RT-PCR to confirm sex-linkage, 
and Northern blot analysis to determine whether the gene was expressed at 
reasonable levels in mammary tissue. Subsequently, the XIST fragment obtained 
by direct sequencing was screened for SNPs by detection of sequence 
heterogeneity at the DNA level. The potential utility of each of the identified 
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SNPs in the proposed bovine mammary gland cellular clonality studies (Chapter 
4) is discussed. 
3.2 Methods and Materials 
3.2.1 Library screening for the Bos taurus G6PD gene 
A probe was produced by PCR amplification with consensus primers designed 





This primer pair amplified a - I kb fragment that included exons 9 to 12 of the 
gene, a region shown to be polymorphic in other species (see Beutler and Kuhl, 
1990). 
The').,, genomic DNA library was screened using an identical method as used for 
the XIST gene screening, which is detailed below in section 3.2.3 and in Chapter 
2, section 2.1.5. 
3.2.2 Detection of SNPs in the Bos taurus G6PD gene 
A direct PCR-based approach was used to amplify regions of the bovine G6PD 
clone isolated from the').,, library. Primers were designed from the pG6PD.B clone 
sequence (as described in section 3.3.1) and these were used to amplify the 
presumed exons IO and 11 from genomic DNA samples. 
Exon 10 specific primers: 
Bov .Ex I O.screen.F 
Bov .Ex I O.screen.R 
Exon 11 specific primers: 
ccaaagcctgctgtgtccatcc (92-114) 
cagggtgtcaccaaggtgctga ( 420-442) 
Product: 350 bp 
pg6pd.B.Ex 11.Screen.F gcaccttggtgacaccctgt ( 423-443) 
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pg6pd.B.ex 11.Screen.R acgaagagggggatggagag (575-595) 
Product: 172 bp 
62 
(The numbers in parentheses indicate primer binding position within the G6PD 
sequence gb: AF53 l 754 published from this study). 
Exons 10 and 11 of the 'G6PD gene' from ten animals were sequenced in both 
forward and reverse directions using the general PCR protocol described in 
Chapter 2 (section 2.3.7). 
3.2.3 Library screening for Bos taurus XIST 
A lambda genomic library was screened for a XIST clone. A 980 bp probe 
fragment was designed to the known bovine sequence (within exon l) using the 
primers shown below: 




Product: 979 bp 
These primers were designed from a genomic Bos taurus XIST gene fragment 
DNA sequence deposited previously into Genbank by the author (gb: AF104906, 
position 1125-2104). PCR products were electrophoresed on a l % TBE agarose 
gel, purified using a gel extraction kit (Qiagen) and end-labelled as described in 
Chapter 2, section 2.1.5. 
A commercial phage library was screened as detailed in Chapter 2, section 2.1. 
library clones that gave a strong signal after hybridization with the XIST probe 
were selected, amplified (see Chapter 2, section 2.1.8) and the 5' and 3' A arms of 
the vector removed by digestion with Notl. The inserts were isolated in a l % 
TBE gel, purified using a gel extraction kit (Qiagen), cloned into a Bluescript 
KS+ vector (see Chapter 2, section 2.1. l 0) and sequenced using ABI dRhodamine 
terminator chemistry with a ABI 377 DNA sequencer (see Chapter 2, 
section 2.2. l and below). 
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Standard T3 and T7 primers (T7: gtaatacgactcactatagggcg, T3: 
aattaaccctcactaaaggg) or M 13-20 and M 13 reverse primer (M 13-21: 
gtaaaacgacggccagtg and Ml3_reverse: tcatggtcatagctgtttcc) were used to obtain 
the initial sequence data. Subsequently, clones that showed similarity to those 
database sequences with a known coding potential were sequenced further using 
internal primers designed as more sequence information was obtained. 
3.2.4 X/ST DNA sequencing and screening strategy for SNPs 
DNA sequencing of PCR products of bovine XIST was carried out as outlined in 
Chapter 2, section 2.2.1. SNPs were detected by direct inspection of 
heterogeneity on electropherograms or by ClustalX-facilitated comparison of the 
sequence data files from a number of different animals. Confirmation of sequence 
heterogeneity for SNP2 was carried out by performing replicate sequencing runs 
(with at least three-fold total sequence coverage). 
This sequencing project focused on the 5' end of the XIST exon I, as sequence 
data for this region had been obtained previously by comparative genetic studies 
in other species (Hendrich et al., 1993). 
A portion of the bovine XIST gene was sequenced from PCR products amplified 
from a B. taurus genomic template using universal consensus primers. Universal 
pnmers (Bov XistF: attgtggtatcatgaggtgggaaa, Bov XistRev: 
agcgaggtgctatgctaactcat), designed to a known 650 bp bison XIST gene fragment 
(Bison bonasus, gb: L10727) but with consideration of sequence data from - in 
order of descending weighting because of different relative similarities to bison 
XIST - human, equine and leporine, were used to amplify and sequence a portion 
of the B. taurus gene. Regions flanking this fragment were amplified by 
sequential 'walking'; each PCR used one known bovine sequence (found m 
earlier sequences) and one primer designed from the XIST sequence data of 
other species. 
A gapped BLASTN search of the bovine XIST fragment was performed against 
sequences stored on the NCBI databases 
(http://www.ncbi.nlm.nih.gov/gquery/gquery.fcgi). ClustalX software was used 
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for the alignment of XIST sequences - human (gb:HUMXIST), murine 
(gb:L0496 I), equine (gb: U509 I I), leporine (gb:OCU509 l 0) and bison 
(gb:BISX/STAA) - to confirm sequence similarity. 
3.2.5 XIST expression analysis by RT- PCR 
The RT-PCR/RFLP method described in detail in section 3.2.7, using primers 
(BXPM.F and BXPM.R) that incorporate a Pvull site in the reaction products, 
was used to amplify a 142 bp fragment corresponding to bovine XIST. 
Beta-actin (/J-actin) was chosen as a house-keeping gene to determine the quality 
of the RNA used and to provide a semi-quantitative measure of relative XIST 
levels in the mammary and liver tissues examined. The primer sequences used for 
amplification of a 25 I bp fragment from the bovine /J-actin transcript were: 
Forward: GGCATCCACGAGACCACCTWCAA 
Reverse: CACA TCTGCTGGAAGGTGGACAG 
3.2.6 Northern blotting 
3.2.6.1 mRNA enrichment from total RNA for Northern blotting 
mRNA was enriched from a 100 µl aliquot of pooled mammary gland total RNA 
(50 µl from each of two animals, representing around 3.2 X 107 cells) using the 
PolyATtract® mRNA Isolation system (Promega), and resuspended in 20 µl of 
DEPC-treated deionised water. This protocol selects mRNA by binding 
biotinylated oligo(dT) beads to polyA RNA and then selecting these beads 
paramagnetically using streptavidin-coated magnetic beads. A 5 µl aliquot of this 
mRNA (-0.5 µg) and enriched mRNA prepared from male bovine liver using the 
same technique were used in Northern blotting as described below. 
3.2.6.2 Gel composition and electrophoresis conditions 
Northern blotting was carried out according to Ausubel ( I 997) at conditions 
recommended for successful blotting of large transcripts (the XIST transcript is 
19.3 kb and 17.4 kb in the human and mouse, respectively (Hong et al., 1999; 
Hong et al., 2000) and it is likely to be of a similar length in Bos taurus). 
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Specifically, gels with a low agarose concentration (0.7%) were used, ethidium 
bromide (EtBr) was omitted from the loading buffer, the gel was pre-treated in 
NaOH before blotting, and blotting was carried using 10 X SSC transfer buffer. 
All gel apparatus was pre-treated by soaking in 0.2 M NaOH. A 0.7% agarose 
MOPS gel (14 X 10 cm) was prepared by dissolving 0.7 g of agarose in 72 ml of 
DEPC water (see Appendix 5) and boiling. The solution was allowed to cool to 
65°C and 10 ml of 10 X MOPS (see Appendix 5) added with continual stirring. 
Finally, 18 ml of 12.3 M formaldehyde was added and the solution mixed and 
poured into a gel tray. 
For each loading, 0.5 µg of an enriched mRNA sample (section 4.2.2.1) was 
bought to a volume of 11 µl with DEPC-H20 in a 200 µl PCR tube and 5 µl of 
I OX MOPS, 9 µl of 12.3 M formaldehyde, and 25 µl of formamide was added. 
The sample was denatured by incubation at 65°C for 15 min. After denaturation, 
10 µl of a formaldehyde loading buffer (see Appendix 5) was added to each 
sample, the contents mixed by gentle flicking, and the samples loaded directly on 
the gel. Electrophoresis was carried out for 4 h at 5 V/cm (50 V) in IX MOPS 
buffer until the bromophenol blue (BPB) dye front had migrated approximately 
half of the length of the gel. A single lane was removed from the gel, washed for 
20 min in 0.5 M ammonium acetate, and then stained for 40 min in the same 
solution after the addition of 0.2 µg/µl EtBr. Staining of this lane showed diffuse 
staining with no clear bands, as would be expected of an mRNA enriched 
specimen. 
3.2.6.3 Blotting 
The gel was washed 2X 5 min in DEPC-H20, soaked in 50 mM NaOH/1.5 M 
NaCl for 30 min and neutralized in 0.5 M Tris (pH 7.4)/1.5 M NaCl for 20 min. 
Finally, the gel was soaked in lOX SSC for 45 min before blotting overnight onto 
Hybond N+ nylon membrane using a standard upward capillary transfer (Ausubel 
et al., 1997). Following blotting, the membrane was washed briefly in 2X SSC to 
remove residual agarose and allowed to air-dry. The RNA was then cross-linked 
to the membrane in a UV cross-linker (Stratagene, 254 nm, 120 mJ/cm2). 
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3.2.6.4 XIST DNA probe hybridization 
The membranes were hybridized overnight at 60°C with the probe produced as 
described below, washed in 3X SSC/0.1 % SDS for 10 min at 60°C and for 5 min 
in IX SSC/0.1 % SDS, and exposed to autoradiographic film (XR-MAT) 
overnight. 
A 303 bp XIST DNA probe encompassing the SNP-containing region, was PCR 
amplified from a SNP2 heterozygote DNA template (animal 696) using the 
primers PFl and BXPR (see section 3.3.5), gel-purified, and labelled using 
random priming (Rediprime™ kit, see Chapter 2, section 2.1.5). 
3.2. 7 Measuring the frequency of SNP2 by PCR-RFLP 
A PCR/RFLP test was designed to allow the routine and reliable detection of 
SNP2. This diagnostic test utilises mismatches incorporated into a forward primer 
(BXPM.F) to produce a Pvull restriction site (CAGICTG) in products with a 
guanine residue immediately 3' of the primer binding site (G-allele). The PCR 
product from the other allele gives a PCR product (T-allele) that is indigestible 
with Pvull. The PCR product represents positions 161 to 303 of Genbank 
AF104906 (Appendix A.3.2); SNP2 is at position 188 of this sequence. 
A partial nested-PCR reaction, minimised the co-amplification of a SINE 
sequence (submitted to Genbank as gb:AF181665) that was sometimes seen as a 
spurious product on the gel at about 430 bp. This reaction used the following first 





The PCR reaction was carried out using 50 ng of genomic DNA in a final reaction 
volume of 25 µl (comprising 200 µM dNTPs, 0.7 U of Taq DNA polymerase, and 
0.8 pmol of each primer, for 94°C/2 min and 20 cycles of 94°C/30 sec, 60°C/20 
sec, 72°C/30 sec), and gave a 303 bp product. 
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A second round of PCR was carried out using the forward primer: 
BXPM.F AATTCATAAAATATTTTTAAACAGCT 
TARGET TTAAGTATTTTATAAAAATTTTTGGA Actual bovine XIST sequence 
The forward primer BXPM.F annealed to its target with first cycle mismatches 
(bolded) to produce a PvulI site. BXPM.R was used as the reverse primer in this 
second reaction. 
Five to ten ng of PCR product from the first reaction was used as template in a 
reaction with a final volume of 25 µl (with identical amounts of PCR reagents to 
those used above). The PCR conditions used were 94°C/3 min followed by 25 
cycles of 94°C/15 sec, 50°C/30 sec, 72°C/30 sec with a final extension of 2 min 
at 7i'c. 
Following PCR, 1 OU of Pvull was added directly to the reaction and, after 3 h of 
digestion at 37°C, the resultant fragments were ethanol-precipitated, washed and 
re-suspended in TE buffer before final electrophoretic separation on a 2% TBE 
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Figure 3.1. Sample TBE agarose gel (2%) showing a range of digested PCR products from 
homozygous (lanes 2, 8-10 showing 'G' allele homozygotes, lanes I and 3 showing the 'T' Allele 
homozygotes), and heterozygous (lanes 4-7) animals. Lane 11 is a negative control from the PCR 
and the lanes on the far left and right of the gel are 100 bp DNA ladder (New England Biolabs). 
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3.2.8 SNP2 frequency calculated on pooled DNA from a large 
number of animals 
A population-wide assessment of allelic ratios was measured using a protocol 
described previously (Uejima et al., 2000) with minor adaptations. A 142 bp 
fragment was amplified from a 1 µI aliquot (approximately IO ng) of the first 
round template using the Pvull restriction site primers BXPM.F and BXPM.R, as 
described above using 26 cycles of PCR. Finally, 0.2 pmol of a 33P end-labelled 
reverse primer was added before the final cycle of PCR and an extension at 72°C 
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Figure 3.2. Diagram showing PCR strategy for both individual animal and mass-screen allelic ratio 
determination experiments. Screening of individuals was carried out using nested PCR with the 
primers: PFI and BXPM.R, followed by an 'internal' PCR with the primers: BXPM.F and 
BXPM.R. The mass-screening experiment used a 33P-5' labelled reverse primer (BXPM.R) in the 
final cycle of PCR before final digestion with the restriction enzyme Pvull. 
Templates used included DNA extracted from a retail consumer milk sample (see 
Chapter 2, section 2.2.3). The control for this experiment was a heterozygous 
DNA sample from animal #696. 
After PCR, fragments were digested with Pvull (as described above) and 
separated on a 0.75 x 80 x 80 mm 15% acrylamide gel (see Appendix 5) run at 20 
V /cm for 1.5 h. After electrophoresis the gels were dried and exposed overnight 
to a phosphor-imaging plate. Digital images of the phosphor plates were collected 
and relative quantities of cut to uncut fragments determined for each of the 
samples using gel analysis software. 
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3.3 Results 
3.3.1 pG6PD.B clone: AF531754 
Preliminary sequencing of putative G6PD clones using M 13 sequencing primers 
identified one clone that potentially contained the G6PD target region of interest. 
This clone, which was inserted in the 5'-3' orientation relative to the vector's 
Reverse primer site, showed similarity to exons 9-12 of previously published 
G6PD sequences. Notl restriction digest of this sub-cloned fragment and gel 
electrophoresis for fragment size analysis on a 0.7% TBE agarose gel, showed 
that the clone corresponding to the putative G6PD gene insert size was around 5 
kb (Figure 3.3). 
The clone was sequenced from the reverse primer end of the vector using a 
walking approach until the putative end of the gene was reached (that is, only the 
region similar to G6PD was sequenced). Sequence analysis was carried out using 


























Figure 3.3. Photographs of0.7% TBE agarose gels showing the selected A clones after sub-cloning 
into pBluescript, plasmid purification and restriction digest with Natl (plus Sall for pXIST). 1) 
pXIST a fragment with total length of around 12 kb (represented as fragments of approximately 8 
kb, 1.2 kb, 1.3 kb, 700 bp and 500 bp) and 2) a bovine G6PD-like clone (pG6PD.B) comprising a 
5 kb insert (digested just with Natl). The band at 3 kb is the linearized vector. 
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As detailed in the Appendix, this clone was later shown to be a likely pseudogene 
sequence, with similarity to published authentic G6PD sequences, and was 
annotated accordingly before being submitted to Genbank (reference gb: 
AF531754). 
3.3.2 Bovine X/ST 
3.3.2.1 Sequencing XIST 
In total, 2182 bp of XIST was sequenced from PCR products and submitted to 
Genbank (gb: Af 104906) (See Appendix A.2.3.2 for sequence data and Chapter 
2, section 2.6, for primer list). 
3.3.2.2 BLAST confirmation of XIST sequence 
BLASTN searching (http://www.ncbi.nlm.nih.gov/BLAST) returned 410 hits for 
the bovine X/ST sequence (in section 3.3.1.1 ). These gapped results were 
predominantly short sequences but also included two H.sapiens (gb:AL353804, 
M97168), one leporine (gb:U50910) and an equine (gb:U5091 l) sequence, all of 
which have at least moderate overlap with the query sequence and some of which 
encompass its entire length. Similarity was also found to several rodent 
sequences including Mus musculus (Mouse; gb:MMU29341) and Microtus 
rossiaemeridionalis (Southern vole; gb:AJ3 l O 130). 
The Bison bonasus (gb: L10727) sequence (that had the most weighting placed on 
it for the initial primer design) had 98% identity to Bos taurus XIST in the 650 bp 
overlap between the two sequences. 
3.3.2.3 RT-PCR to confirm XIST sex-linkage 
As shown in Figure 3.4, the XIST transcript was detected in the mammary and 
female liver samples but not in the male liver sample. 
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Figure 3.4. RT-PCR to confirm female-specific XIST expression and lack of expression in the 
male liver control tissue. A bovine /J-actin product was amplified as a control and the expected 
product of this house-keeping gene (251 bp) is shown. 
This RT-PCR result showed X-linkage of the XIST transcript as no XIST mRNA 
was detected in RNA extracted from male liver. Furthermore, expression was 
detected in the mammary specimen, which indicated that XIST would be 
detectable in the mammary specimens analysed in Chapter 4. 
3.3.2.4 Northern blot 
A Northern blot was carried out according to the protocol in section 4.2.2. The 
negative control (male liver enriched mRNA) was chosen, as male somatic cells 
are not expected to express XIST and an XIST probe should not give an 
autoradiographic signal in this sample. The suitability of the male liver mRNA 
negative control was previously confirmed by an RT-PCR reaction using RNA 
samples from the livers of both female (+ve) and male (-ve) animals that showed 
the expected female specific expression XIST expression profile and that the 
house-keeping gene control gene ~-actin was detectable in all tissues examined 
(section 3.3.2.3). The blot was probed with a 303 bp XIST probe and the resultant 
autoradiograph is shown in Figure 3.5. 








Figure 3.5 . Northern blot of mammary and liver (male) enriched mRNA (0.5 µg loaded). A 303 
bp a-[32P]dCTP labelled DNA corresponding to a 5' region of exon 1 of the XIST gene was used as 
a probe. 
This Northern blot confirmed the findings of the RT-PCR experiment presented in 
section 3.3.2.3. Specifically, this blot showed that the XIST gene is expressed in a 
sex-specific pattern, with expression detectable in mammary tissue (female) but 
not in liver tissue (male). We endeavoured to repeat this experiment but had 
insufficient enriched RNA to do so. Ideally, this experiment should be repeated 
with: 1) a greater amount of enriched mRNA, 2) detection of a housekeeping gene 
to confirm the quality of the specimens loaded, and 3) an additional specimen of 
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enriched mRNA from female liver. As an alternative, real-time quantitative PCR 
(QPCR) could be used as, like Northern blotting, this would show relative levels 
of XIST expression and would confirm the sex-specific expression pattern. 
3.3.2.5 pXIST clone: AF531755 
0.7% TBE agarose gel electrophoresis showed that the putative XIST clone insert 
had a length of around 12 kb (Figure 3.3, above). The selected subclone was 
sequenced from the 'Reverse primer' site towards the insert to yield a total 
fragment size of 3562 bp. Sequence obtained from the M13 -21 direction showed 
database similarity to SINE and LINE-rich sequences. Somewhat 
disappointingly, Genbank searches using the sequence obtained showed that the 
presumed 'X/ST-positive' clone had no similarity to XIST gene sequences from 
other animals (or to the probe used in its identification). An in silica translation of 
this sequence showed significant similarity to the huntingtin-associated protein 1 
(HAP-I) gene in mouse and human (mouse gb: NM_010404; human gb: 
NM_003949). 
A complete sequence analysis, with exon/intron boundary prediction, was carried 
out and is described in Appendix 2.2.2. The clone was annotated as an HAPl-like 
pseudogene (from the limited available sequence data available) and was 
submitted to Genbank (gb: AF531755). X-linkage of this fragment was 
not confirmed. 
3.3.3 SNPs in the Bos taurus XIST gene 
Analysis of the 2182 bp of XIST gene sequence (gb:AF104906) obtained by direct 
sequencing revealed two SNPs. 
3.3.3.1 Candidate XIST SNP 1 (SNPl) 
Ten cows were screened for polymorphisms in the 2182 bp fragment of XIST 
exon 1 by direct sequencing, using ClustalX to compare the obtained sequences. 
A putative SNP designated SNPl, resulting in an Mnll RFLP, was detected in 
some sequences (Figure 3.6). Unfortunately, this polymorphism could not be 
reliably detected. This possibly could be due to allelic dropout during PCR of the 
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region. However, this explanation is not likely, given that optimal amounts of 
template was used in the PCR wheras allelic dropout usually only occurs under 
suboptimal conditions when the total template is present at a low copy number 
and/or is of poor quality, for example, where PCR is performed on single cells. A 
number of alternative strategies were used in an attempt to eliminate this problem. 







Figure 3.6. Partial electropherograms showing sequences from animal homozygous for the: a) 'C' 
variant b) 'T' variant and c) a heterozygous animal. While early sequencing efforts gave 
promising results, this polymorphism was not reliably detectable (images were cropped from 
complete electropherograms). 
However, none of these methods, including the use of a proof-reading polymerase 
(Pwo) in equal proportion to Taq polymerase or PCR using an allele-specific PCR 
forward primer that bound immediately 5' to the SNP, produced a reliable 
detection of both alleles of the SNP. 
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3.3.3.2 Candidate XJST SNP 2 (SNP2) 
A second putative SNP was identified by direct examination of the sequence 
electropherograms obtained in 3.3.4.1 (Figure 3.7). This polymorphism has two 
alleles, designated as 'G allele' and 'T allele' to indicate that one variant has 
guanine while the other variant has thymine at position 188 of Genbank sequence 
AFI 04906 (see Appendix A.3.2). 
ACCAAMA'ITCATAAM 'mTTTI'IAAAMCC TNl\AC 'ITTCTTCThGTATTIT CTTGACACC TT 
130 140 150 160 170 180 
+ 
Figure 3.7. A partial electropherogram showing both the position of SNP2 and general sequence 
quality obtained for this region of the bovine XIST gene. The SNP is indicated by an arrowhead 
and heterogeneity is seen at this position as the template DNA for this sequencing reaction was 
sourced from a heterozygous animal. 
Initial sequencing of the putative SNP-containing region was carried out at least 3 
times to ensure high sequence accuracy and to confirm the authenticity of the 
polymorphism (a complete electropherogram for this region of XIST in a 
heterozygous animal is presented in Appendix 1 ). 
3.3.4 Screening a population for SNP2 by PCR-RFLP 
The PCR-RFLP protocol described in section 3.2.7 was applied to the 
polymorphic XIST loci of 88 female animals (representing 176 total alleles). The 
'G allele' : 'T allele' ratio was found to be about 4: 1, with frequencies of 0.8 and 
0.2 for the G and T alleles, respectively. 
While the numbers of animals screened were reasonably low (n=88), differences 
in the allelic frequency were apparent in the three different breeds examined. 
Friesian animals showed a frequency of 0.74 to 0.26 (n=58) while Jersey cows 
exhibited a frequency of 0.65 to 0.35 (n=20) for the G and T alleles, respectively. 
None of the Sahiwal animals examined in the screen (n=lO) exhibited the T 
allele (Table 3 .1 ). 
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Breed No. of cows Frequency of G allele Frequency of T allele 
Fresian 58 0.74 0.26 
Jersey 20 0.65 0.35 
Sahiwal 10 1 0 
88 total Avg. 0.80 0.20 
Table 3.1. Allelic frequencies for SNP2. SNP2 Allelic ratio calculation from a population of 
animals (n=88). 
Total number of individuals with genotype data: 88 
Population data sample size (number of chromosomes): 176 
Average estimated heterozygosity: 32% 
G 
T 









3.3.5 SNP2 Allelic ratio calculation on pooled DNA from a large 
number of animals 
Samples of commercial milk were assessed for total allelic ratios (section 3.2.5) 
and, after comparison of the relative amounts of cut to uncut PCR product, were 
found to display an allelic ratio of approximately 1 :5 for the T and G alleles of 
SNP2 respectively. This result is similar to that obtained by large scale screening 
of individual animals (Figure 3.8) but may overestimate the frequency of the 
G allele. 
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Figure 3.8. A 15% acrylamide gel phosphor image showing separation of digested PCR products 
in the allelic ratio experiment. The homozygous control samples (TIT and G/G) gave a single 
band after PCR, restriction digest and electrophoresis. The individual heterozygote sample gave a 
ratio of around 2: I (G:T alleles) which deviates from the expected l: l ratio for this sample. The 
pooled retail milk sample (Retail) gave a ratio of approximately 5: I for the G and T alleles, 
respectively. This showed a higher G allele than the allelic average determined by direct PCR-
RFLP (with agarose gel analysis). The higher molecular weight fragment (142 bp) is uncut 
product (all T allele product) and the lighter fragment (124 bp) is completely cut (just G allele 
product) . Also, see Figure 4.3 in Chapter 4, which shows the amplification bias in the Gff lane 
more clearly than in this figure. 
3.3.6 Other potential bovine X/ST SNPs 
The bovine X-inactivation centre (XIC), which contains the XIST gene, was 
recently sequenced and has been published in Genbank in 2002 (gb:AJ42148 l) 
(Chureau et al., 2002). This sequence was determined from a number of bovine 
genomic bacterial artificial chromosomes (BAC) (determined by 'shotgun' 
sequencing of sub-cloned sheared BAC fragments to 10-fold coverage) to produce 
a 233 kb XIC fragment. This fragment was subjected to a two-sequence BLAST 
search using AFI04906 XIST (the partial bovine XIST sequence obtained in the 
present study) as a query. This search revealed an additional putative SNP. The 
putative A-C SNP is located at position 116103 of AJ421481; position 17 
of AFI04906. 
AJ421481: 116087 ttcttaaagcgctgcactttgctgcgaccgcca 116119 (Chureau BAC sequence) 
AF104906: 1 ttcttaaagcgctgcaatttgctgcgaccgcca 33/EXON 1 start (our sequence) 
A portion of the original electropherogram is shown in Figure 3.9. 
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Figure 3.9. Electropherogram, in both forward and reverse directions, showing sequence data for 
AF104906 corresponding to SNP-containing region in the BAC sequence (AJ42148 l) and 
confirming a putative polymorphism A+-+C SNP3 (Grey bars). 
This corresponds to the promoter region of the bovine XIST gene located 16 bases 
5' to the start of the exon and therefore, while possibly evidence for an authentic 
SNP, is not useful in the proposed study (Chapter 4) as it would not be present in 
transcripts. The frequency of this SNP (designated SNP3) remains to be assessed 
at the population level. 
3.3. 7 Bos taurus XIST transcript features 
This bovi11e XIST sequence was compared with similar regions in human, mouse 
and bovine (Figure 3.10). The comparison revealed marked sequence 
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Figure 3.10. Showing conservation of gene orientation in the bovine, murine and human XIC. 
Used with permission from Chureau (2002). 
between all three species. Bovine XIST is likely to share mouse exons 1-7, and 
possibly exon 8, which is immediately adjacent to the poly A signal region. While 
there has been no experimental confirmation of these exons in the bovine gene, 
their presence was confirmed in the human gene ( with the exception of a predicted 
homolog of mouse exon 3). The bovine gene sequence and its predicted 
transcript, most closely matches the murine homolog and lacks human XIST exon 
2 and 7 equivalents, as predicted by Chureau et al. (2002). 
In summary, these sequence data indicate that the bovine XIST transcript size is 
likely to be between 16-19 kb and is more similar, structurally, to the murine than 
the human XIST/Xist gene. 
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3.4 Discussion 
A 2182 bp (2.2 kb) fragment of the bovine XIST gene was sequenced and 
confirmed to be expressed in a sex-specific pattern using RT-PCR, with 
expression detectable in tissues from female animals (mammary and liver) but not 
in male liver tissue. The confirmation of XIST expression in bovine mammary 
tissue indicated that, if a suitable polymorphism was found to distinguish different 
alleles of XIST, the gene transcript could be used as a marker of inactive X 
chromosome choice in our study of cellular clonality in the bovine mammary 
gland (Chapter 4). 
Three SNPs were detected within the 2.2 kb Bos taurus XIST fragment making 
this sequence highly polymorphic when compared to the human X chromosome in 
general; where about I SNP is found every 3.8 kb (Sachidanandam et al., 2001 ). 
Of the three putative SNPs identified in bovine XIST, one was confirmed to be 
authentic by PCR/RFLP-based screening of a large population of animals. This 
SNP (SNP2) was selected for use in our bovine mammary gland clonality 
experiments (Chapter 4). Assuming that the 1x sequencing coverage used in this 
study gave accurate results, the SNP frequency, at about I SNP per 700 bp, may 
reflect weak sequence constraints within the analysed sequence. It is interesting 
to note that none of the SNPs identified in this study are located in the XIST 5' 
repeat region, which has been shown to be centrally important to transcript 
function (Beletskii et al., 2001). While this is likely to mean that the SNPs 
identified here are functionally silent, it is possible that SNPs within the XIST 
gene or promoter affect the initiation and establishment of X inactivation by 
somehow affecting either the "randomness" of X chromosome choice or transcript 
function. While it has not been fully characterized, SNP3 may be particularly 
interesting in this respect, as it is found in the promoter region of the XIST gene. 
In a screen of 88 animals of a variety of breeds, the XIST G allele was found at 
80% of SNP2 loci with the T allele accounting for the remaining 20% of loci. 
This is, therefore, a reasonably common polymorphism and, as around 32% of 
animals are heterozygous for the SNP, the sourcing of informative heterozygotes 
is very simple. 
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The mass-screening allelic screening experiment (section 3.3.4), which effectively 
averages out of differences in allelic frequency between breeds, revealed a similar 
ratio of T to G alleles to that found in the individual animal screening for SNP2 
(presented in section 3.3.5). One assumes that retail milk represents the pooled 
somatic cells from the thousands of animals commercially milked in a large 
collection area; maybe 2-10 X 103 animals. The results of this screening indicated 
that in this large female population, the G and T alleles are present at a ratio of 
approximately 4: 1. Unfortunately, however, the PCR approach used was found 
to have an amplification bias to the G allele and this placed limitations on the 
usefulness of this technique at the population level. This bias is examined further 
and discussed in the next chapter. 
Future investigations 
The experiments in this chapter identified a highly heterogeneous SNP for use in 
the clonality studies presented in the next chapter. However, more direct 
approaches would have improved the efficiency of screening for both the targeted 
gene sequences and for SNPs within these sequences. 
The titre of the 11. library used in this study was low (1.4 X 105 pfu/µl) and would 
not have been fully representative. In fact, considering the low titre, screening of 
this library should probably not have been attempted. However, by using a library 
of suitably high titre, an XIST exon 1 probe applied to a bovine genomic DNA 
library is likely to have revealed an authentic XIST clone. Exon 1 of XIST in both 
human and mouse is an extremely long exon (about 10kb), so a positive clone 
identified in this way is likely to contain a large stretch of XIST 
"coding" sequence. 
Alternatively, a bovine mammary cDNA library or EST database could have been 
used. This would have almost certainly prevented the isolation of pseudogenes, 
which was found to be a problem when using the genomic library. The fact that a 
library sourced from mammary tissue would also immediately confirm the 
expression of these genes in the mammary gland is an additional advantage. After 
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their identification in a library, the X-linkage of these genes could be confirmed 
using expression analysis in male and female animals. Then, techniques such as 
single strand conformation polymorphism (SSCP) analysis, originally used by 
Orita et al. ( 1989), could be used to identify polymorphic DNA, and SNPs could 
be subsequently identified by sequencing these polymorphic templates. Finally, 
the frequency of specific SNPs could be determined by allele-specific PCR or 
single nucleotide primer extension (SNuPE), and suitable SNPs selected for use in 
clonality studies. 
Chapter Four Clonal Profile of the Bovine Mammary Gland 83 
Chapter 4 
The • size and distribution of 
cellular clones • 1n the bovine 
mammary gland 
4.1 Introduction 
The measurement of the size and distribution of cellular clones in bovine 
mammary tissue is important for a number of reasons. First, there is potential for 
economic gain through improvements to gland development and the generation of 
more persistent lactation by manipulation of growth from mammary stem cells. 
Second, close anatomical similarities between the bovine and human glands make 
the bovine gland a possible model for human breast cancer (Ellis and Capuco, 
2002). Third, and although this may seem paradoxical given the statement just 
made above, the fact that bovine mammary tumours are extremely rare (Povey 
and Osborne, 1969; Swett et al., 1940) suggests that there may be critical 
differences between human and bovine stem cell regulation, and the elucidation of 
these may aid research into the prevention and treatment of human breast disease 
(Ellis and Capuco, 2002). 
While cellular clonality in the bovine gland has never been directly studied, 
Novelli et al. (2003) used histochemistry to identify the extent of homogeneity in 
sections of human breast tissue by determining the extent of expression of a 
temperature sensitive G6PD variant (the Sardinian mutant). This in situ study 
showed homogeneity in all 111 small ducts and 57 lobules examined with 
heterogeneity (polyclonality) detected in just a single large duct. This study 
supported the idea that many terminal ductal alveolar units (TDLU) have a 
monoclonal origin. However, in vitro studies using PCR based assessment of X-
linked markers have been inconclusive, with Tsai et al. (1996) and Noguchi et al. 
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( 1992) producing data suggesting that the small ducts and TDLU in the human 
gland were, respectively, monoclonal and polyclonal in origin. Peng et al. (2000) 
obtained data that suggested general clonal heterogeneity in the mammary gland, 
using one-step RT-PCR and PvuI discrimination of a G6PD polymorphism to 
show both heterogeneous and homogeneous patterns of clonality in 
microdissected samples collected from normal and carcinoma tissue, respectively. 
Considered together, these data indicate that monoclonality exists in individual 
TDLU but that individual cellular clones or patches do not extend over large 
portions of the gland. 
In the light of these human data, the working hypothesis being explored in the 
current work is that the bovine MG will display a similar clonal profile to that 
observed in the human MG. 
In order to measure the size and distribution of cellular clones in the bovine MG 
and to draw comparisons between the clonal profiles in the two glands, we chose 
to use an X chromosome inactivation (XCI) based approach. Methods based on 
XCI are commonly used in clonality studies and reveal cellular clonal profile in 
vitro by comparison of ratios of expressed alleles of X-linked genetic 
polymorphic in heterozygotes (Busque and Gilliland, 1996; Shibata et al., 1996; 
Tsai et al., 1996). 
Small blocks of bovine mammary tissue were examined to ascertain whether they 
were clonal in nature using a direct RT-PCR/RFLP protocol. 
This approach, first described by Uejima et al. (2000), measures ratios of 
expression of two allelic variants of an expressed SNP by incorporation of a 
radioactively-labelled primer in the last cycle of PCR followed by allele-specific 
digestion of the reaction products and measurement of ratios of the two alleles by 
polyacrylamide gel electrophoresis (PAGE). The bovine XIST SNP used in the 
current study, SNP2, is an expressed Gff difference close to the 5' end of exon 1, 
as described in Chapter 3. 
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4.2 Methods 
All RNA extractions and enzymatic manipulations were carried out in solutions 
made usmg diethylpyrocarbonate (DEPC) treated deionized double-
distilled water. 
4.2.1 Sample collection and storage 
Fresh mammary and liver tissue samples were dissected into -2 cm3 blocks, snap-
frozen in liquid nitrogen, and stored at -70°C until required. 
4.2.2 RT-PCR/RFLP - Hot Stop method 
In this method, total RNA was extracted from a series of small mammary tissue 
blocks; each was 30 mm3 and comprised around 3X107 cells. First strand cDNA 
synthesis with random hexamer primers was used to produce cDNA (section 
4.2.2.3). A fragment of the XIST cDNA was amplified by PCR with primers 
designed to introduce a Pvull restriction site in products from one of the 
expressed variants of the gene (allele 'G'; as described in Chapter 3, section 
3.2.7). A 5' 33P[ydATP] labelled reverse primer was added before the last cycle of 
PCR to label all reaction products. RFLP was performed using the restriction 
enzyme Pvull and this revealed either heterogeneity (indicating polyclonality) or 
homogeneity (indicating possible monoclonality) by examination of digested 
products on a 15% PAGE gel (Figure 4.1 ). 
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Figure 4.1. Strategy used to measure allelic ratios in MG samples. Total RNA was extracted from 
bovine mammary tissue and RT-PCR used to amplify a diagnostic XIST fragment. Restriction 
enzyme digest of the fragment and PAGE shows a banding pattern that reflects the ratio of alleles 
in the tissue. RFLP produce three possible banding patterns: l) just the 'G'-allele, indicating 
homogeneity, 2) heterogeneity, indicating polyclonality, and 3) homogeneity for the 'T' allele. 
4.2.2.1 RNA extraction from tissue blocks - estimated cell number 
Total RNA was extracted from approximately 30 mm3 cubes of frozen tissue (see 
Chapter 2, section 2.2.2) and was resuspended in 50 µl of DEPC-H20. Each of 
these tissue samples weighed around 30 mg. Assuming that 1 g of tissue contains 
around 109 cells, total RNA from approximately 3.0 X 107 cells (106 cells/mm3) 
would be present in each resuspended total RNA sample. 
In addition, IO µm thin sections of mammary tissue were collected from paraffin 
blocks. Each of these 1 cm2 thin sections contains a total around 1 mm3 of tissue, 
which corresponds to approximately 106 cells (section 4.2.2.1 ). 
4.2.2.2 DNase treatment of total RNA 
DNase treatment of extracted RNA was carried out to ensure that no 
contaminating DNA was present in the sample used in the RT-PCR experiments. 
Chapter Four Clonal Profile of the Bovine Mammary Gland 87 
One microlitre of a IOx Mn2+ buffer (6.6 mM MnCh, 100 mM Tris pH 7.8) and 1 
µl (IU) of RNase-free DNase (Promega; cat.# M610A) was added to 8 µl of total 
RNA and the reaction incubated at 37°C for 30 min. The reaction was stopped by 
adding 1.8 µl of 25 mM EGT A (final concentration of 2 mM) and incubation at 
65°C for IO min. An aliquot of this RNA was used in first strand 
cDNA synthesis. 
4.2.2.3 First strand cDNA synthesis 
A 2 µl aliquot of DNase-treated RNA was added to a PCR tube with 0.5 µl of 
random hexamer (50 ng/µl) and 7 .5 µl of DEPC water, mixed thoroughly and 
incubated at 75°C for 5 min before being placed on ice. After 5 min, 2 µl of lOX 
synthesis buffer, 4 µl of 25 mM MgCb, 2 µl of O. IM DTT, 1 µl of 10 mM dNTPs 
and 0.5 µl of SuperScript™III Reverse Transcriptase (200 U/µl) was added to 
each tube, the tubes incubated at RT for 10 min then at 50°C for 1 h. The reaction 
was stopped by incubation at 70°C for 5 min. 
4.2.2.4 PCR of XIST SNP diagnostic fragment 
A 1 µl aliquot of the cDNA produced by first strand synthesis was added to a 25 
µl PCR reaction with 2.5 µl of 1 OX PCR buffer (Roche), 2 µl of dNTPs (2.5 µM), 
17 .5 µl of high quality deionised water, 0.625 µl of Tag Polymerase (0.625 U), 
and primers for the desired XIST product, and amplified using 35 cycles of PCR: 
94°C/30 sec, 50°C/30 sec, 72°C/30 sec. The primers used, BXPM.F and 
BXPM.R, are described in Chapter 3, section 3.3.5. 
The 'hot-stop' PCR reaction was completed by including end-labelled (see 
Chapter 2, section 2.2.4) reverse primer (BXPM.R) in each reaction tube, to a 
final concentration of 1 pmol, and carrying out a final cycle of PCR. This 
prevents the production of labelled heteroduplex products, which could be 
produced if the labelled reverse primer was incorporated at an earlier cycle 
of PCR. 
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4.2.2.5 RFLP 
PCR products were digested by the direct addition to a 25 µl PCR reaction of 5 U 
of the restriction enzyme Pvull followed by brief mixing and incubation at 37°c 
overnight. After digestion, the PCR products were loaded onto a 15% TBE 
acrylamide gel (see Appendix 5) and electrophoresed at 180 V (18 V/cm) 
for 1.5 h. 
Gels were dried using a flat bed gel drier (Biorad) and exposed to phosphor plates 
for 2-12 h (as described in Chapter 2, section 2.3.1). 
4.2.2.6 Direct extraction of RNA from 10 µm tissue sections for RT-PCR 
Multiple 10 µm sections were collected from paraffin blocks of MG from each of 
three animals, two XIST GIT heterozygotes and a homozygous XIST G allele 
animal. Next, total nucleic acids in the samples were extracted according to the 
protocol described by Frank ( 1996) who compared nine different extraction 
protocols and found that the following protocol gave the best yield of RT-PCR 
amplifiable RNA. 
The sections were placed in 1.7 ml tubes, 100 µl of 0.5% Tween-20 (DEPC) was 
added and the tubes agitated briefly before incubation at 90°C for 10 min. After 
the samples had cooled, 100 µl of 5% Chelex (in TE buffer) was added to each 
sample and the tubes incubated at 99°C for 10 min. Next, the tubes were briefly 
vortexed and centrifuged at 11 000 g for 15 min. Following centrifugation the 
residual wax was removed from the surface of the solutions and, after heating the 
samples to 45°C, 100 µl of chloroform was added. The solutions were gently 
mixed by finger-flicking and were again centrifuged at 11 000 g for 10 min. The 
upper phase was collected and the nucleic acids concentrated by precipitation in a 
I/101h volume of 3 M sodium acetate (pH 5.5) and 3 volumes of 100% ethanol 
(AR). This RNA was used as template in a first strand extension reaction as 
detailed in section 4.2.2.3. 
Chapter Four Clonal Profile of the Bovine Mammary Gland 89 
4.2.2. 7 PCR controls 
In Chapter 3, an amplification preference for the 'G' -allele was noted. To 
measure this effect, and to determine the influence of contaminant polyclonal 
tissue on the ability to detect clone homogeneity in tissue blocks, two control 
experiments were performed: 
1) Firstly, a heterozygous DNA template was amplified using 25 cycles of PCR so 
that the unequal amplification of the alleles of SNP2, which was seen in earlier 
experiments, could be quantified. 
A genomic DNA template was diluted 1/10 (200 ng/µl), 1/20 (100 ng/µl), 1/30 
(66 ng/µl) with water, and a 1 µl aliquot of each dilution was PCR amplified in a 
25 µl reaction as described in section 4.2.2.4. The PCR products were digested 
and electrophoresed using 15% PAGE to determine allelic ratios. The results of 
this experiment are shown in section 4.3.4.1. 
2) To determine whether contamination from non-epithelial polyclonal regions 
within the sampled tissue would affect detection of clone homogeneity in the 
glandular tissue a further control experiment was carried out. 
A PCR product was amplified from two male animals, hemizygous for the T and 
G alleles, respectively, using the primers BXPM.F and BXPM.R. The product 
was diluted to the ratios indicated in Table 4.1. As the detected allele was also 
present in the "contaminant", the actual basic ratios of "contaminant" to "sample 
epithelia", of between 1 :3 and 1 :7, were effectively equivalent to ratios of 
between 1: 3 .5 and 1 :7 .5. Fifty nano grams of this mixed "contaminant:epithelia" 
template was reamplified using 20 cycles of PCR (as detailed in section 4.2.2.4) 
and digested with Pvull (5 U) directly in the PCR reaction buffer. The effect of 
the inclusion of the contaminant mock "polyclonal tissue" was determined by 
comparison of the ratios of products obtained from each PCR reaction. These are 
presented in section 4.3.3.2. 
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Sample Ratio Spiked Contaminant 'Bpi thelial' 
1 I :3 0.5 G/0.5 T 3G 
2 I :3 0.5 G/0.5 T 3T 
3 I :4 0.5 G/0.5 T 4G 
4 I :4 0.5 G/0.5 T 4T 
5 I :5 0.5 G/0.5 T 5G 
6 I :5 0.5 G/0.5 T 5T 
"'" oc 
7 1:6 0.5 G/0.5 T 6G 
8 1 :6 0.5 G/0.5 T 6T 
9 1:7 0.5 G/0.5 T 7G 
10 1:7 0.5 G/0.5 T 7T 
Table 4.1. Table showing the ratios of template used in control experiments. These experiments 
were designed to determine whether inclusion of connective tissue in the epithelial sample would 
affect the resolution of the proposed RT-PCR/RFLP experiments. 
4.2.2.8 Calculation of percentage epithelia in mammary blocks 
Photographs were collected from haematoxylin/eosin stained mammary gland 
sections from each of the animals in the study. Epithelial cell numbers were then 
measured relative to cells within the connective tissue component of the sections 
by counting nuclei of each cell type in five 400 µm 2 frames within each 
photograph. This count was then used to calculate the average percentage 
contribution for both stromal and epithelial cells in the sections. 
4.2.2.9 Animals used in the study 
The primary study used mammary tissue from cull animals (animal/genotype: 696 
GIT, 5780 GIG and 6244 GIT) and liver samples from a heifer and a male animal. 
In an extension to this study, mammary samples from a further three SNP2 
heterozygous heifers were analysed by the same RT-PCR/RFLP method applied 
to the samples from the above animals. The heterozygous control used in PCR 
optimisation was DNA from animal 696 (a heterozygote), and the two 
hemizygous control samples for the 'T' and 'G' alleles were from male animals. 
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4.3 Results 
4.3.1 Calculation of percentage of epithelia in mammary blocks 
Analysis of cell nuclei in haematoxylin and eosin stained mammary tissue 
sections revealed that only around 80% of the cells in mammary gland sections 
were epithelial cells. Because there were considerable variations from animal to 
animal, analyses were carried out on a number of glands from which total RNA 
was to be extracted for the RT-PCR experiments (Table 4.2). The table shows a 
'corrected ratio' determined by measuring the actual areas of lobular tissue, 
comprised of epithelial cells, and of connective tissue (CT) in each sample. This 
correction factors in relative density of cells in epithelia and CT with the area of 
the sampled sections in which each cell type is found. These estimates were used 
when interpreting the results of the control experiments, which are relevant to the 
potential resolution of the Hot-Stop method. 
Animal Ratio of cell density Corrected ratio 
Sampled (CT:Epithelial nuclei) % Area epithelia of CT:epithelia 
696 1: 4.8 66.3% 1:5.6 
5780 1:4 79.5% 1:5.18 
6244 1: 3.25 83% 1:4.3 
Table 4.2. Table showing ratios of nuclei found within connective tissue and epithelial 
components of mammary gland sections that correspond to the blocks sampled for the RT-
PCR experiments. CT: Connective tissue. 
Images collected from thin sections of each of the glands are shown below (Figure 
4.2). These images show both the extent of individual lobules (in two 
dimensions) and the relative numbers of epithelial and stromal cells. 




1000 µm 250 µm 
Figure 4.2. Bovine Mammary Gland Sections. The extent of lobular bundles and distribution of 
nuclei within the mammary glands of the animals can be seen. Images A, C and E are from glands 
696, 5780 and 6244 respectively. Images B, D and F are higher magnification images from the 
same glands, 696, 5780 and 6244, respectively. 
4.3.2 Control experiments for RT-PCR/RFLP method 
4.3.2.1 Xist SNP2 Heterozygote DNA PCR/RFLP 
In earlier work, preferential G allele amplification was observed. This was 
quantified by PCR (Figure 4.3) and, after 25 cycles, twice as much G as T allele 
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product was found using Gelstar 4™ software quantification. Although different 
PCR conditions were tried (annealing temperature, cycle time etc.) it was not 
possible to correct for this preferential amplification (data not shown). 
Amplification of DNA control 
Tallele 
G allele 
1:2.2 1 :2.1 1 :2.1 
Ratio of band intensity (T:G) 
Figure 4.3. Amplification of a heterozygous DNA (from animal #696) as a control. After 25 
cycles of PCR, twice as much 'G' -allele product as 'T' -allele product was observed. The amount 
of genomic DNA loaded to each reaction is indicated on the figure as is the ratio of band intensity. 
4.3.2.2 Contaminant spiking experiment 
The methodology used in the contaminant spiking experiment, using different 
ratios of 'contaminant' to 'target' is described in section 4.2.2.7. The results of 
this experiment are shown in Figure 4.4. 
The results of this experiment were difficult to interpret, especially in light of the 
known amplification bias, which favours the G allele. Where the G-allele 
predominated, co-amplification of a T-allele product was always observed. 
Furthermore, amounts of this co-amplified product were not seen to decrease with 
increasing relative concentration of the G allele. It is perhaps possible that 
incomplete digestion of the products meant that the G allele product band was 
underrepresented in these lanes. However, this seems unlikely as this RFLP 
method had previously been used to successfully genotype animals (including 
males) in the individual animal screening experiments in Chapter 3. 
Where the T-allele was predominant, at a ratio of between I :5.5 and 1:7.5 of 
"stromal (contaminant) cells" to "epithelial cells", a product corresponding to the 
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T allele was found to predominate, with only minimal amplification of the 
contaminating G allele. Even when the contaminant was present at a ratio of 1 :3 
to the target T allele, effectively meaning that the T allele template was 3.5 fold 
the amount of the G allele template, there was clearly more T allele product than 
G allele product. The T allele product was found in increasing amounts with 
decreasing amounts of contaminant. As noted above, this was not true of the 
reactions where the G allele was predominant. 
T allele 
G allele 
Contaminant template:target template 
1 :3 1 :4 1 :5 1 :6 1 :7 
T G T G T G T G T 
Predominant allele 
G -ve 
Figure 4.4. Allele ratio banding patterns observed using different amounts of a mixed 
'contaminant' template with 'desired' template. The ratio of contaminant to target template is 
shown above the gel picture while the predominant allele is indicated below the picture. A PCR 
negative control is shown at the extreme right of the gel picture. 
If the same allelic ratio as that observed in PCR amplification from a 
heterozygous genomic DNA template (see 4.3.2.1) was found in this experiment, 
it would be expected that the amplification preference should have doubled the 
amount of G allele product relative to the T allele product. Clearly, this was not 
the case. 
This contaminant spiking experiment showed that inclusion of stromal tissue with 
epithelial tissue in the mammary blocks sampled may affect the resolution of 
homogeneously 'G' -allele expressing samples (Figure 4.4). The apparent 
preferential amplification of the T allele, which is the opposite result from that 
expected in this PCR, is difficult to explain. 
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4.3.3 RT-PCR/RFLP showed differential allelic expression 
Figures 4.5 and 4.6 show gel pictures of alleles expressed in older cull animals 
and heifers, respectively. Tables 4.3 and 4.4 show this data in tabulated form with 
an indication of relative amounts of each allele detected in heterozygous animals. 











Figure 4.5. Alleles expressed in cull animals. Three controls are included: homozygotes for the 
'G ' -allele and the 'T' allele, and an amplification product from a heterozygous sample. Actual 
tested mammary RNA samples are sourced from: I) and 2) animal #696, a heterozygote, samples 
3) and 4) animal #5780, a homozygote for the 'G' allele, and 5) and 6) animal #6244, 
a heterozygote. (See Figure 4.8 for controls). The circled number corresponds to the only 
suspected homogeneous specimen from the 16 blocks sampled. 
Animal Genotype Sample I Sample 2 
696 GIT glT Git 
5780 GIG G G 
6244 GIT Git GIT 
Table 4.3. Table showing expressed alleles in random mammary gland samples in heterozygous 
and homozygous animals. The relative intensity of each amplified band is shown by the case of 
the letter used in the results boxes. The letter case used indicates relative band intensity. 
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Patterns of clonality in MG of heifers 




TIT GIG GIT 
Figure 4.6. SNP2 Alleles expressed in five samples from three individual heifers. Control 
amplification/RFLP from a DNA template is shown in the inset panel. 
Animal Genotype I ') 3 4 
3 GIT Git Git Git Git 
4 GIT Git Git Git Git 
5 GIT Git Git Git Git 
Table 4.4. Table showing detected alleles in samples collected from three heifers. In all samples, 
the G allele preferentially amplified but due to limitations of the PCR strategy used it was 
impossible to determine if this digestion pattern reflected genuine homogeneity (for exclusively G 
allele expressing regions) in the sample. 
Analysis of the 30 mm3 samples from 6 animals gave largely equivocal results. In 
nearly all cases, the G allele predominated, but it could not be determined whether 
this was due to preferential amplification during the PCR or actual homogeneity. 
In only one sample, sample l from animal #696, was evidence for homogeneity of 
the T allele found. If this result is viewed alongside the preferential amplification 
for the G allele found in the first control experiment (section 4.3.2. l ), then it may 
be significant, as it would indicate that there was a predominance of cells 
expressing the T allele in this specimen. 
At least some of these technical problems would have been overcome if it had 
been possible to RT-PCR from much smaller tissue samples. However, efforts to 
use template extracted from l mm3 tissue samples failed to give reliable PCR 
amplification (data not shown). 
Chapter Four Clonal Profile of the Bovine Mammary Gland 97 
4.4. Discussion 
The results obtained here are clearly not definitive. Little evidence for 
homogeneity (suggesting possible monoclonality) was found in samples taken 
from bovine mammary glands. However, the fact that these samples were 
relatively large (30mm3, corresponding to approximately 3 x 107 cells, containing 
an estimated 27000 TLDUs, at approximately 1 TDLU per 1 mm3 and 1000 cells 
per TDLU) might mean that smaller areas of homogeneity, <30 mm3, would not 
be detected. Interesting though, if one was to accept that one sample out of the 
sixteen analyzed (that is, specimen 1 for animal #696; see Figure 4.5) was actually 
displaying homogeneity, then probability considerations, with 1 of 16 30 mm3 
regions shows homogeneity so 1 of 8 15mm3 regions will show homogeneity etc., 
would predict that, on average, regions of around 2 mm3 in the bovine gland must 
be homogeneous. If this is the case, then these regions would be larger than those 
shown to be homogeneous in the mouse (Thomas et al., 1988). However, given 
that the bovine gland has a weight of approximately 10 kg, compared with 
approximately 0.7 g for the mouse gland, it is perhaps likely that much larger 
areas of the bovine gland have a monoclonal origin (the standard formula for 
calculating mammary weight [kg] is: 0.045 X W 0·82; where W=matemal 
bodyweight). This would particularly likely if the numbers of progenitors in both 
glands are approximately equal. If, however, the bovine gland is derived from a 
larger progenitor population, say 1000 fold that found in the mouse gland, then it 
would be unlikely that extensive regions of homogeneity would be found in the 
bovine gland. If the size of the progenitor population for both glands is found to 
be similar, then a transit-amplifying cell population may be particularly important 
in the bovine gland. Future studies on glands from these species are likely to 
examine the relative size of the stem cell progenitor population and possible 
differences in involvement of a transit-amplifying cell population in gland growth. 
It is interesting to note that, in the 0.7 g murine mammary gland, analysis of 
epithelial patch sizes show that the gland is predominantly heterogeneous, with 
homogeneity only observed in some terminal ducts (Kisseberth and Sandgren, 
2004; Thomas et al., 1988), whereas, in the ::::::1500 g human gland, homogeneity is 
reported in individual TDLU (Novelli et al., 2003; Tsai et al., 1996). In these 
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studies of the human breast, heterogeneity, indicating polyclonality, was seen only 
in larger ducts. 
Clearly, it would be preferable to measure clonality in individual TDLU or, at the 
very least, just a few TDLU, in a sample of :'.SI mm3 (the approximate size of a 
single TDLU). Attempts were made to analyze the clonal profile in single IO 
mm2 sections, comprising around 1 mm3 of tissue (106 cells), but these were not 
successful, as it proved impossible to extract sufficient RNA from these tissues 
for RT-PCR. If amplification had been possible, then such specimens are more 
likely than larger blocks to reveal possible homogeneity in expression of the 
SNP marker. 
Two technical problems appeared to limit the RT-PCR analyses, the amplification 
method and the low level of XIST transcripts. The RT-PCR/RFLP technique used 
in this study was adapted from the Hot Stop technique originally described by 
Uejima (2000). In our hands, this method was found to have a number of 
limitations, especially when applied to discrimination of alleles of the XIST SNP. 
A requirement of the Uejima method was that very few cycles of PCR were 
performed. This is to limit the potential for amplification bias and possible 
inaccurate assessment of clonality. We found that the XIST transcript was 
difficult to amplify directly from cDNA. We believe that this may be due to 
either of two possible reasons: 1) the expression of the gene was too low for 
reliable detection (as seen in the requirement for an enriched mRNA for detection 
of the XIST transcript by Northern blotting in Chapter 3), or 2) the mismatches in 
the forward primer that were required to produce a Pvull site in products of the G 
allele. This may have prevented the primer from annealing correctly during early 
cycles of PCR. The PCR amplification bias was an added complication, as it 
resulted in a two-fold preference for the G allele after 25 cycles of PCR. Although 
the PCR conditions were manipulated in an attempt to counteract this bias, no real 
improvement was produced. In summary, the analyses lacked both sensitivity and 
discrimination. 
Future investigations 
• A full characterization of cellular clonality in the bovine MG will benefit 
our basic understanding of MG biology. In particular, deducing the 
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'where and how' of mammary stem cell proliferation and cellular clone 
formation will reveal ways in which the bovine gland can be manipulated 
to achieve more sustained lactation and greater output. It is also possible 
that identification of differences between the human and bovine glands 
may give clues as to why cancer is so rare in the bovine gland (that is, 
beyond the obvious difference in lifespan). 
• XIST SNP2 has potential as a marker of clonality as heterozygotes are 
found at a high frequency (32% heterozygosity) and this makes the 
selection of informative animals simple. Furthermore, many studies of 
XIST expression have shown that it is expressed exclusively from a single 
X-chromosome so it should be a very reliable indicator of the inactive 
X chromosome. 
• More sensitive RT-PCR techniques should be able to extend the detection 
sensitivity enormously, for example, making it possible to analyse the 
clonal profile in a sample of just 10 to 100 cells from a 
microdissected TDLU. 
• As an extension to our experiments, an in situ hybridization approach 
could be applied to thin sections to discriminate alleles of the XIST SNP. 
Allele specific in situ hybridization (ASISH) had been used previously to 
distinguish single nucleotide differences in HI 9 and IGF2 transcripts with 
a 35S labelled 30mer oligoprobe (Adam et al., 1996). Alternative in situ 
methods, such as allele-specific primed in situ synthesis (PRINS) or allele-
specific 'padlock' probe hybridization (Nilsson et al., 2000) may also be 
trialled to achieve the desired resolution and sensitivity for discrimination 
of an SNP. We believe that these techniques may be applicable to 
mammary clonality studies, particularly when a highly expressed gene is 
chosen for analysis. Such an approach would allow measurement of 
clonal profiles by direct observation of individual TDLU and ducts on l 0 
µm sections and profiles would not be affected by the presence of 
surrounding stromal tissue. 
• With the publication of bovine mammary EST databases it has now 
become simple to look for SNP in other (more highly expressed) X-linked 
genes. As outlined in the discussion of the previous chapter, this would 
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allow the rapid identification of alternatives to XIST for both in vitro and 
in situ experimental assessment of clonality. 
• In situ approaches using a well-expressed X-linked gene polymorphism as 
a marker of clonality will be useful as it eliminates the potential effect of 
contaminating stromal (which is presumably polyclonally-derived) tissue. 
Such methods will reveal the clonality of individual structures in the 
bovine and comparison of these profiles with those of human and mouse 
may reveal differences that must be considered when using particular 
animal models of human breast disease. 
• Serial sections through a portion of gland could be reconstructed using 3D 
imaging software after in situ hybridization on these sections to detect 
each allele of the marker. This would give a better indication of general 
patterns of cellular clone size and distribution throughout the gland than 
would be possible from observations of 2D sections. 
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Chapter Five 
The H253 Mouse as a Model of 
Cellular Clonality 
5.1 Introduction 
The bovine study in presented m Chapters 3 and 4 did not give a reliable 
measurement of cellular clonality in the mammary gland. Therefore, it was 
decided that an alternative approach, using observations of patterns of mosaic 
expression of an X-linked transgenic marker in whole mount mouse mammary 
glands, would allow a better description of clonality in the mammary gland and 
aid future attempts to determine the cellular clonal profile of the bovine gland. 
5.1.1 Mouse models of cellular clonality 
Both whole mount and serially-sectioned mouse organs have been used in studies 
of cellular clonality, for example, during kidney ductulogenesis (Lipschutz et al., 
1999). While very few studies have directly examined clonality in the mouse 
mammary gland, the use of G6pd isozymes as markers of different cellular clones 
in C3H-GPDX "normal" mice enabled Thomas et al. (1988) to score the clonality 
of individual structures in mouse mammary glands. They found staining patterns 
that indicated polyclonality in both ducts and alveoli. However, the marker could 
only be reliably detected in lactating animals, so this animal was not useful in 
investigations of cellular clonality at other developmental time-points. 
The best model systems for study of cellular clonality allow for the unambiguous 
detection of the reporter gene activity without interference from high background 
levels of endogenous gene activity (Weiss et al., 1997). Obviously, for 
transgenic mouse models of cellular clonality, transgene expression must also 
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reflect the X-inactivation status of the cell. However, it is a well-established that 
anomalies of transgene expression occur quite frequently. Krumlauf (1986) 
observed tissue variation in the expression of an X-linked transgene for an a-
fetoprotein minigene that, when present on the inactive X chromosome, 
underwent transcriptional repression in the foetal liver but was not inactivated in 
the visceral endoderm. Furthermore, other X-linked transgenes, such as a 
concatemeric chicken transferrin gene insert (Goldman et al., 1987) and a human 
al(I) collagen gene (Wu et al., 1992) insert, have been found to either totally 
escape normal inactivation, due to lack of methylation, or are incompletely 
inactivated, and hence expressed at low levels from the, supposedly silent, 
inactive X chromosome. 
Despite the problems that are sometimes encountered with transgenic animals, 
some X-linked mouse transgenes have been found to be expressed in a similar 
pattern to endogenous genes; examples include CAT-32 (Collick et al., 1998) and 
M-TKneol (Dandolo et al., 1993) transgenes, which are methylated and 
inactivated similarly to endogenous X-linked genes. 
5.1.2 Selection of mouse strain for this study 
The inherent weaknesses in many of the existing X-linked transgenic mouse lines 
led Tam ( 1992) to develop the H253 transgenic mouse line for study of 
organogenesis. H253 animals exhibit an X-linked lacZ reporter gene construct 
that is reliably inactivated in a similar manner to the endogenous genes on the 
inactive X chromosome. This construct is 8.9 kb in size and contains the E.coli 
lacZ gene encoding ~-galactosidase (~-gal) under the regulation of the 
'housekeeping gene' promoter from the mouse 3-hydroxy-3-methylglutaryl 
coenzyme A reductase (Hmgcr) gene. The SV40 large T-antigen nuclear 
localization signal (nls) is present at the 5' end of the lacZ gene, and the transgene 
product is a fusion of ~-galactosidase and NLS (Figure 5.1). The authors showed 
that 14 tandem constructs were incorporated in the X chromosome at position A6 
(Figure 5.2), producing a 120 kb transgenic region, and that expression of the lacZ 
gene gave detectable amounts of gene product in the tissues examined (Tam and 
Tan 1992). 
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Mouse Hmgcr promoter 
nls • SV40polyA 
I I 
1 kb 
Figure 5.1. Diagram of the 8.9 kb transgene lacZ-NLS fusion construct used in the H253 mouse. 
The construct includes 5.6 kb of Hmgcr promoter elements and a 3.3 kb region including a 60 bp 
fragment of the SV40 large T antigen (nls) for nuclear localization, the bacterial Lacz gene and the 
SV40 polyadenylation signal (redrawn from Tam and Tan, 1992). 
Furthermore, it has been shown that, in H253 animals, the transgene: 1) was 
expressed in all cells examined in homozygotes and in a mosaic pattern in 












Figure 5.2. Schematic representation of the location of HMG-lacZ, Hprt, G6pd, Xist and Pgkl 
genes relative to the chromosomal bands on the murine X-chromosome. (adapted from 
Hadjantonakis et al., 2001). 
on chromosome Xp, and 3) was present on an intact chromosome, and therefore 
did not accelerate chromosomal deterioration by translocation (Tam and Tan, 
1992; Tan et al., 1993). 
H253 mice have been used to study the timing of X-inactivation during 
embryogenesis. Using these mice, Tan ( 1993) showed that pronuclei of newly 
fertilized oocytes exhibit histochemically detectable ~-galactosidase and that this 
marker was detectable until d3.5 when the blastocyst began to show mosaic 
! 
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expression, with preferential expression of genes on Xp that indicated the 
beginning of X inactivation. 
5.1.3 The HMG-CoA reductase (Hmgcr) gene promoter 
Three regulatory elements have been found within the rat Hmgcr promoter: 1) a 
sterol response element (SRE) for SRE-binding protein (SREBP) mediated 
regulation of expression, 2) a cAMP-response element (CRE) and 3) an estrogen-
response element (ERE). These elements are located at, respectively, -160, -100 
and -90 nucleotides relative to the transcription start site in the endogenous gene 
and show significant sequence similarity among human, rat, mouse and hamster 
Hmgcr genes (Di Croce et al., 1999). All of these sites could modulate transgene 
expression levels. 
So, in tissues or developmental stages when the concentration of estrogen is low, 
it could be predicted that clonality assays that rely on expression from the HMG-
lacZ transgene construct (described in section 5.1.2) may not be informative. This 
is likely to be a particular problem in tissues that lack other strong up-regulatory 
signals, such as mammary tissue and possibly the endometrial components of the 
uterus, where expression of both the endogenous gene and any transgene 
employing the Hmgcr promoter may be too low for reliable detection (Figure 5.3). 
Estrogen responsive Non-responsive 
tissue (e.g. mammary) tissue (e.g. liver) 
Virgin Systemic E2 is low 
0 Activity from HMGCR Steady-state high activity • promoter is minimal from the HMGCR promoter 
Pregnant Systemic E2 rises 
• HMGCR promoter responds HMGCR promoter maintains to increased E2, via ERE sites, high steady-state of expression • to upregulate expression 
Figure 5.3. Diagram showing Hmgcr promoter activity in relation to physiological state and 
systemic estrogen levels. A low level of expression from genes with the Hmgcr promoter occurs 
in the estrogen-responsive tissues of virgin animals (in the absence of other upregulatory signals). 
In contrast, expression levels in the liver, the site of cholesterol biosynthesis (and therefore 
exhibiting steady-state requirement for the endogenous gene product from Hmgcr), are not 
dramatically affected by increased systemic estrogen. Expression in mammary tissue is predicted 
to increase during pregnancy. (Drawn from data in Di Croce et al., 1999). 
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These potential effects on the expression of gene constructs that use the Hmgcr 
promoter can be best predicted by examining systemic maternal levels of estrogen 
(specifically, estradiol [E2]). As indicated in Figure 5.4, estradiol levels are raised 
in pregnant animals and peak at around dl8. Progesterone levels show an even 
more dramatic increase in response to pregnancy, but fall sharply after peaking at 
around d 15 of gestation. 
Graph showing hormone levels in the pregnant mouse 
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Figure 5.4. Graph showing systemic hormone levels in the pregnant mouse. Pregnant mice were 
sacrificed and the mammary glands removed for lacZ staining within the 2-day period between 
d 12.5 and d 13.5 of gestation (green bar). Estradiol (E2) levels begin to increase at around d IO of 
gestation and peak at around d 18. In contrast, progesterone levels rise sharply at the beginning of 
gestation and peak earlier than estrogen levels (around dl5) at which time they decrease sharply 
until parturition where progesterone levels approximate those seen in virgin animals - the decline 
in level of systemic progesterone is necessary for lactogenesis. (Adapted from: 
http://mammary.nih.gov/reviews/lactation/McCarthyOOl/index.html). 
Based on the graph reproduced in Figure 5.4, the pregnant animals used in the 
present study were estimated to have estrogen levels of between 35 and 46 pg/ml 
and progesterone levels of between 100 ng/ml and 137 ng/ml. Nonpregnant 
animals were estimated to have approximate levels of estrogen and progesterone 
of 25 pg/ml and 5 ng/ml, respectively. 
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5.1.4 Estrogen: Mode of action via nuclear receptors 
Upon ligand (estradiol) binding, estrogen receptors (ER) dimerise and associate 
with specific 15 bp inverted palindromic repeats (the ERE - discussed below) in 
the promoters of target genes. After association with the ERE, the receptor 
complex interacts with other components of the cellular machinery to effect 
expression of the target gene (Couse and Korach, 1999). 
Estrogen receptor knock-out (ERKO) animals display a very rudimentary 
mammary ductal system relative to controls and this structure is devoid of 
terminal end buds (TEBs) (Couse and Korach, 1999). Tissue recombination 
experiments using subrenal capsule grafts in nude mice, which lack ER on 
mammary epithelial or stromal cells, have demonstrated that the estrogen 
dependency of mammary growth is stromally-mediated (Cunha et al., 1997). 
That is, the signal for epithelial cells to proliferate appears to come from adjacent 
stromal cells "activated" by estrogen. 
5.1.5 Aims 
Our experimental design focussed on determining the utility of this transgenic 
animal as a model for assessment of cellular clonality, specifically of glandular 
development in mammary tissue. Specifically, we aimed to: 
1) Confirm that tissues in the animal model show normal X inactivation in 
epithelial cellular populations and that exogenous (transgene product) 
histochemical staining can be distinguished from endogenous staining. 
2) Assess the mammary gland as an environment for efficient expression of the 
transgene by determining the relative levels of expression of the endogenous 3-
hydroxy-3-methylglutaryl coenzyme A reductase (Hmgcr) gene in various tissues 
by RT-PCR. 
3) To determine relative expression levels of the lacZ reporter construct in the 
mammary and liver tissues from both virgin and pregnant transgenic mice. 
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4) To optimise a staining method for histochemical detection of the trans gene 
product in mammary tissue. 
5) To determine whether the H253 transgenic mice are suitable for study of 
cellular clonality in the mammary gland. 
5.2 Methods 
5.2.1 Dissection of mammary glands from transgenic animals 
Glands were dissected immediately after CO2 euthanasia. A throat to pubis 
incision was made and extended down each of the legs. The skin was drawn back 
from the underlying muscle and pinned to the dissection board. Glands were 
visible as fatty tissues on the underside of the skin. Thoracic and inguinal glands 
were prepared for removal by dissection of skeletal muscle remnants, particularly 
of those muscles that overlay the thoracic glands, and by cutting through the thin 
layer of connective tissue surrounding each of the glands (Figure 5.5). 
A 
B 
Figure 5.5. Diagram showing mouse mammary gland dissection. A) and B) The location of the 
murine mammary glands (labelled 1-10) and C) the presentation of the glands after ventral-side 
dissection (Ball, 1998). 
Forceps were used to hold the most dorsal parts of the glands while they were 
carefully lifted away from the skin by gentle strokes with a #10 scalpel blade. 
Next, the glands were placed onto glass microscope slides and spread out to their 
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original in vivo dimensions. Finally, the gland was placed into a glutaraldehyde-
based fixative solution (as detailed in section 5.2.3) for 1-2 h. 
Most other tissues examined, including intestine and liver, were dissected from 
the animal after another throat to pubis incision through the ventrally-located 
muscle and connective tissues surrounding the peritoneum. These tissues were 
fixed as above, but thin-walled structures such as intestine were found to stain 
more successfully when the fixative was supplemented with 
2% paraformaldehyde. 
5.2.2 Determination of relative expression levels of endogenous 
Hmgcr gene and of the transgene by RT-PCR 
A comparative assessment of expression of the endogenous mouse gene Hmgcr in 
both pregnant and virgin animals was carried out to examine the possibility for 
tissue-specific expression of the lacZ transgene, which is under the control of the 
same promoter. 
Mouse mammary gland and liver were collected from three-month-old pregnant 
and virgin animals immediately following euthanasia. Total RNA was extracted 
from a portion of these tissues using Trizol™ reagent (as detailed in Chapter 2, 
section 2.2.2), an aliquot of the total RNA diluted in 10 mM Tris (pH 7), and 
quantified using a spectrophotometer (Smartspec, Biorad). A one-step protocol 
was used (Superscript II kit - Invitrogen) with a 'Tag polymerase positive, 
Reverse transcriptase negative' reaction included as a control. 
RT-PCR was performed on 1 ng of template cDNA to detect the Hmgcr gene 





Product size: 161 bpfrom cDNA (457 bpfrom DNA) 
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5.2.3 RT-PCR to confirm /acZ expression in mouse tissue 
RT-PCR was performed as above to measure lacZ expression in liver tissue from 





Product size: 163 bp from cDNA (also 163 bp from DNA) 
5.2.4 Histochemical detection of B-galactosidase presence 
5.2.4.1 Staining protocol selection 
Many different tissue methods for lacZ reporter staining have been reported. In 
order to select a method that was appropriate for general and mammary whole 
mount staining, two different staining protocols were assessed using a selection of 
different tissues. 
Method 1. Fixation in 2% paraformaldehyde (PFA), 0.25% glutaraldehyde, and 
0.01 % Nonidet-P40 (NP-40) in IX PBS for 2 hat RT. 
Incubation in: 2 mM MgCh, 0.01 % sodium deoxycholate (NaDOC), 0.02% NP-
40 for 2 h with rocking. Staining in a solution comprising I mg/ml X-gal (in 
dimethyl formamide - DMF), 30 mM ~Fe(CN)6, 30 mM K3Fe(CN)6.3H20, 2 
mM MgCh, 0.01 % NaDOC, 0.02% NP-40, in IX PBS overnight at 30°C. 
(This method can be found 
at http://mammary.nih.gov/tools/histological/Histology). 
Method 2. Fixation in 0.2% glutaraldehyde, 0.5 mM EGTA (pH 7.3), 2 mM 
MgCiz in IX PBS at 4 °C for I h. 
Staining overnight at 30°C in a solution comprising 1 mg/ml X-gal (in DMF, as 
above), 2 mM MgCI2, 0.01 % NaDOC, 0.02% NP-40 (final concentration 0.02%), 
5 mM ~Fe(CN)6, 5 mM K3Fe(CN)6.3H20, in IX PBS (Lobe et al., 1999). 
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NaDOC and Nonident-P40 are detergents included to aid penetration of the tissue 
by the staining reagents. MgC}i is included as a p-galactosidase cofactor. The 
EGTA in the fixative acts by chelating excess divalent cations (exhibiting a higher 
affinity for calcium, log Kapp 6.68 at pH 7, than magnesium, log Kapp 1.61 at pH 7, 
so as not to deplete enzyme cofactor; EGT A acts similarly to EDT A). 
After overnight staining by either method, tissues were post-fixed in 4% PFA and 
stored in 2% PFA. The relative amounts of staining were determined by visual 
assessment. It was found that the standardised Method 2 (Lobe et al., 1999) gave 
superior mammary gland staining compared to other published methods. 
5.2.4.2 Technical notes 
A number of technical factors critical to the success of these experiments were 
identified. These were choice of fixative, length of fixation, staining pH, 
composition of the staining solution and method of storage of stained tissues. 
It was found that to ensure complete staining throughout the entire gland, a short 
fixation in 0.25% glutaraldehyde, rather than the frequently recommended 
fixation in 2-4% paraformaldehyde, ensures adequate penetration of staining 
reactants at a later stage of the experiment. Furthermore, this fixative seemed to 
preserve enzyme activity more efficiently than a more thorough fixation in 
paraformaldehyde. A caveat is that tissues 'pre-fixed' in such a manner also 
required 'post-fixing', in 4% paraformaldehyde overnight, to prevent tissue 
deterioration and subsequent diffusion of the histochemical stain. It is relevant to 
note that Shimohama et al. ( 1989) recommended that longer term storage of 
stained tissues should be in a fixative solution, to preserve both staining patterns 
and general morphology. 
As detailed in the introduction, the pH at which the staining reaction was carried 
out was critical to the success of the histochemical staining. Ideally, one would 
like to use a pH near to the transgenic P-galactosidase optima of pH 7.3, but a 
higher pH is necessary to decrease the background resulting from the endogenous 
mammalian enzyme, which has a pH optima of around pH 7. In order to find an 
optimal pH, which gave acceptable P-galactosidase activity with minimal 
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background, trials with Tris-HCI buffered staining mixtures were carried out. The 
inclusion of 100 mM Tris (pH 8), recommended in some studies, was initially 
thought to negatively affect the staining efficiency of mammary tissues. It was 
later realised that this result was misleading, as the very weak staining found in 
mammary tissue from virgin animals was later attributed to low estrogen levels in 
the animals causing a low transgene expression (as discussed below). 
Accordingly, most subsequent experiments utilised low concentrations (usually 
20 mM) of Tris-HCI (pH 7 .8) buffering, as this was found to be sufficient to 
buffer the staining reaction at the desired pH overnight. 
5.2.5 Whole mount mammary staining: controls and 
assumptions 
5.2.5.1 Controls 
If random inactivation of an X chromosome within each stem cell in a large pool 
of mammary progenitors occurs, then mammary tissue in transgenic animals has a 
certain number of 'in-built' staining controls. That is, when both the 
histochemical staining reaction and random X-inactivation are 100% efficient 
throughout an organ in a hemizygous animal, one expects to find an 
approximately equal number of blue- and non-staining epithelial elements. In the 
mammary gland, this would be best seen at the level of individual terminal end 
buds and/or ducts. 
Direct examination of whole mount tissues permits an approximate measurement 
of the penetration efficiency of the staining reagents to be made. A gland 
displaying random X-inactivation is presumably a mosaic of cells representing 
both inactive X chromosome 'choices'. Hence, blue-stained tissues should be 
represented at all depths throughout the mammary gland. If not, then one assumes 
that staining did not take place evenly and that only thin, well-stained, portions of 
the gland should be assessed. The unavailability of homozygous H253 animal as 
a positive control was disappointing, as this control would have showed whether 
histochemical staining could be detected throughout the gland. 
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5.2.5.2 Assumptions regarding detection of the transgene product 
It was assumed that the lacZ trans gene construct in the H253 mice: 1) is expressed 
like other X-linked genes in the mouse, and 2) does not cause uneven inactivation 
profiles to the X chromosome in the mouse tissues examined. If statistically 
useful results are to be obtained, then chimeric and/or transgenic animals used in 
such studies must: 1) exhibit random mixing of the parental progenitor cell types, 
or of cells exhibiting each inactive X chromosome "choice", for chimeric and 
transgenic animals, respectively, and 2) exhibit approximately equal numbers of 
descendents from each of the two possible progenitor 'lines'. That is, for the 
transgenic animal, equal numbers of cells exhibiting either an inactive Xp or an 
inactive Xm (Hermiston and Gordon, 1995). 
5.2.6 Assessment of X-inactivation fidelity in transgenic animals 
The present study used both H253 transgenic and C57 lab-strain mouse lines. To 
confirm that H253 transgenic mouse showed normal patterns of X chromosome 
inactivation when bred with the C57 mice, the percentage of positive 
histochemical staining of crypts or follicles, in intestine and skin, respectively, 
was measured in both a hemizygous H253 transgenic mouse and in a C57 mouse. 
Intestine was removed, cut longitudinally, stained for ~-galactosidase, placed 
between two glass microscope slides, and flattened. Skin was removed from the 
animal, fixed, and stained. A series of images were obtained at 1 OOx 
magnification using a light microscope and a Nikon 995 'Coolpix' camera. 
The following digital image analysis methods were devised using advice from 
contributors at various online imaging discussion forums. The digital JPEG 
images were imported into the computer program "Photoshop 7™" (Adobe) and 
their brightness/contrast adjusted to ensure that stained regions could be clearly 
distinguished from the background. The colour images were then converted to 
greyscale (IMAGE>MODE>GREYSCALE) and the threshold command 
(ADJUST>THRESHOLD; with a greyscale midpoint of 128) used to convert the 
images to black and white. Finally a histogram of greyscale 
(IMAGE>HISTOGRAM) was obtained (effectively all pixels were converted to black 
or white) and the percentage of the frame that was black (corresponding to stained 
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regions) was ascertained (Figure 5.6). This technique relied on extensive 
manipulation of the original image, but simple trials on frames with a known 
percentage blue-staining area showed that an accurate measurement of such areas 
could be obtained using these methods. 
Assessment of X inactivation fidelity 
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Figure 5.6. Image analysis steps completed using Photoshop 7™. A raw TIFF image at 3.3 mega-
pixels was: 1) captured using a Nikon 995 camera (fine quality mode) and converted to greyscale 
(2a and b). Then, 3 a) the image was "bitmapped" with a threshold of 500/o, resulting in a black 
and white image and finally, 3 b) a histogram of greyscale (effectively of just black and white 
channels) was obtained. The stained (J3-gal positive) area in this sample frame is 44.66%. 
The percentage area of stained intestinal crypts or hair follicles was measured in 
each of the examined frames. The combined average of stained regions for each 
tissue type was determined and is presented in Table 5.1 . 
5.2. 7 Whole mount mammary staining: experimental 
Entire mouse mammary glands were stained according to the protocol detailed in 
"Method 2" (section 5.2.4). The relative amounts of histochemical staining in 
whole glands from transgenic virgin and pregnant animals, as well as from non-
transgenic animals, are shown in results section 5.3.8. 
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5.3 Results 
5.3.1 RT-PCR indicates that the H253 mouse expresses the JacZ 
transgene in liver 
As detailed in section 5.2.3, a preliminary RT-PCR experiment was performed to 
ensure that the model animal was expressing the transgenic construct. The 
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Figure 5.7. RT-PCR for Lacz in liver tissue from H253 mice. The products were electrophoresed 
on a 2% TBE agarose gel (5 V/cm for 50 min). Taq+ve/RT-ve: Taq Polymerase only, no reverse 
transcriptase (control); Taq+ve/RT+ve: has both Taq Polymerase and reverse transcriptase. 
The reverse transcriptase (RT) positive lane shows a product of the size expected 
for the lacZ gene ( 163 bp ). The control reaction gave no products. This simple 
RT-PCR experiment showed that bacterial lacZ was expressed in a H253 mouse 
tissue in the breeding background used in this study. 
5.3.2 RT-PCR indicates that endogenous Hmgcr expression in 
the mammary tissues of pregnant animals is higher than that in 
virgin animals 
A product of the size expected for the Hmgcr gene ( 161 bp) was observed in both 
mammary and liver tissues. Levels of the fragment in tissue collected from 3-
month-old hemizygous H253 animals at d 12.5-13.5 of gestation were 5 to 10 fold 
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higher than levels in mammary tissue from their virgin littermates (Figure 5.8). 
However, the liver sample controls showed no obvious differences between 
expression levels in pregnant and virgin animals. 
RT-PCR: HMGCR expression In the mammary gland 











Figure 5.8. RT-PCR products showing relative levels of expression of the Hmgcr gene product in 
the mammary gland and liver of transgenic animals. While the mammary sample from the 
pregnant animal showed detectable levels of Hmgcr gene product (with I ng of total RNA 
template), a similar sample from a virgin animal showed very low levels of expression, as seen by 
the faint product band after 35 cycles of PCR. In contrast to the general measurement of 
expression from the mammary glands, both liver samples showed strong expression. This was 
expected, as hepatic cell lines have been shown to exhibit up to I 0-fold the expression relative to 
other cell lines examined (Tam et al., 1994). The RT-PCR results from a series of Gapdh control 
amplifications were as shown below in Figure 5.9. 
The difference in relative expression of the endogenous Hmgcr gene was 
measured using gel analysis software (GelPro 4™). A 5-fold higher Hmgcr 
expression was found in mammary tissue from the pregnant animal compared to 
levels in tissues from the virgin animal. 
5.3.3 RT-PCR for the /acZtransgene showed a marked reduction 
in expression in mammary tissue from virgin animals 
Relative expression levels of the construct were measured. The level of lacZ 
reporter gene transcript in the tissues from the pregnant animal was between two 
and five-fold higher than the level found in the virgin animal (measured using 
GelPro 4™ software). This is similar to the five-fold difference found in 
endogenous Hmgcr expression (see section 5.3.2). There appears to be a slightly 
lower transgene expression in the liver tissue from the virgin animal when 
compared with liver tissue from a pregnant animal. 
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RT-PCR showing relative expressed levels of 
lacZ and Gapdh in H253 mouse tissues 
100 bp mammary I liver I mammary I liver 








Figure 5.9. RT-PCR showing relative levels of expression the Lacz transgene and Gapdh in 
mammary and liver samples from MZPG mice. Tissues from pregnant (P) and virgin (V) animals 
were sampled, total RNA extracted, and RT-PCR performed using 1 ng and 0.1 ng of total RNA as 
template. The Gapdh control was amplified using the primers shown in Chapter 2 using only 0.1 
ng of RNA as template. 
5.3.4 Optimization of staining protocol 
Staining trials were carried out using two basic protocols, as detailed above in 
section 5.2.4. Firstly, a Lacz staining technique published online, involving 
fixation in 2% PFA, and histochemical staining in a reagent mixture that included 
30 mM ferri- and ferro-cyanide (see 
http://mammary.nih.gov/tools/histological/Histology), was tested. The second 
protocol tested (Lobe et al., 1999) required a short (1 h) fixation in 0.2% 
glutaraldehyde and staining in 1 mg/ml X-gal, in a reaction solution that included 
5 mM of each of ferro- and ferri-cyanide with standard ~-gal/X-gal 
staining reagents. 
Although neither method resulted in complete penetration of dense tissues, such 
as intact liver, the latter technique (Method 2) yielded superior results, as 
determined by direct observation of relative depths of staining. Using this 
method, entire liver stained superficially to a depth of approximately 1 mm. 
However, the entire mammary gland showed thorough staining, as indicated by an 
observation of blue-stained cells at all depths of the tissue. 
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5.3.5 Assessment of X-inactivation fidelity 
Random digital images were collected from both intestinal epithelia and skin 
epidermis and image analysis carried out to measure the percentage blue staining, 
as detailed in the methods section (section 5.2.6). 
Data from a total of 11 x 0.8 mm2 of epidermis and 13 x 0.8 mm2 of intestine was 
collected and the average percentage staining determined (Table 5.1 and Figure 
5.10). 
Epidermal frames Intestinal Epithelial frames 
SAMPLE Frame# Percentage SAMPLE Frame# Percentage 
1 660 40 1 652 80 
2 666 55 2 653 45 
3 679 59 3 654 51 
4 676 59 4 655 40 
5 774 49 5 656 53 
6 775 48 6 657 61 
7 777 38 7 658 42 
8 778 58 8 651 61 
9 781 52 9 659 25 
10 783 47 10 660 63 
11 784 26 11 666 52 
12 676 71 
AVG% stained 48 13 677 66 
AVG% stained 55 
Table 5.1. Showing tabulated data from the assessment of percentage-stained regions of both 
epithelial and epidermal tissues examined as detailed in section 5.3.5. Averages of 48% and 55% 
of stained tissue were obtained for epidermis and intestine respectively. 
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Figure 5.10. Graphs showing the dataset as represented in table 5.1. A) epidermal staining and B) 
intestinal staining, each result is shown in a bar-graph with the average result indicated with a 
horizontal red bar. 
The data shows that, when measurements are made from a large area of an 
epithelial tissue, approximately 50% of cells are found to be positive for lacZ 
expression. The percentage staining results obtained ranged from 26 % to 59% of 
imaged area for the epidermis, and from 25% to 80% of the imaged area for the 
intestinal epithelium. The average area of blue staining cells was 48% for 
epidermis and 55% for intestine. 
5.3.6 Histochemical staining of gross whole mount tissues 
The inguinal mammary gland from a pregnant animal was physically larger, 
specifically 2.2x the size of the control gland from a virgin animal of the same 
age, and was more intensely blue-stained than the gland from a virgin animal 
(Figure 5. I I). The relative levels of staining detected were consistent with the 
hypothesis that elevated estrogen levels during gestation enhance the expression 
of the lacZ transgene. Interestingly, weak staining was seen in the gland from the 
virgin animal immediately after X-gal treatment but this was no longer detectable 














Figure 5.11. Digital images showing side-by-side comparison of whole mount mammary glands 
before counterstaining using Method 2 (section 5.2.4). I) Number 4 inguinal mammary gland 
from a virgin non-transgenic H253 animal, 2) Number 4 inguinal mammary gland from a virgin 
transgenic animal (hemizygous H253), and 3) Number 4 inguinal mammary gland from a dl2.5 
pregnant transgenic (hemizygous H253) animal. All animals were three months old at sacrifice. 
Gland sizes are about 2 cm2 for the virgin animal and 4 cm2 for the pregnant animal. 
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5.4 Discussion 
5.4.1. General comments 
The mouse Hmgcr promoter, that mediates expression of the transgene in the 
H253 animal, has the potential to upregulate transgene activity via EREs. Hence, 
our working hypothesis was that expression mediated by this promoter would be 
severely reduced in tissues in which HMGCR was not normally required and/or 
those tissues exposed to low amounts of systemic estrogen. This was supported 
by our observations and explained the observation of the group who developed the 
H253 line, that mammary tissue from virgin animals did not show appreciable 
lacZ-positive staining (pers. comm. S.S. Tan, Children's Medical Research 
Foundation, Camperdown, NSW, Australia). 
In contrast to mammary glands from virgin H253 animals, glands from pregnant 
animals (measured at dl2.5 of gestation or later) showed considerable lacZ 
staining (evidenced in Figure 5.11 of the results section). We believe that, in the 
mammary gland, increased levels of the ovarian hormone estrogen causes 
upregulation of expression from the transgenic construct. This up-regulation 
results in increased ~-galactosidase that produces a more intense histochemical 
stain in mammary glands from gestational versus virgin animals. 
Our RT-PCR experiment showed that transgene expression in the mammary was 
affected by physiological state, with pregnant animals exhibiting lacZ levels that 
were 2 to 5-fold higher than in their virgin litter-mates. In contrast to the levels 
seen in mammary tissue, lacZ reporter expression levels in liver tissue were not 
found to vary significantly between pregnant and virgin animals. 
The hypothesis regarding the effect of estrogen on expression from the HMG-lacZ 
reporter gene is strongly supported by our observations of appreciable Hmgcr 
promoter activity, and detectable lacZ transcripts, in the mammary tissue from a 
pregnant H253 animal but minimal expression in same tissue from a virgin 
animal. Unfortunately, because only a few animals were tested in the RT-PCR, 
further evaluation of this would be required for us to conclude that this result is 
real. This is because stochastic effects could occur during gland development to 
produce a gland that is derived from just a few progenitors, making the possibility 
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of an over-representation of one X-chromosome choice more likely (Takagi, 
2001). If the underrepresented chromosome was the transgene-bearing 
chromosome, then histochemical staining would be deficient or absent, regardless 
of high levels of systemic estrogen. 
5.4.2 RT-PCR analysis of endogenous levels of Hmgcr gene 
transcripts 
Although, in some cases, transgene artefacts may suppress the expression of 
reporter genes, our study of endogenous Hmgcr expression suggested that this 
problem with the promoter is intrinsic to the transgene construct itself. In fact, 
RT-PCR detection of Hmgcr transcripts in mammary tissue from pregnant 
animals ( d 12.5-13 .5) confirmed that endogenous expression was approximately 5-
fold higher in mammary tissue from pregnant animals than that found in the same 
tissue in their virgin littermates. 
In contrast to the findings in mammary tissue, liver tissue from both pregnant and 
virgin animals showed high levels of expression. This supports evidence that 
Hmgcr is highly expressed in the liver, and is not subject to an estrogen-mediated 
regulation of expression. It is worth noting the slightly reduced expression 
measured in the virgin liver in the RT-PCR experiment (section 5.3.2). This was 
thought to have resulted from an unknown reaction variable. The main finding in 
this experiment, of high levels of Hmgcr expression in liver tissue relative to 
mammary tissue, agrees with previous reports that showed that the basal activity 
of the Hmgcr promoter in hepatic cells was 8-10 fold higher than that observed in 
other cell lines (Tam et al., 1991) and that, in vitro, high levels of Hmgcr 
expression in hepatic cell lines does not require stimulation via activated estrogen 
receptor (ERa.) (Di Croce et al., 1999). 
5.4.3 Published studies on the Hmgcr promoter 
The results presented above suggest that the Hmgcr promoter is not "ideal" in 
several respects. In particular, as evidenced by the lack of expression in the virgin 
mammary gland, the true "housekeeping" properties of this gene are questionable. 
Tam's use of the Hmgcr promoter as a 'ubiquitously active promoter' was 
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justified, at the time, on the previous description of Hmgcr as a housekeeping 
gene (Tam and Tan, 1992). However, after a more thorough examination of the 
literature regarding this promoter, we found a report that described an ERE in the 
Hmgcr gene and the subsequent measurement of its activity in artificial constructs 
with reporter genes (Di Croce et al., 1999). These experiments showed that, in 
mammary cell lines, expression from the Hmgcr promoter is upregulated by 
estrogen and this explained why, in some tissues, the promoter might lack 
constitutive activity. 
The Hmgcr promoter has other sites (the SRE and cAMP binding sites) via which 
regulation may occur. The SRE has been tested with HMG-P-gal constructs and 
promoter activity has been found to be down-regulated in the presence of sterols 
and upregulated when sterols are at either present at low concentrations or are 
totally absent (Skalnik et al., 1988; Smith et al., 1990). While it was not 
investigated in the H253 mouse, cholesterol levels may also play a role in 
regulation of the transgene expression, possibly via a sterol level feedback loop. 
It is possible that maintaining the animals on a low cholesterol, low LDL diet, 
supplemented with either estrogen or drugs that stimulate estrogen production or 
Hmgcr promoter activity, may counteract the negative regulation of expression 
from the Hmgcr promoter's regulatory sites and effect trans gene expression in a 
broader range of tissues. 
The tissue-specific transgene expression patterns observed in our studies of the 
H253 mouse are not unique; other "housekeeping" gene constructs also give 
ambiguous expression. For example, a CAT reporter gene under the regulation of 
a cytomegalovirus (CMV) immediate early gene 1 enhancer/promoter, while 
expressed in all 28 tissues examined, had expression level variations of up to 
100,000 fold between individual tissues (Furth et al., 1991). Another study that 
tested the activity of the same promoter found expression in only 24 of 28 tissues 
examined (Schmidt et al., 1990). 
As well as the intrinsic properties of a promoter per se, another possible 
complication is that, at a high copy number, a transgenic promoter may be 
methylated and/or not in the correct chromatin conformation. In the case of the 
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Hmgcr promoter, it has been suggested that this could occur as the result of 
incomplete coverage of DNA binding proteins that normally act to protect the 
promoter from methylation (Mehtali et al., 1990). If such methylation patterns 
varied from tissue-to-tissue due to this phenomenon, this effect could have serious 
implications for studies like ours that rely on constitutive expression of the 
transgene as a marker of X-inactivation. 
5.4.4 Does HMG-/acZ transgene expression reflect X-
inactivation choice in the mammary gland? 
We were not able obtain a homozygous H253 animal for use as a control in this 
study as our collaborators were unable to generate such an animal due to in-house 
breeding problems. Because of this, we assessed expression of the HMG-lacZ 
construct in hemizygotes by measuring X-inactivation profiles in a number of 1.0 
X 0.8 mm2 frames of intestine and skin epithelia, as an alternative control. We 
believed that if a 1: 1 ratio of blue-staining to unstained cells were observed in 
epithelial populations then the mammary epithelia would almost certainly display 
a similar profile, allowing the study to proceed despite the absence of the +ve 
control. Our observations showed a staining ratio that was close to the desired 
1: 1 ratio of stained to unstained cells (with percentage staining of 48% for 
epidermis and 55% for intestinal epithelial). In keeping with this assumption, 
other authors have suggested adult intestinal tissue from homozygous H253 
animals displays ubiquitous transgene expression (see Figure 1 in Seymour et al., 
2004). This suggests that the transgene expression system is working reliably, 
both with respect to the tissues examined as controls in the present study, that 
exhibited staining close to the expected 50%, and to the efficacy of detecting lacZ 
expressing cells in all tissues in H253 mice. Assuming that entire glands are 
derived from a large pool of mammary stem cell progenitors, each of which 
displays a random choice of inactive-X chromosome, a similar 'normal' pattern of 
X-inactivation is very likely to exist in the mammary glands from 
H253 hemizygotes. 
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5.4.5 Future investigations 
Confirmation of the importance of estrogen in the positive histochemical staining 
seen in mammary tissues from pregnant, but not virgin, H253 animals could be 
carried out using experiments that monitor changes in levels of expressed Hmgcr 
and lacZ in virgin animals after the administration of estrogen. If estrogen was 
found to be important for the constitutive expression of the transgene in mammary 
tissue, animals at different stages of development could be induced to express 
detectable levels of P-gal by administering estrogen. This would facilitate an 
extension to the observations of clonality in gestational animals to include 
examination of glands at important developmental time-points, such as in the 
embryo and pre-pubertal animal, and of changes in glands occurring throughout 
pregnancy, lactation and involution. However, there is a strong possibility that 
artificially increased estrogen levels may affect glandular growth. This may affect 
the interpretation of the staining data as it relates to anatomical structures 
normally found at the particular stages of development studied. 
Studies of cellular clonality, via assessment of the inactivation of different X 
chromosomes as a marker of different cellular clones, require an inactivated X-
linked transgenic reporter construct that is highly expressed in a broad range of 
tissues. Therefore, one must conclude that the H253 mouse line, which exhibits 
marked tissue-specific expression patterns, has too many innate experimental 
limitations for recommendation as a general model animal in which to observe 
cellular clonality in the mammary gland. 
It is recommended, therefore, that to ensure maximum utility for studies of 
cellular clonality in the mammary gland, an alternative model system is found. 
We suggest that an interesting alternative is an animal with an X-linked transgene 
construct that includes a reporter gene, such as the bacterial lacZ gene, under the 
expressional regulation of the human ubiquitin C gene promoter (Schorpp et al., 
1996). Ubiquitin C has been found to be expressed in all tissues examined and is 
involved in non-lysosomal intracellular protein degradation. Particularly high 
expression in spleen, lung and salivary glands has been reported. Schorpp (1996) 
found that transgenes under the transcriptional regulation of this promoter are well 
expressed in mammary tissue and this would make it potentially useful as an 
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alternative to the HMG-lacZ construct used in this study. However, as the 
construction of an entirely new X-linked transgenic animal for studying clonality 
is a lengthy and difficult process, it would make better sense to test the utility of 
alternative existing transgenic animals for studying cellular clonality in the murine 
mammary gland. 
Other transgenic mouse lines that express non-invasive cellular markers from X-
linked transgenes exist and some of these may be suitable for the study of cellular 
clonality in mammary tissue. Hadjantonakis (1998) developed the D4/XEGFP 
mouse line that has an X-linked EGFP gene. Nakanishi (2002) produced over 100 
GFP lines, including the X-linked transgenic line 152A in which the transgene is 
under transcriptional regulation of the chicken P-actin promoter and a 
cytomegalovirus enhancer. This transgene was found to be subject to X-
inactivation and was ubiquitously expressed in embryonic and adult homozygous 
tissues. In future studies, a mouse line with both X-linked HMG-lacZ ano 
XEGFP transgenes in trans could be bred. Detection of each transgenic product 
could be achieved using a combination of histochemistry and fluorescent 
detection strategies for the HMG-lacZ and XEGFP products, or 
immunohistochemistry could be used on serial thin sections of entire glands to 
detect each marker. Subsequently, images of these sections could then be 
reconstructed to produce a 3D model of mammary cellular clone and patch size 
and distribution. 
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A complete analysis of cellular clonality in mammary glands from H253 
transgenic mice was carried out by direct histochemical staining of whole mount 
glands for ~-galactosidase, the expressed product of the HMG-lacZ reporter gene 
construct. In total, four glands were examined for their cellular clonal profiles by 
entire gland staining and this was followed by measurement of staining in 
intermediate major ductal structures and in individual terminal end buds/ducts 
(TEBsffEDs). The total percentage of blue-staining (transgene-expressing) cells 
observed across 4 glands was 46%, with the remaining 54% of ductal tissue 
comprising red, counterstained, cells. It was found that the predominant clonal 
pattern in mouse mammary tissue was polyclonality (involving 57% of all ductal 
termini examined); this suggests that a large number of precursor cells contribute 
to the mouse gland ductal tissue. Terminal ductal structures, particularly those 
distal to the gland origin, appeared to be derived from a precursor pool of 
decreasing size, as was evidenced by the large fraction of homogeneously staining 
terminal structures (21 % and 22% for blue and red termini respectively) in many 
peripheral lateral ducts and TEBsffEDs. On the basis of these staining levels, it 
was estimated that two to three progenitor cells contribute to each TEBffED ( of 
around 500 cells), an estimate that was supported by statistical analysis. A model 
of murine mammary gland cellular clonality is proposed. 
6.1 Introduction 
6.1.1 Mouse mammary gland development revisited 
The murine mammary gland arises from an embryonic ectodermal thickening that 
invades the underlying mesenchyme. At birth, the gland comprises of a collection 
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of branched epithelial cords. The most significant growth of the mammary ductal 
network occurs after puberty and requires intensive proliferative activity from 
tightly clustered "balls" of cells, the terminal end buds (TEBs), at the end of each 
growing duct (See Chapter One, also reviewed in Smith and Medina, 1988a). 
The TEB is a specialized structure that exhibits a population of progenitor cap 
cells at the tip of the bud. Proliferation of these cells gives rise to both the 
mammary epithelial and myoepithelial lineages (reviewed in Hennighausen and 
Robinson, 1998; Humphreys et al., 1996). It is thought that cap cells may 
represent the primary progeny of the 'light cells', which are the suspected 
mammary stem cells and are found throughout the mammary ducts in the adult. 
In culture, these cells give rise to myoepithelia and luminal and intermediate 
epithelia, through a series of increasingly differentiated progeny (Li et al., 1998; 
Smith and Medina, 1988b). Accordingly, the cap cell is described as a bipotent 
stem cell (SC) with the capacity to give rise to both of the distinct primary cellular 
lineages in the mammary gland (Williams and Daniel, 1983). Further evidence of 
widely dispersed mammary stem cells has come from experiments where BrdU 
pulse-labelled mammary cells were transplanted into a cleared mammary fat pad. 
After 5-8 weeks, label-retaining cells (the presumed SCs and their immediate 
progeny) were observed in transitional units located about 250 µm apart along the 
ducts, and within larger TEBs (Kenney et al., 2001). 
SC anchoring to the basement membrane (via integrins) is likely to be important 
in directing the " ... definition of form ... " of the growing duct and probably acts by 
modulating responses to mitogenic factors (Alford et al., 1998), such as the 
fibroblast derived growth factors and the matrix metalloproteinases from stromal 
tissues (reviewed in Simian et al., 2001). 
6.1.2 Estimating progenitor numbers 
The clonal outgrowth of epithelia, by SC and transiently activated (TA) cell 
progeny, occurs from the pool of progenitors found within the embryonic 
mammary bud (Ellis, 1998). While the exact numbers of stem cells in individual 
mammary gland progenitor populations cannot be observed directly, progenitor 
numbers can be estimated by studying patterns of X-chromosome inactivation. 
Methods that use statistical interpretation of the relative numbers of cells 
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displaying X-linked markers have been developed for studying approximate 
progenitor pool sizes for erythrocytes (<10 cells) and for scalp hair follicles (4 to 
6 cells) in humans (reviewed in Nesbitt, 1971 ). 
To apply this method to the measurement of the number of precursor cells for the 
mammary gland requires the assumption that the gland is derived from a precursor 
pool that is large and heterogeneous. This ensures that, after clonal expansion, an 
approximately equal number of SCs with either one or the other parental X-
chromosome active are found throughout the gland. For accurate analysis there is 
also an assumption that no preferential growth of one stem cell 'line' over another 
occurs during mammary development (McMahon et al., 1983). In practice, this is 
difficult to test at the level of the entire gland and, therefore, in this study, 
conclusions about progenitor numbers were made only for individual terminal 
ducts and buds. 
6.1.3 Studies of cellular clonality in the mammary gland 
Thomas (1988) used G6PD isozymes as a cellular marker of X-inactivation choice 
and found heterogeneous expression patterns throughout the mouse mammary 
gland. This indicates that polyclonality is the predominant clonality pattern in the 
murine gland. Previously, in vitro approaches that involved detecting X-linked 
markers of both diseased and normal breast tissue from heterozygous human 
samples ( as discussed in Chapter 1) have been used to measure patterns of cellular 
clonality (Diallo et al., 2001; Going et al., 2001; Noguchi et al., 1992; Noguchi et 
al., 1994a; Noguchi etal., 1994b; Noguchi etal., 1995; Thomas etal., 1988; Tsai 
et al., 1996), and the findings of these studies are summarised in the table below 
(Table 6.1 ). 
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.\nimal !\ larker used Approach Authors Normal Tumour 
M ouse G6PD h1stoche1TUstry Whole mount PC n/a 
Human HUMARA in vitro MC MC 
POK in vitro PC MC 
POK in vitro PC MC 
POK in vitro PC MC 
HUMARA in vitro 
Thomas et al., 1988 
Diallo et al., 200 l 
Noguchi et al., 1992 
Noguchi et al. , 1994 
Noguchi etal., 1995 
Going et al., 200 l 
Tsai et al., 1996 
PC 70%MC 
in vitro MC NIA 
Table 6.1. Summary of experimental findings from studies of clonality in normal and diseased 
human breast tissue. G6PD - glucose 6-phosphate dehydrogenase, HUMARA - human androgen 
receptor, PGK - 3-phosphoglycerate kinase, PC-polyclonal, MC-monoclonal. 
The sometimes contradictory results obtained in these studies of cellular clonality 
in human mammary tissue show that there are inherent limitations in in vitro 
approaches. Possible errors in some of these experiments are thought to be caused 
by inadvertent sampling of non-target regions, for example, stromal regions 
within the sampled area (Noguchi et al., 1992). Such sampling error may be 
avoided by direct in situ observation of markers of clonality, that is, within either 
ducts/lobules in section (see discussion in Chapter 4) or of entire intact ducts in 
whole mount mammary glands. In addition, Diallo et al. (2001) found that the 
healthy human gland is comprised of large homogenous patches of separate 
cellular clones. They warn that this may make it difficult to accurately measure 
cellular clonality in human breast tumours, as a polyclonal tumour is very likely to 
exhibit a homogeneous staining pattern, despite a potential origin from more than 
one stem cell. 
6.1.4 Ductal clonality in mouse mammary tissue 
Initially, patterns of X-inactivation in the H253 mouse were analysed to confirm 
that the particular breeding used (with H253 and C57 lines) would give the 
expected random X-chromosome inactivation profile (detailed in Chapter 5). 
Next, histochemical staining of the whole mount tissues was performed, and 
image analysis of both whole mount and serially-sectioned (10 µm) mammary 
tissue from H253 mice hemizygous for the HMG-lacZ transgene, was carried out 
to measure the size and distribution of cellular clones in the gland. The clonal 
profile of terminal ducts was measured in high magnification images by counting 
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heterogeneously and homogeneously staining ductal termini. From these data, 
estimates of stem cell numbers contributing to individual TEB were obtained. 
To our knowledge, this study represents the first use of a transgenic animal for 
direct examination of cellular clonality in the mammary gland. 
6.2 Methods 
6.2.1 Detection of ~-galactosidase in mammary tissue 
Five adult mammary whole mount glands (four thoracic glands and one inguinal 
gland - see section 5.2.1) from pregnant animals (> 12.5 <14.5 d.p.c) were 
removed and placed immediately in fixative, as detailed in Chapter 5. After 1-2 h 
of fixation, the glands were subjected to 3x 2 min washes in PBS and for a further 
5 min in a buffer (lacZ wash) comprising 2 mM MgCh, 0.01 % NaDOC, 0.02% 
NP-40 in PBS (pH 7.8) - as per Method 2 (detailed in Chapter 5, section 5.2.4). 
The lacZ wash buffer was then replaced with the same buffer supplemented with 
5 mM potassium ferrocyanide, 5 mM potassium ferricyanide and 1 mg/ml of 5-
bromo-4-chloro-3-indolyl-~-D-galactoside (X-gal) dissolved in 
dimethylformamide (DMF). The staining reaction was followed visually for the 
first 3-4 h and usually allowed to continue for at least 12 h. If overnight staining 
was carried out, the solution was adjusted to 20 mM Tris-HCl and the pH of the 
solution adjusted to 7.8 before overnight incubation at 30°. After incubation, the 
tissues were washed as before (2x 5 min in PBS) and post-fixed for 6 h in 
4% PFA. 
The glands were then dehydrated in a graded ethanol series, cleared of fatty tissue 
by soaking for 30 min in acetone, hydrated and counter-stained in carmine alum 
as detailed in Chapter 2, section 2.4.6. Then the glands were dehydrated, and 
finally cleared in xylene for I h before mounting with D.P.X. mounting medium 
between glass microscope slides. 
Chapter Six Mammary Cellular Clonality in H253 Mice 131 
6.2.2 Thin sections 
After X-gal staining, one of the five glands used in the study (Gland E, thoracic# 
3 mammary gland) was paraffin-embedded (see Chapter 2, section 2.4.3) and 10 
µm sections produced in the transverse plane using a microtome. 
6.2.3 Whole mount mammary gland clonality measurement 
Low resolution/magnification images, encompassing the entire gland, were 
analysed after separation of the different staining patterns with Photoshop™ 
image analysis software using techniques developed with advice obtained from 
various online digital imaging discussion forums (see section 6.2.3.1). 
Subsequently, measurement of histochemical staining patterns in high 
resolution/magnification images was carried out. 
This high magnification analysis involved counting the number of homogeneously 
(exclusively blue- or red-staining) and heterogeneously staining (mixed blue- and 
red-staining) termini in selected frames from four whole mount mammary glands 
dissected from hemizygous H253 animals, as detailed below in section 6.2.3.2. 
6.2.3.1 Entire gland examination: low magnification 
Adjustment of hue can be used to reduce the staining to just three colours which 
can then be individually removed from an image, allowing the selective removal 
of blue-staining, mixed blue/red staining (seen as magenta) and red-staining 
portions, and the calculation of the percentage of each staining type. This process 
also requires a calculation of total ductal area by creation of a software-facilitated 
'gradient map' that selects authentic ductal tissue away from lightly-stained 
stromal tissues in the image. 
A limitation of the method used is that the low magnification images collected, 
while exhibiting superior depth of focus compared to images collected at higher 
magnifications, have a far lower resolution. Hence, for informative analysis of 
staining in these regions, one must consider the fact that such low magnification 
images tend to be blurred to a point where ducts that contain predominantly blue-
staining cells may appear as solid blue-staining. Conversely, ducts that are 
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predominantly red-staining, exhibiting just a few /acZ-expressing (blue-staining) 
cells may appear solid red and be scored as homogeneously stained in these low 
resolution images. 
Therefore, at these low resolutions, the imaging approaches used in the image 
analysis may affect the accuracy of the staining data. This was acceptable for the 
initial overview examination, as it allowed determination of the degree of staining 
within each gland, but was inappropriate for assessment of ratios of clonal 
structures. Hence, the low magnification results were supplemented with, and 
viewed along-side, higher magnification images. 
6.2.3.2 High resolution examination at high magnification 
High magnification measurement of the glands allowed counts of blue and red-
staining TEBs/fEDs to be made. This data was used to determine the ratio of 
homogeneously- to heterogeneously-staining TEBs/fEDs, which is a prerequisite 
for estimating stem cell numbers contributing to these structures. Data collected 
"locally" could be extrapolated to allow gland-wide estimates of ratios of blue to 
red-staining TEBs/fEDs. High magnification assessment was, therefore, the 
preferred method for measurement of patterns of cellular clonality in the 
mammary gland. 
6.2.6 Image data collection: flat images 
Histochemically stained whole mount mammary glands from hemizygous females 
were examined using both high and low magnification with a Leica microscope. 
Either 5 or 13 megapixel TIFF images were collected using a Zeiss AxioCamHR 
digital camera. 
6.2.7 Combining multiple low resolution frames to produce 
entire gland image: 
Entire whole mount gland images were produced by digitally "stitching" multiple 
frames together. This ensured maximal resolution and gland coverage at 2x 
final magnification. 
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All images were opened into Photoshop Elements TM software and 
brightness/contrast adjusted as necessary to provide clear definition of staining 
patterns. The photo-stitching function was applied and the result saved as a 
Photoshop file (* .psd) for later analysis. 
6.2.8 Calculating total viewable ductal area: 
An imaging method that selected ductal regions from the surrounding matrix was 
developed. This simple method allowed for rapid determination of ductal area in 
whole mount mammary images: 
A photo-stitched image (as above) was imported into Photoshop™. 
Ducts were selectively visualized by manipulation as follows: 
IMAGE>ADJUSTMENTS>GRADIENT MAP (Grey) 
Brightness/contrast was again adjusted and the 'Threshold' image 
(IMAGE>ADJUSTMENTS>THRESHOLD) command used to convert tones in the 
greyscale range < 128 (between 1-128) to white and greyscale tones between 129-
256 to black. 
A histogram (IMAGE>HISTOGRAM) was read to determine the percentage of the 
frame that was black (corresponding to ductal tissue). This value was used to find 
the ductal area by multiplication of the percentage black by the total frame area. 
If an approximation of the actual entire duct area was required, then this number 
(the viewable ductal 'diameter') was multiplied by 1t, assuming that half of the 
duct is visible from the viewpoint. Total ductal area is provided for reference 
only and, for the purposes of the present calculations, perspective and other 
considerations were deemed unnecessary. 
6.2.9 Calculating area of blue, red and mixed staining from low 
resolution images 
Hue adjustment of the original stitched entire gland picture (using Photoshop 7™ 
software), allowed segregation of blue, red and magenta (purple-pink) shades: 
IMAGE>ADJUSTMENTS>HUE/SATURA TION. 
Subsequent to an initial separation of the three component colours, each was 
isolated by editing away the other colours by digitally adjusting individual colours 
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(red, blue or magenta) to grey, and then using the 'replace colour' command: 
(IMAGE>ADJUSTMENTS>REPLACE COLOUR) to remove the residual grey tones. 
Finally, the area of each set of coloured ducts was measured by conversion to 
greyscale (IMAGE>MODE>GREYSCALE), adjustment to desirable brightness/contrast, 
and thresholding to convert to a black and white image. 
The threshold image was assessed for the percentage of each individual staining 
colour as detailed above (in the total ductal area calculation). 
Note: For the low magnification images below, blue and the 'blue/magenta' 
shades were grouped together, as were red and 'red/magenta' shades. 
6.2.10 Calculation of cells per cm2 of ductal tissue 
Representative regions of the duct that exhibited good resolution of individual 
cells were chosen from a number of locations in the gland. Individual cells were 
counted within each of these regions and an estimate of average 
cells/cm2 determined. For this study, a TEB or TED was defined as a budding 
structure comprising approximately 500 cells at the terminus of a lateral branch. 
6.2.11 Cell counting by percentage staining 
In order to measure the proportion of each staining type in mammary ducts, high 
resolution images (3600 X 3000 pixels; 10 MB TIFF images) were collected at 
either 1 OOx or 200x magnification. 
The images were enhanced by various software-based manipulations to maximize 
resolution of cells displaying blue-staining nuclei from 'non-staining' 
(counterstained only) cells. These manipulations included basic 
brightness/contrast adjustment, hue adjustment (sometimes with specific selection 
of either staining type, that is, of red-stained cells or of cells with histochemically-
stained blue nuclei) and removal of areas where muscle had been co-dissected 
with the gland. 
Ductal area calculation (as detailed above) was performed for the region under 
analysis and this figure was used to determine percentage of the region staining 
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either blue or red (counter-staining). The determined percentage staining was 
multiplied by the known cells/cm2 to determine approximate cell numbers staining 
either blue or red. 
The best glands for further analysis of cell number were those that exhibited a 
general blue to red eel I ratio of close to 1: 1. Blue nuclei within such regions were 
counted and this number doubled for an actual cell count to give an estimate of 
actual cell numbers in TEBs etc. 
6.2.12 Analysis of cellular clonality 
Whole mount analysis was carried out as detailed above. Images were "stitched" 
to allow whole gland assessment of blue, red and intermediate staining (magenta 
shades indicated a mixture of blue and red cells, and therefore polyclonality). The 
results of this analysis were collated and an estimate of percentage involvement of 
each staining type determined for each gland. 
Finer detail of cellular clonality was analysed by sequential examination of higher 
magnification images from each whole mount gland. The magnification used was 
lOOx for all of the images collected. Camera-based optical zooming gave further 
magnification (up to 3x). 
6.2.13 Statistics 
When approximate staining ratios for TED were known, the x.2 test was applied to 
test the hypothesis that TEBs, found to include around 500 cells, were derived 
from either two or three stem cells. The hypotheses were that average findings 
from 1 O frames in each gland examined did not deviate from a ratio of either 1 :2: 1 
(for a two stem cell origin) or 1 :6: 1 (for a three stem cell origin) of 
blue:polyclonal:red cells. (p values greater than the P(o.os) indicated that the data 
did not deviate significantly from the null hypothesis). 
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6.3 Results 
6.3.1 General entire gland analysis of clonality 
6.3.1.1 GLAND A 
Gland A whole mount: low magnification analysis 
136 
Gland A, an inguinal mammary gland from a hemizygous H253 mouse, gave 
staining patterns that showed clear resolution of blue- and red-stained portions 
(Figure 6.1 ). This was because a light counter-staining (in carmine alum) was 
used, so as not to saturate the histochemical (blue) stain. 
B 
1000 µm 
Figure 6.1. Gland A low magnification entire gland image. A) Showing hue-adjusted gland A (#4 
mammary) and colour dissection for B) blue and C) red. The yellow circle represents the primary 
lymph node. Note the general distribution of blue- and red-staining duct. Peripheral ducts 
generally display a predominance of red-staining. 
As detailed in the table below (Table 6.6), general low magnification analysis of 
staining in this gland showed relative percentages of blue- and red-staining at 30% 
and 44% respectively, with the remainder showing intermediate (magenta) 
staining 26%. The percentage of red-staining tissue may have been overestimated 
as the counterstain often stained stromal elements as well as the desired target 
ductal mammary epithelia. 
High magnification analysis of cellular clonality within Gland A 
Ten high-resolution, high-magnification images, representing 676 ductal terminal 
structures, were analysed for percentage blue, polyclonal, and red-staining of 
termini, and for total percentage of red and blue epithelial tissue in the frames 
(Table 6.2). 
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Total Total 
Gland A epithelia epithelia 
Number 
Frame of term ini Blue Red Mixed %Blue %Red 
1 42 29 0 13 83 17 
2 81 16 38 27 26 74 
3 55 27 0 28 85 15 
4 76 0 0 76 41 59 
5 116 28 62 26 39 61 
6 78 56 22 0 65 34 
7 76 31 0 45 78 22 
8 61 24 9 28 59 41 
9 38 4 14 20 21 79 
10 53 20 15 18 40 60 
Total 676 235 160 281 
34% 24% 42% 54% 46% 
Table 6.2. Table showing staining patterns of both termini and total ductal tissues in Gland A. 
The total percentage blue and red staining (54% blue- and 46% red-staining) for 
all epithelial tissue across all of the high magnification frames examined, agrees 
with the l : I staining ratio expected if X-inactivation is occurring normally in the 
mammary gland. The majority of termini in Gland A exhibited heterogeneous 
staining indicating polyclonality (42% of termini). Sometimes this was a biased 
heterogeneity, such as in Figure 6.5 (B), where staining of regions within the same 
termini (or even duct) was heterogeneous but skewed towards overall red- or blue-
staining. This effect was particularly common within peripheral regions of the 
gland, where general heterogeneity (polyclonality) predominates and homogeneity 
(just red- and or blue-staining cells) was found within smaller terminal ducts and 
termini, such as in Figure 6.5 (C)-(M). Figure 6.6 (A) shows two adjacent 
polyclonal ducts each displaying this "biased" staining; the duct on the left is 
composed predominantly of transgene non-expressing cells while the nearby duct 
has a predominance of transgene-expressing cells against a background of ducts 
exhibiting a polyclonal pattern. Homogeneity was observed in 58% of termini 
examined (34% blue and 24% red-staining termini); these termini were often 
found at the ends of lateral branches from larger polyclonal ducts. 
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6.3.1.2 GLAND B 
Gland B whole mount: low magnification analysis 
Low magnification imaging of Gland B, a thoracic mammary gland from a 
hemizygous H253 mouse, revealed a predominance of red-staining cells (Figure 
6.2). However, closer inspection, at 40x and higher magnification, showed blue-
staining regions throughout the gland, even within those regions that appeared 
solid red after hue adjustment of low magnification images. The blue stain was 
far less intense than that observed for either gland A or C and may indicate an 
artefact from staining reaction variations or, possibly, the effect of storage times. 
Another possibility is that cells within this tissue were expressing less of the ~-gal 
transgene product than the other glands. 
8 
A 
1000 µm C 
Figure 6.2. Gland B low-magnification entire gland image. In A) the entire analysed area of the 
hue-adjusted gland is shown. B) Shows just the red-staining regions and C) just the blue-staining 
regions. (A portion of the gland was not analysed because overlying muscle obscured the field). 
After elimination of much of the red background staining in the image by 
manually erasing background portions, blue-staining cells were found to comprise 
39% of the total stained ductal network. The remainder of the tissue (61 %) was 
red-staining. No magenta staining tissue was detected in this gland. 
High magnification analysis of cellular clonality within Gland B 
Analysis of high magnification images of Gland B revealed staining similar to that 
observed for Gland A. A number of representative images collected to show 
general staining patterns throughout the gland are shown in Colour Plate Figure 
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6.7. Polyclonal regions, that showed a predominance of cells with one staining 
type, were frequently observed and are shown in Figure 6.8 and, in fine detail, in 
Figure 6.9. 
Ten random frames, with 1213 termini, were analysed for staining patterns and 
the entire frame examined for percentage of blue- and red-staining cells 
(Table 6.3). 
Total Total 
Gland B Termini s,,', epithelia · epithelia 
Number 
Frame of termini Blue Red Mixed %Blue %Red 
1 126 18 36 72 27 73 
2 38 5 18 15 13 87 
3 102 33 33 36 44.6 56.4 
4 87 12 45 30 16.4 83.6 
5 57 7 20 30 33 67 
6 164 73 55 36 49 51 
7 179 10 36 133 47 53 
8 175 22 38 115 53 47 
9 148 9 64 75 25 75 
10 137 12 39 86 71 .3 28.7 
Total 1213 201 384 628 
17% 31% 52% 38% 62% 
Table 6.3. Table showing staining patterns of both termini and total ductal tissues in Gland B. 
Across the entire mammary gland, red-staining epithelia predominated (62% ). 
This high proportion of red-staining was also reflected in analysis of individual 
red, homogeneously staining, termini that were observed in 31 % of cases, whereas 
blue termini were only seen in 17% of all termini. 
Both high- and low-magnification estimates of percentage blue-staining in Gland 
B indicated that total blue-staining was in the range of 38-39% of the gland. 
Magenta staining, indicating polyclonality, was frequently observed (in 52% of 
termini). While Figure 6.7 (A) , (E) and (H) show general mixed clonality, a 
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number of the representative frames, for example, (B)-(D), (F), (G) and (I), show 
a predominance of one staining type. Sometimes, distinctly homogeneously 
staining ductal structures were observed, such as in Figure 6.7 (C), in areas with 
adjacent blue and red-staining ducts. This same effect is seen in images (A)-(E) 
from Gland B (Figure 6.8), that show adjacent termini displaying different 
predominant staining patterns. 
6.3.1.3 GLAND C 
Gland C whole mount: low magnification analysis 
Low magnification, gland-wide, analysis of Gland C, a thoracic mammary gland 
from a hemizygous H253 mouse, revealed a high percentage of blue-staining 
(42%) relative to intermediate magenta (37%) and red-staining (21%) 





Figure 6.3. Gland C: low magnification image of the entire gland. In 'wide-field' at low-
magnification, blue and red regions seemed equally well distributed throughout the gland but blue 
(at 42%) predominated the total stained regions with the remainder staining magenta (37%) and 
red (21%). 
It is possible that red stain represents more of the actual area as the calculation of 
percentage involvement sometimes relies on arbitrary assignment of colour level 
cutoffs, that is, some of the staining scored as 'magenta' may have in fact 
been 'red'. 
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High magnification analysis of cellular clonality within gland C 
Ten high resolution/high magnification images were collected from Gland C 
(examples are shown in Figures 6.10 and 6.11) and scored for relative numbers of 
red and blue-staining cells, and for total red and blue-staining within all the 
structures in the frame (Table 6.4). 
Total Total 
Gland C Termini epithelia epithelia 
Number of 
Frame termini Blue Red Mixed %Blue %Red 
1 48 29 0 19 72 28 
2 43 20 0 23 81 19 
3 61 38 0 23 90 10 
4 40 2 0 38 44 66 
5 69 0 5 64 37 63 
6 45 6 0 39 31 69 
7 69 16 0 53 24 76 
8 117 47 0 70 67 33 
9 147 23 74 50 27 73 
10 88 31 0 57 59 41 
Total 727 212 79 436 
29% 11% 60% 53% 47% 
Table 6.4 . Table showing staining patterns of both termini and total ductal tissues in Gland C. 
Total ductal staining, of 53% blue and 47% red, was close to the expected I: I 
ratio. The number of exclusively red-staining homogeneous termini (11 %) was 
less than half the number of homogeneously blue-staining termini (29%). Image 
analysis of high magnification images of Gland C also showed the presence of 
high numbers of heterogeneously stained termini, totalling 60% of all termini (as 
seen in Figure 6.10). Figure 6.10 (G) and (J) show polyclonal ducts with different 
predominant cell staining types (blue- and red-staining, respectively) and Figure 
6.10 (A), (B) and (E) show adjacent ducts with "skewed" or biased heterogeneity, 
with predominance of one staining type over the other. As in the other glands 
analysed, it is possible that some homogeneously staining structures were 
genuinely monoclonal, but it was not possible to test this in the present study (see 
discussion). 
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6.3.1.4 GLAND D 
Gland D whole mount: low magnification analysis 
Low magnification examination of the entire ductal tissues from Gland D, a 
"number 3" thoracic mammary gland from a hemizygous H253 mouse, showed 




Figure 6.4. Gland D low magnification entire gland image. A) Gland D showed B) a low 
percentage of blue-staining (18%) with C) a predominance of red-staining (62%). Intermediate 
stained regions were indicated by the 20% of ducts that gave a magenta staining pattern (magenta 
shades are merged with red and blue in this figure). 
After Photoshop-based image analysis, including colour discrimination, this gland 
showed a low percentage of blue-staining, with only 18% of the gland exhibiting a 
strong blue stain, 62% showing red-staining and 20% showing intermediate, 
magenta, staining. The preponderance of red-staining seen in this analysis may 
have been due, in part, to weak transgene expression resulting in weak blue-
staining within a gland that had strongly stained red ducts and stromal tissue. It is 
more likely, however, that these data reflect the limited resolution obtained using 
analysis of entire glands from low magnification images. 
High magnification analysis of cellular clonality within gland D 
A number of high magnification images were collected from Gland D. These 
images show a range of staining profiles, including all of the staining types found 
in the other glands examined (Colour Plates, Figures 6.12 and 6.13). Ten 
randomly selected images were analysed for relative numbers of red-, mixed- and 
Chapter Six Mammary Cellular Clonality in 8253 Mice 143 
blue-staining termini, and for total percentage blue- and red-staining cells within 
the frame (Table 6.5). 
,.•'', Total Total 
' 
Gland D Terminl;~-\tt epithelia epithelia 
Number of 
Frame termini Blue Red Mixed %Blue %Red 
1 261 14 72 175 26 74 
2 96 73 4 19 63 37 
3 141 14 48 79 27.6 72.4 
4 103 21 24 58 53 47 
5 96 7 6 83 45 55 
6 93 18 23 52 38 62 
7 97 3 24 70 43 57 
8 92 0 21 71 23 77 
9 116 3 6 107 34 66 
10 165 0 6 159 56 44 
Total 1260 153 234 873 
12% 19% 69% 41% 59% 
Table 6.5. Table showing staining patterns of both termini and total ductal tissues in Gland D. 
The predominant staining pattern across all epithelia tissue in the frames 
examined was red-staining (59%) while heterogeneity was clearly the major 
staining pattern in termini (with 69% heterogeneous staining relative to 12% and 
19% for homogeneously staining blue and red termini, respectively). Higher 
magnification (40x) inspection of all regions in the examined frames that 
appeared to be totally 'red' staining (see Figure 6.4) revealed a predominantly 
heterogeneous staining pattern in both ducts and termini. When the higher 
magnification images are examined, one must conclude that the low magnification 
analysis used, in particular the hue-adjustment step that enhances blue and 
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Figure 6.5. Images from gland A: number 4 mouse mammary gland showing ducts that stained 
heterogeneously and TEBsffEDs with both homogenous and heterogeneous staining. In some 
cases the staining in ducts and tennini appeared to be biased, with a predominance of either blue-
or red-staining cells. (A) Polyclonal ducts, (B) and (C) Mainly heterogeneously staining polyclonal 
ducts with some homogeneously staining structures, (D)-(M) Tenninal structures that originate as 
polyclonal ducts but tenninate in homogeneously red-staining regions (see note in the discussion). 
The base of image (M) is 500 µm. Images (A)-(C), (G) and (I) were optically enlarged, up to 3x 
using the Nikon camera. 
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Polyclonality in Gland A: Fine detail 
Figure 6.6. Polyclonality (biased) suggested in ducts from Gland A. A common staining pattern 
found in Gland A was of ducts that stained with a predominance of either red or blue nuclei, but 
always including some cells of the other staining type. The base of images (8) and (C) is 
approximately l 000 µm, while image (A) was optically zoomed 3x and has a horizontal axis 
length of around 300 µm. 
Gland B 
Images from Gland B 
Figure 6.7. A selection of images from Gland 8. Heterogeneous sta1mng, suggesting 
polyclonality, was the predominant staining pattern observed in this gland. Homogeneous staining 
was seen much less frequently than heterogeneous staining. This is shown in the figure below and 
in image (F) above. 
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Typical staining observed in Gland B 
Figure 6.8. Heterogeneously staining ducts from Gland B showing bias for one staining pattern. 
(A) Homogeneously staining terminal ductal regions (both blue and red) within a polyclonal 
background. (B) Adjacent lateral buds showing different homogeneous staining after origin from 
the same polyclonal primary ductal structure. Images (C)-(E) show fine detail of both 
heterogeneously and homogeneously staining ducts and termini. 
Fine detail of Gland B showing polyclonality 
Figure 6.9. Fine detail images from Gland B showing heterogeneity (polyclonality). Images 
(lOOx magnification) showing polyclonal terminal ductal structures exhibiting strong bias for (A) 
red-staining over blue-staining or (B) blue-staining over red-staining. 
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Gland C 
Images from Gland C 
Figure 6.10. Representative images from Gland Cat IOOx magnification. Showing (D), (G), (H) 
the predominant polyclonal pattern with (A)-(C), (E), (J), (I) frequent observation of skewed 
polyclonality or (F) ducts exhibiting homogeneous staining of terminal structures at the peripheral 
regions of the gland. The scale is the base of (8) which is l 000 µm across, although optical 
zooming via the digital camera used allowed up to 3x magnification, e.g. this produced a 
horizontal scale of 300 µm for image (A). 
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Fine detail of Gland C terminal structures 
d 
Figure 6.11 . Showing high-magnification images of structures within Gland C. In these frames, 
heterogeneous (Polyclonal) patterns predominate. Although, image (D) shows a duct with 
markedly skewed staining that branches to produce more evenly polyclonal lateral structures. 
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Gland D 
Images from Gland D 
Figure 6.12. Images collected from gland D. Both homogenously and heterogeneously staining 
regions were observed in the gland, as were TEBs/TEDs showing biased heterogeneity. Image (A) 
(magnified below) shows all three staining types and has a baseline scale of approximately 
1000 µm. 
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Images from Gland D 
Figure 6.13. Fine detail of termini in images from Gland D. Most terminal structures (A)-(C), (F) 
show a mixed population of both staining types. A minority of such structures (D), (E), (G) show 
homogeneous staining within some ducts. The horizontal axis of image (A) is 300 µm and the 
magnification at the microscope is I OOx. Some camera based optical zooming was used in these 
images to give a horizontal axis of :::::300 µm to the base of image (A) and a similar scale for the 
other images shown. 
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6.3.2 Summary of observed staining patterns 
6.3.2.1 Whole mount low-magnification staining analysis 
Analysis of staining patterns across entire mammary glands revealed relative 
staining percentages, as shown in the table below (Table 6.6), and in graph format 
(Figure 6.14 ). 
Gland 
A 
Gland Gland Gland 
B C D 
Total viewable ductal area cm2 1.16 0.82 0.86 0.64 
Total actual ductal area (cm2) 3.64 2.56 2.69 2.01 
Area of predominantly blue-staining ducts (cm2) 0.45 0.30 0.34 0.11 
Blue-staining '<%) 
Area of predominantly red-staining ducts (cm2) 
Red•staining ( % ) 
Area of predominantly magenta staining ducts (cm2) 
Magenta (polyclonal) staining(%) 
Table 6.6. Showing ductal area (viewable and total) and areas of each staining type (blue, red and 
magenta) expressed in cm2 and as a percentage of total ducts. The percentages of blue, red and 
magenta staining are calculated relative to the viewable area only. 
Graph showing percentages of staining 
in the mammary glands examined 
Percentage stained 





Figure 6.14. Graph showing relative contributions of each staining type to the mammary glands 
analyzed. Gland B lacked any discernable magenta staining. Furthermore, glands A and D were 
observed to have a relatively low percentage of blue-staining, with 30% and 18% blue, 
respectively. 
As noted above, the percentage of red-staining shown in this graph (Figure 6.14) 
may have been overestimated due to the fact that red-staining of ducts was 
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analysed against a background of lightly stained stromal elements that were 
stained red. 
6.3.2.2 High magnification analysis of staining in Glands A-D 
High magnification image analysis of staining patterns in all of the glands 
examined revealed three staining patterns (Table 6.7). Terminal ductal structures 
and total ducts were analysed separately for clonality patterns in all 
observed frames . 
Glahd A 676 
Gland B 1213 
GlandC 727 













Total termini observed 3876 
Total blue termini 801 
Total red termini 857 
Total polyclonal termini 2218 
% Polyclonal 
termini 
42 24 54 46 
52 31 38 62 
60 11 53 47 
70 18 41 59 
Table 6.7. Showing combined data for high magnification analysis of Glands A-D. In total, 40 
frames, exhibiting a total of 3876 duct termini, were examined. 
Polyclonality was observed in 57% (2218/3876) of all terminal structures 
throughout the glandular tissue examined. Terminal structures displayed 
homogeneous red-staining in 22% (857/3876) and homogeneous blue-staining in 
21 % (801/3876) of all observations. 
Total ratios of red to blue-staining within ducts in the selected frames were 
measured for each set of frames from each gland. Glands A and C, with 
percentage blue-staining of 54% and 53% respectively, showed staining consistent 
with the notion that the gland originates from a large progenitor population, with 
an equal representation of both transgene expressing and transgene non-
expressing stem cells. In contrast, Glands B and D, with only 38% and 41 % total 
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blue-staining ducts respectively, were somewhat low in transgene expressing cells 
(and this was also reflected by the analysis of clonality in terminal structures, 
where blue to red structure ratios of approximately 1 :2 were found). The overall 
average staining for Glands A-D was 46.5% blue-staining and 53.5% red-staining. 
This combined average is in close agreement with the 1: 1 ratio that is expected if 
the gland is sourced from a large pool of SC with about half of the SCs expressing 
the transgene from an active X chromosome. 
6.3.2.3 Concordance between low and high magnification 
analysis of Glands A-D 
The relative staining measured by low magnification analysis of all glands 
showed a slight overestimation of the area of red-staining total mammary tissue 
compared with the higher resolution analysis, with total red-staining of 57.4% and 
53.75% from low and high resolution analysis, respectively. Individual gland 
variation detected by the two methods was most apparent in Gland A (57% vs. 
47% red), Gland C (39% vs. 47% red) and Gland D (72% to 59% red), while 
Gland B showed almost perfect concordance between the results obtained using 
these different methods (61 % vs. 62% red). 
Not surprisingly, gland wide analysis of low magnification images by image 
manipulation and 'colour dissection' was found to lack the sensitivity of the high 
magnification technique. This was particularly apparent in the underestimation of 
blue-staining areas detected using this method and is most likely due to weak 
histochemical staining resulting in dominance of the counter-staining ducts. 
6.3.2.4 Gland E in serial section 
General clonal analysis 
Selected portions of Gland E, mammary number 4, were serially-sectioned to 
produce a high magnification 'walk-through' analysis of the numbers of blue- and 
red-staining cells within ducts and their arrangement within these ducts (Figure 
6.15, below). 
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Figure 6.15. Heterogeneously staining (Polyclonal) ducts, with a bias for one staining type, were 
commonly observed. Sections from Gland E showing what seems to be a heterogeneously 
staining polyclonal (red stain predominant) duct penetrating a region predominated by other 
polyclonal (blue stain predominant) ducts. No ducts in these frames were found to exhibit shows 
complete homogeneity. 
In the portion of this gland (-50 mm2) analysed for clonality, the majority of ducts 
showed a heterogeneous (polyclonal) staining pattern. In the series shown in 
Figure 6.15, two polyclonal ducts, one with a bias for blue-staining cells, are 
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shown to exist adjacent to one another within the same field. A weakness of this 
serial sectioning approach, relative to direct analysis of staining in whole mount 
glands, is that the primary 'duct of origin' for the ducts shown is impossible to 
determine and that actual termini structures are difficult to identify for clonality 
analysis and blue/red cell staining ratio determination. 
6.3.3 Estimating the number of TEB/TED progenitors 
The combined average for staining in Glands A to D indicated a 1 :3: 1 ratio ( that 
is, 21 % blue-staining homogeneous, 57% heterogeneous and 22% red-staining 
homogeneous termini). If the data from Gland D is ignored as 'outlying' (the 
high percentage of heterogeneous staining of 70%, and the low percentage of 
homogeneous blue-staining termini of 12%, seemed incongruous), then corrected 
percentage staining in all termini is: 27% homogeneously blue-staining, 51 % 
heterogeneously staining and 22% homogeneously red-staining. 
Stone (2002) estimated progenitor numbers in taste buds using counts of blue-
stained versus non-stained cells in individual buds. This approach, represented in 
Figure 6.16, shows that numbers of monoclonal structures are expected to 
decrease with increasing progenitor population size. 
Stem cell contribution to terminal ductal structures 
Two Stem Cell Origin 
Choice 
Ductule 1 2 
1 •• Homogeneous Blue 25% 
2 • • 
3 • • Heterogeneous 50% 
4 •• 1-iomogeneous Red 25% 
Three Stem Cell Origin 
Choice 
Ductule 1 2 3 
1 ••• Homogeneous Blue 12. 5% 
2 • • • 
3 • •• 
4 • • • Heterogeneous 75% 
5 ••• 
6 • •• 
7 ••• 
8 ••• Homogeneous Red 12. 5% 
Figure 6.16. Schematic diagram showing cellular clonality ratios expected if either two or three 
stem cells contribute equally to a terminal duct. The experimental data supports both these 
patterns and, in practice, both may exist at different termini within the same mouse mammary 
gland. (Adapted from Stone et al. 2002 with modification). 
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Accordingly, if each structure was derived from two cells, then around 25% of 
buds would be blue-staining and, for three progenitors, authentic monoclonal 
blue-staining structures would be seen in only 12.5% of observations. 
6.3.3.1 .,_2 test of staining data 
The staining data obtained from the high magnification measurement of TED 
staining in four glands, A to D (see Tables 6.2-6.5), was subjected to x2 analysis. 
The results presented in Table 6.8 show that the observed staining patterns 
support the hypothesis that two or three distinct progenitor cells are involved in 
the formation of individual termini . 
2 progenitors 3 progenitors 
ratio 1:2:1 ratio 1:6:1 
Gland A p< 0.01 
GlandB p< 0.01 
Gland C p=0.021 
GlandD p< 0.01 
Table 6.8. Table showing x.2 test results (p-values) for glands A to D. The three values that were 
either greater than or very close to p(0.05) are shaded. 
Chapter Six Mammary Cellular Clonality in H253 Mice 157 
6.4 Discussion 
6.4.1 Controls and sample suitability 
Due to breeding problems in the colony that supplied the H253 mice for this 
study, we were unable to obtain tissues from homozygous H253 animals for use 
as a staining control in our experiments. The problems encountered in producing 
homozygous mice may, in part, reflect an inherent limitation in the H253 line, as 
Tam ( 1992) found that homozygotes were generally underrepresented in litters. 
Despite the absence of the ideal control for this study, that is, histochemically-
stained mammary tissue from a mid-gestational (dl2.5-13.5) homozygous H253 
mouse, a number of lines of evidence show that H253 expresses the lacZ 
transgene reliably. Tam (1992) showed that lacZ expression was ubiquitous from 
2.5 dpc to at least 13.5 dpc in H253 homozygous embryos, and others have found 
that the transgene is ubiquitously expressed in intestinal and epidermal tissues of 
adult homozygous females or hemizygous males (Bennett et al., 2003; Seymour et 
al., 2004). In the present study, we found that the ratio of lacZ stained to 
unstained cells in both skin and small intestine from H253 hemizygotes was close 
to 1: 1 (48% and 55% for skin and intestine, respectively; see section 5.3.6 in 
Chapter 5). We believe that this evidence is sufficient to justify using the H253 
mice in studies of clonality in the mammary gland. 
A number of preliminary conclusions about cellular e:lonality in the mammary 
gland can be made, particularly for those glands that show a ratio of about 1: 1 
blue- to red-stained cells. In this respect, all of the glands, A to D, seem to fit 
this requirement. 
6.4.2 The majority of ducts display a polyclonal staining pattern 
A heterogeneous staining was the most frequently observed pattern in ducts and 
this indicated polyclonality. We found no large continuous patches of cells of 
either staining type within these polyclonal larger ducts. This suggests that 
progeny of SC become "mixed" during the formation of larger ducts or that 
outgrowth from SC is minimal and produces very small cellular clones. 
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However, smaller ducts and termini were found to sometimes show an uneven 
heterogeneous staining pattern, with a predominance of one staining type 
(examples in Gland C; Figure 6.12 a-b,e). This observation led us to conclude 
that, while the majority of ducts in the gland may originate from a large 
population of SC and give rise to a largely heterogeneously staining ductal 
network, smaller structures, in particular those some distance from the gland 
origin, sometimes show staining that indicates derivation from a very small 
number of stem cells. 
6.4.3 Terminal portions of the ductal network stain either 
heterogeneously or homogeneously for the transgenic marker 
In general, our findings were in keeping with previous observations in the murine 
mammary gland of l) predominant heterogeneity in larger ducts, indicating 
polyclonality and, 2) frequent homogeneous staining in termini, indicating the 
presence of a single clone with the same inactive-X choice or of a "patch" with 
similarly staining clones adjacent to one another (Thomas et al., 1988). In our 
observations of 3876 terminal structures each comprising around 500 cells, 
homogeneous staining was detected in 43% (1658/3876) of termini (22% red-
staining, 21 % blue-staining), with the remaining 57% (2218/3876) of termini 
exhibiting a heterogeneous staining pattern, indicating polyclonality. 
Outgrowth from a single stem cell is almost certainly capable of forming 
genuinely monoclonal TEBs. However, an alternative explanation, that better fits 
the data collected in this study, is that two or more stem cells with an identical 
inactive-X choice, and therefore identical transgene expression patterns, produce 
homogeneously staining TEBs. This is in agreement with a report by Kissenberth 
and Sandgren (2004), who found both homogeneous and heterogeneous staining 
in individual alveoli in sections taken from chimeric mammary glands. This 
possibility is discussed below in relation to the estimation of stem cell numbers 
contributing to individual termini (section 6.4.5). 
Homogeneous staining for transgene non-expressing (red-staining) cells was 
observed at a high frequency in some peripheral regions of the gland. Examples 
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of the effect are shown, in the figures showing staining in Gland A; Figure 6.7 
(D), (E), (F), (J), (L) and M). Moreover, this homogeneous staining was more 
common in the extremities of the gland space, particularly in the periphery of 
Gland A, an inguinal mammary gland that, in contrast to thoracic glands, is 
elevated along its longitudinal axis. Whether this anatomical feature is important 
remains to be determined. 
There is a possibility that the mammary epithelia underlying the minimal fat pad 
found in peripheral regions of the gland is comprised of cells exhibiting active X-
chromosomes bearing the HMG-lacZ transgene construct. However, if this was 
the case, then one would expect that the blue histochemical stain would be 
detected in these areas. A possible explanation for the lack of detectable staining 
is that these cells fail to express the transgene product in detectable quantities 
because of the absence of strong, stromally-mediated, upregulation of transgene 
expression (see Chapter 5, section 5.4.3, for an explanation of the hypothesized 
link between systemic estrogen levels and transgene expression in the H253 
mouse mammary gland). This may be due to reduced expression of estrogen 
receptor (ER) in and around TEBs located in these regions, which are close to the 
borders of the fat pad, although there are no reports suggesting such an expression 
pattern. Mitogen-responsiveness would be lost by a reduction in expression of ER 
resulting in reduced expression of the transgene. In future studies, this effect 
could be tested by analysing histochemical staining patterns in 
H253 homozygotes. 
6.4.4 Direct examination of whole mount tissues 
Examination of staining patterns in lacZ histochemically stained and fat-cleared 
mammary glands under low magnification showed clearly demarcated regions of 
transgene-expressing blue-staining and 'counterstained only' red-staining ductal 
tissue. In some glands, hue-adjustment using image analysis software allowed 
separation of red-staining from blue-staining regions by replacement of the non-
target colour with white, and measurement of the remaining area. However, this 
technique was found to be possible only in those glands that were lightly 
counterstained. The higher magnification images yielded far more information on 
clone size and distribution than obtained using the low magnification images. 
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Accordingly, in future studies, these high magnification images would be used in 
preference to the low magnification images. 
6.4.5 How many stem cells contribute to single ductal termini? 
Clonality studies that used coat colour as a marker of epidermal cell origin in mice 
exhibiting Cattanach's translocation (ln7;X) revealed a low frequency of extreme 
skewedness of predominance of either active translocation-bearing or normal 
chromosomes (Nesbitt, 1971 ). This observation suggests that murine epidermis is 
derived from a large population of precursor cells. Alternatively, where a tissue is 
derived from a very small number of progenitors, a considerable stochastic 
skewing in cells is likely to be observed and this would be reflected in a departure 
from the 1: 1 ratio of X11 to Xm inactive X chromosome choice. Extending these 
predictions further, if a single stem cell contributed to each terminal end bud or 
duct, then completely homogeneous staining should be observed in all termini. 
Furthermore, if each TEB was derived from two stem cells then a overall 
'homogeneously staining red:heterogeneous:homogeneously staining blue' ratio 
of 1 :2: 1 would be observed in all termini (see schematic in Figure 6.16). 
Statistical analysis of the 'observed' staining ratios and the ratios predicted from 
experimental observations ('expected') by the ·x.,2 test, showed that patterns in 
Glands A and B, with p-values ~ Pco.os) did not deviate from the expected ratio 
1 :2: 1 ratio for blue:blue/red:red termini if TEB structures in these glands were 
derived from two stem cells. The results from the Gland C data did not support an 
origin of termini from either two or three stem cells. Gland D, with a p-value of 
0.087 did not deviate from an expected 1 :6: 1 ratio, that is, suggesting that TEB 
structures in this gland may be derived from three stem cells. 
While the observed overall ratios of blue-, red- and mixed staining indicates an 
origin of termini from two mammary progenitor SCs, the observation in all glands 
of terminal structures that were polyclonal but exhibited biased staining patterns, 
presumably as the result of stochastic effects, supports an origin of many termini 
from three division-competent SCs. 
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6.4.6 Do numbers of available mammary stem cells reduce with 
gland outgrowth? 
We believe that one possible explanation for the observation of increased numbers 
of homogeneously staining terminal structures in peripheral regions of the glands 
could be that SC 'units' (that is, SCs and their proliferation-capable daughter 
cells) are reduced in number as gland growth proceeds, due to these units 
becoming committed to the formation of lateral branches. This reduction may 
increase the likelihood that a single terminal structure may be sourced from a low 
number of SCs ( or even a single SC) and hence display a homogeneous staining 
pattern. In this situation, the gland would, in effect, begin to "run out" of stem 
cells as growth progresses towards the periphery of the gland, thereby placing a 
natural limitation on further growth. 
If a reduction in available SC numbers does occur during murine mammary gland 
development then it is possible that a similar pattern of reduction exists in the 
human breast, in which entire TDLUs have been found to exhibit homogeneous 
expression of X-linked markers (see Diallo et al., 2001), with a single patch 
encompassing a number of TDLU (Novelli et al., 2003). 
6.4. 7 Models of normal murine mammary clonality 
As discussed above, we found that large primary ductal structures were comprised 
of a heterogeneous mixture of cells of each staining type, that is, such structures 
had a polyclonal origin. In contrast, smaller ducts and lateral branches were 
sometimes observed to stain in a homogeneous pattern with 21 % showing blue 
staining and 22% negative for the lacZ marker, while the remaining 57% of 
termini showed a polyclonal staining pattern. 
These data suggest that, in normal mammary development, a heterogeneous 
starting population of mammary progenitors in the mammary bud expands to 
produce a primary ductal structure comprising many individual cellular clones 
(Figure 6.17). It has been reported that within such primary structures, 
transitional units occur on average every 250 µm and also possibly within larger 
TEBs (Kenney et al.. 2001 ). These transitional units contain SCs and their 
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immediate progeny (the transiently activated cells) that respond to particular 
systemic and stromally-derived signals by initiating lateral budding. As is shown 
schematically in the figure, homogeneous staining is observed when a lateral bud 
forms either from a single SC clone or from a small number of SCs that give the 
same staining pattern, that is, a stochastic effect. A similar observation would be 
made if total SC number in the mammary precursor pool was very low, hence 
resulting in an increased chance of a stochastic effect leading to a skewed (non 1: 1 
stained to unstained cells) profile. However, as widespread staining heterogeneity 
was seen in the glands examined in this study, we assume that the glands were 
indeed derived from large populations of progenitors. 
Observations of glands from pregnant animals suggested that a reasonably large 
population of SCs must be involved in the initial population of the fat pad by 
mammary epithelia. Alternatively, mammary progenitors may be deposited along 
the primary ducts, where they remain until they are subjected to signals prompting 
their growth and the formation of lateral buds. In this model, some progenitor 
cells in the adult gland may be mitotically senescent because they are not within a 
stem cell niche (Schofield, 1983) that is subject to signals for growth. This could 
be due to the fact some such progenitors may not be correctly positioned to allow 
for even spacing between individual lateral buds, which is a characteristic of 
mouse mammary gland architecture. After the cessation of lactation, involution 
would reduce the mammary network back to a "resting state", with SC clones 
remaining as transitional populations for later repopulation of the fat pad, which is 
required in subsequent pregnancies. 
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------- Branching morphogenesis-------.... 
Mammary bud 
e XpStem cell 
e xp progeny 
e XmStem cell 
e xmprogeny 
Polyclonal primary sprout 
Homogeneous ducts 
Figure 6.17. Schematic a showing a general model of clonality for the mouse mammary. Red and 
pink cells represent, respectively, SCs and their daughter cells that have an inactive maternally 
derived X chromosome. Dark blue and pale blue cells represent, respectively, stem cells and their 
daughter cells that are derived from cells with an inactive paternally-derived X-chromosome. As 
shown in this diagram, outgrowth from precursors in the mammary bud produces predominantly 
polyclonal ductal epithelia. Homogeneity in ducts results from outgrowth of a small number of 
SCs that both express the same marker. 
Further investigation is required to test whether this alternative model more 
accurately describes clonality in the murine mammary gland. Such investigation 
would include evaluation of expression patterns of both spatial and temporal SC-
specific markers so that growth from these SC reservoirs deposited during initial 
gland development could be measured. 
6.4.8 General aspects of the H253 mouse as a mammary gland 
clonality model 
It is not possible to confirm monoclonality by whole mount examination of 
histochemical staining patterns. While the observation of homogeneity in a 
terminal glandular structure (such as a lateral bud/branch) indicates that cells 
within the structure are derived from progenitors with the same inactive X 
chromosome choice (that produce identical staining), it does not prove a clonal 
origin from a single stem cell. This is because there is currently no method 
available to determine whether such a structure is the product of a single SC 
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(producing an authentically monoclonal structure), or the product of two or more 
SCs with the same choice of inactive X-chromosome (a multi-clone "patch"). 
DNA fingerprinting has been used to distinguish clonality in tumours (Fey et al., 
1988; Ng et al., 2003) and, if appropriate microdissection techniques were to be 
applied, it may also be possible to conclusively determine monoclonality in 
individual TEB or TED using similar methods in wild-type animals. 
True polyclonality is the predominant pattern seen in the mouse mammary and 
this is evidenced by direct observation of staining heterogeneity of larger ducts. 
Of these heterogeneously staining structures, a large number showed evidence of 
"stochastic skewing" effects, exhibiting heterogeneous staining with a 
predominance of one staining type over the other. As noted above, this suggests 
that these termini are derived from a small pool of around three mammary 
precursor cells, and this was supported by statistical analysis of patterns found in 
Gland D at higher magnification and by observations of various images from 
all of the glands in this study. 
6.4.9 Cellular clonality in murine and bovine mammary tissue 
As outlined at the beginning of Chapter 5, the mouse gland study was carried out 
in order to measure indi victual cellular clones in the murine mammary gland and 
to provide an experimental base upon which to base future bovine experiments; 
ultimately, both types of studies are envisaged as useful models for the study of 
human breast disease. It is, therefore, valuable to compare the two experimental 
approaches used in studying the murine and bovine glands, so that conclusions 
about general similarities in patterns of cellular clonality can be drawn. 
The first and most obvious comment to be made is that it would be totally 
impossible to detect clonality in murine mammary blocks of the same size as 
those sampled in the bovine experiments. Recall that these were 30mm3 in 
volume; a block of equal size would comprise some 4% of the murine gland, 
which weighs around 700 mg. This sample would contain 100 TEBs and would 
include both ductal tissue (57% of which display a heterogeneous pattern) and 
terminal end ducts/buds (of which only about 43% exhibited homogeneous 
staining); clearly, homogeneity would never be detected in murine samples of this 
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size. Given that, in the mouse gland, homogeneity is only found in individual 
TED/TEB, one would presumably have to take much smaller samples (a fraction 
of a mg) in order to detect homogeneous lacZ expression patterns using the in 
vitro RT-PCR technique. 
If the bovine mammary gland had a similar clonal architecture to the mouse gland, 
equally small samples would have to analysed and one would have to deal with 
the added complication that, because of the technical reasons one allele of the X-
linked marker (SNP) could only be detected when that allele was present at a ratio 
equal to or greater than 3.5: 1 compared to the alternate allele (Chapter 4, section 
4.2.4.2). However, the preliminary results presented in Chapter 4 do indicate 
that regions of clonality in bovine tissue may be somewhat larger than in mouse, 
of the order of several mm3 - if this proves to be the case, it would represent an 
important difference between the two mammary glands, and also make bovine in 
vitro RT-PCR analyses more feasible. 
6.4.10 Future work: 
• To confirm that expression of the transgene occurs in all cells in mammary 
tissue, a homozygous H253 animal needs to be sourced as a control. 
Presently, we assume that staining would be found to be ubiquitous in 
such glands and in tissues from male hemizygous H253 animals. 
• If the transgene was found to be expressed at reasonable levels, perhaps 
after induction of estrogen production, then glands could be analysed from 
animals at various developmental time points such as embryonic, new-
born, pre-pubertal, lactating, nonpregnant multiparous animals and from 
animals undergoing mammary involution. This would help to determine 
the clonal characteristics of the precursor population in the embryo and 
would show chronological changes occurring in the clonal architecture of 
the gland throughout the life of the animal. 
• Alternative nuclear-specific counter-stains, such as nuclear fast red or 
brazilin, could be tested on whole mounts or thin sections to better 
distinguish the transgene expressing cells from the counterstaining non-
expressing cells. 
Chapter Six Mammary Cellular Clonality in H253 Mice 166 
• An alternative model, such as a transgenic mouse expressing an X-linked 
EGFP gene, is likely to provide clearer insights into the size and 
distribution of cellular clones in murine mammary tissue. Transgene 
expression profiles in such alternative model animals would have to be 
rigorously examined to confirm their utility in cellular clonality studies. 
• DNA fingerprinting techniques may be able to be used in determining the 
extent of authentic monoclonality of termini in mammary samples from 
wild-type animals (the inbred nature of lab strains make them unsuitable 
for such analyses). 
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Chapter Seven 
General discussion 
A significant limitation that arises when using X-chromosome inactivation based 
assays to investigate clonality of both normal and diseased tissue is that, when the 
patch size is large, polyclonality cannot be determined with complete certainty. 
This is because polyclonal structures may arise from stem cells in the same 
"patch" and hence display the same X-linked marker, despite their polyclonal 
origin (Schmidt and Mead, 1990). Thus, if the patch size in mammary tissue was 
large, encompassing many hundreds of termini, then it would be impossible to 
conclude anything about the patterns of clonality in the individual termini 
themselves. Obviously, this limitation is negated if the patch size is small, and 
therefore useful data about normal patterns of clonality can be obtained from 
tissues that exhibit small patches. 
In the present study, data on clone and patch size and distribution in the murine 
mammary gland was obtained. These data indicated small patch sizes in the 
murine mammary gland, which means that the murine gland could be a suitable 
model in which to test theories about the frequency of mammary tumours that 
have a polyclonal origin but a clonal evolution. Such studies in the murine gland 
have the potential to give a better understanding of tumour origin and biology. It 
is likely that patterns of clonality in murine mammary tissue would approximate 
those is human mammary tissue, as the murine TEB and the human TDLU - and 
the bovine TDLU - have anatomical, and probably developmental, similarities. 
Patch and clone size estimates for Murine mammary 
Patch size, defined as the average size of groups of contiguous cells that share a 
common (X chromosome) epigenotype (Nesbitt, 1974), is important as it 
determines the extent to which conclusions about clone size and distribution can 
be made. 
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The existing experimental evidence indicates that patch size differs within and 
between species. In thin sections of the human mammary gland, the ductal 
epithelial patch size has been estimated to be between 0.08 and 0.45 mm2, and 
these relatively large patches have been found to include entire TDLU (Tsai et al., 
1996). Another study, in which patches were measured using heterozygous 
expression of a temperature-sensitive human G6PD variant as a marker of X-
inactivation, showed that patch size in the human breast is much larger than that 
which was observed in the Tsai study, and that entire TDLU, of between 1 and 8 
mm2 in diameter, may lie within the same patch (Novelli et al., 2003). 
In the present study, our experimental data showed that the ductal termini, with an 
estimated area of around 0.03 mm2 when viewed in 2D, are comprised of two or 
three cellular clones, thereby making the average clone size between 0.015 and 
0.01 mm2• Around 40% of these termini stained homogenously, thereby 
suggesting that patches could be as large as 0.03 mm2. However, as about 60% of 
termini showed heterogeneous staining, the average patch size is likely to be 
smaller than 0.03 mm2 and that these patches may comprise of progeny from a 
single stem cell. Clone size can also be estimated in a quite independent manner, 
using the total ductal area for 'Gland A' (36 mm2) coupled with the estimate of 
900-1000 stem cells in the inguinal murine mammary gland (Kordon and Smith, 
1998). Considered together, this would indicate an average clone size of around 
0.04 mm2 (36 mm2 divided by 950 SCs). If clones in the thoracic glands are 
approximately the same size, then we can estimate that the thoracic mammary 
glands analysed in this study (Glands B to D), with an average total ductal area of 
24 mm2, have around 600 stem cells (24 mm2 divided by 0.04 mm\ Using this 
method it is possible to predict that patch size could be as large as 0.08 mm2 (two 
clone diameters); although, using the present data, it is not possible to accurately 
determine the average patch size. Taken together, these data indicate that murine 
mammary patches arc much smaller than those observed in humans, with the 
maximum observed patch sizes only just approaching the minimum patch sizes 
observed in the human gland. These relatively small patches could render the 
murine mammary gland a potentially useful model of clonal processes, because, if 
more than one clone exists in an examined region then this polyclonal pattern is 
likely be detected. 
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The general observation of "fine-grained patchiness" in patterns of cellular clones 
throughout the murine gland suggests that mammary tissue is similar, in this 
respect, to murine liver, which is comprised of> 106 small clones and is thought 
most likely to result from considerable "mixing" of lineages during development 
(West, 1976). In contrast, we observed that skin from H253 hemizygotes is 
comprised of large clonal patches, with "mixing" only at the patch boundaries 
(see Figure A 7 in Appendix 4 ), which agrees with observations of large transverse 
stripes in chimeric mouse epidermis (Schmidt et al., 1988). It is likely that glands 
originating from this epithelium would fall within a homogenous patch, so if cells 
for the initial mammary gland progenitor population arose from a portion of the 
epidermal cell population, to form the mammary bud, then it would be expected 
that many of the glands formed would be completely monoclonal. However, 
monoclonality was not observed in any of the five glands analysed in this study, 
suggesting that the mammary committed stem cell population becomes 
determined before the formation of the epidermis and that this cellular population 
is maintained during formation of the epidermis. 
As noted in the introduction (Chapter 1.14), it has been proposed that all epithelial 
organs are likely to all be formed by similar processes to those responsible for the 
formation of intestinal crypt-villi (Zajicek, 1995). In the intestine, polyclonal 
crypts in the neonatal mouse undergo a post-natal "purification" to monoclonality 
(Schmidt et al., 1988). However, we found no evidence for such "purification" in 
the mammary gland, which would have been observed as mainly homogeneous 
individual termini and perhaps even larger structures. It is worth noting, however, 
that there are structural similarities between the large intestinal crypt, in which 
stem cells are thought to reside at the base of the crypt (reviewed in Potten et al., 
1997), and the TEB, where stem cells are thought to reside at the tip of the bud 
(Ormerod and Rudland, 1984). 
Predominant polyclonality in mammary ducts and termini 
Termini and ducts of the adult murine mammary gland from the H253 
hemizygous animals used in our study stained in a heterogeneous manner, 
indicating polyclonality. This polyclonality, which is supported by the findings of 
others (Kisseberth and Sandgren, 2004; Thomas et al., 1988), is perhaps most 
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interesting when viewed alongside the additional observations made by Thomas et 
al. (1988), who found large mammary epithelial patches during early 
development. The presence of these large patches was thought to be due to 
coherent clonal growth. From the present evidence, it is difficult to reconcile 
Thomas' observation of large patches in the embryonic gland, with the 
extensively polyclonal tissue seen in the adult gland. Although, according to the 
model proposed in the previous chapter (Chapter 6, section 6.4.7), stem cells are 
deposited in niches at the base of the luminal epithelia during the formation of 
simple primary mammary ducts, and these cells may be committed to the 
formation of individual lateral ducts. The high frequency of polyclonal termini 
detected in the glands indicates that, despite the relatively large size of the early 
mammary epithelial patch, stem cell clones from both Xp- and Xm- inactivated 
'lineages' are represented in most lateral ducts. Perhaps the mammary gland is 
derived from a small number of progenitors and symmetrical division of stem 
cells occurs during the early stages of gland development, thereby explaining the 
number of individual stem cell derived clones seen in the adult gland. 
Alternatively, stem-cell-like transiently activated cells may be produced by 
asymmetrical division at an early stage of gland development and these may 
function in the formation of small polyclonal structures in the adult gland. 
From the results of serial cell transplantation experiments, it has been theorized 
that 25-27 doublings of a single mammary stem cell in a surgically 
deepithelialized fat pad could produce an entire murine mammary gland (Kordon 
and Smith, 1998). However, normal mammary tissue is clearly polyclonal, and 
the normal colonization of the mammary fat pad is likely to occur via 
developmentally committed lobular and ductal progenitor cells as this provides a 
safeguard against aberrant stem cell behaviour by limiting the number of cell 
divisions required by any one stem cell (Kordon and Smith, 1998). These 
transplantation experiments also indicated that the entire murine inguinal 
mammary gland is comprised of approximately 2.5 x 106 cells. Taken together 
with the estimate of 950 stem cells in this mammary gland, one would calculate 
that outgrowth from each stem cell is responsible for around 2700 daughter cells. 
This number is difficult to reconcile with the observation of polyclonal staining 
patterns in termini (each of -500 cells), indicating that a much lower number of 
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cells, perhaps 1/10111 of the theoretical daughter cell number (-250 cells, half of 
total cell number in the termini) were produced from each stem cell. Possible 
explanations for this difference are that either (1) in termini, clones are much 
smaller than average or, (2) transiently activated cells function as secondary stem 
cells during gland development. Our observations, of small clones of <500 cells 
distributed throughout the glands analysed, support the second suggestion. 
Termini and Hyperplasic Alveolar Nodules (HANs) 
Until quite recently, a basic tenet of tumour biology was that cancer is a clonal 
disease, with entire tumours being derived from individual mutant cells. 
However, experimental reports that disprove this general tenet are now plentiful 
(reviewed in Garcia et al., 2000). In the case of mammary carcinoma, evidence 
for polyclonality has come from both PCR-based studies, in which polyclonality 
was demonstrated in 4 of 12 (33%) invasive breast carcinoma (Going et al., 
2001 ), and from studies of chromosomal banding patterns, where 27 of 79 (34%) 
primary breast carcmomas were demonstrated to contain cells having 
distinguishable cytogenetic differences (Pandis et al., 1995), therefore 
representing different clones. In addition, other studies using human breast 
carcinoma culture have revealed that nearly 50% of benign and malignant tumours 
contain cytogenetically distinguishable (different) clones (reviewed in Heim et al., 
2001 ). Although a number of X inactivation based studies have stated that 
mammary tumours are generally monoclonal (Diallo et al., 2001; Noguchi et al., 
1992), it is possible that the observed clonal patterns were simply a 
"pseudomonoclonality" resulting from the evolution of a single dominant clone 
from a tumour with a polyclonal origin (Teixeira et al., 1994). 
A particularly powerful technique for studying patterns of clonality in normal and 
precancerous murine mammary gland tissues involves the creation of chimeric 
glands. Of particular note, Kissenberth and Sandgren (2004) created a 
transplantation chimeric model of mammary gland hyperplasic alveolar nodules 
(HANs), by introducing into a cleared fat pad mammary epithelial cells from two 
different lines that both expressed the transforming growth factor-alpha (TGF-a) 
gene and one of two cellular markers, either human cytokeratin 18 (hCK18) or 
human placental alkaline phosphatase (R26-hPAP). In alveoli of chimeric glands, 
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they observed relatively large patches of brown (hCK18) staining with, for 
example, a section from one gland showing individual alveoli that displayed: 1) 
all brown staining apart from a single non-brown cell, 2) half brown and half non-
brown staining, and 3) a mixture of both brown and non-brown staining cells 
These observations agree very closely with those obtained in our H253 mouse 
study. One notable exception was that we did not observe any (lacZ+ve) blue-
staining alveoli in which just a single non-blue-staining cell was present. This 
difference is almost certainly due to our use of whole mounts which gave use the 
ability to view alveoli in their entirety whereas Kissenberth and Sandgren (2004) 
used thin sections of the mammary gland, which inevitability, as they pointed out, 
led to an underestimation of numbers of polyclonal alveoli. It was also of interest 
that we found many termini in which cells were either totally non-staining or 
totally blue-staining whereas Kissenberth and Sandgren did not observed such 
homogenous staining. This difference may simply reflect the fact that we were 
observing patch sizes originating from X-inactivation events, whereas the "patch" 
sizes observed in chimeric glands reflected a quite different phenomenon, namely 
the seeding of the fat pad with two types of mammary epithelial cells. 
Kisseberth and Sandgren (2004) also examined the clonal profile of precancerous 
mammary lesions in the chimeric gland. Patterns of staining in these chimeric 
glands indicated that 38% (52 of 134) of hyperplasic alveolar nodules (HANs), 
were mixed chimeric (that is, definitely polyclonal). This led to the suggestion 
that heterogeneous HANs may represent a "target" population within which a 
clonal tumour might later arise by "clonal evolution", which is the selective 
outgrowth of a single lineage from a larger initial tumour clone population. The 
high number of polyclonal HANs also hinted at the possibility that cellular 
interaction, via direct cell-to-cell contact or paracrine factors, may be important in 
neoplasia formation. Our experimental findings clearly demonstrated that 
individual TEB have a polyclonal origin, specifically, from two to three stem 
cells, and this strong I y suggests that intercellular interactions, like those suggested 
to occur in some HANs, could also operate in directing the formation of alveoli. 
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Future investigations 
Although it would be possible to marginally improve the quality of the data we 
have obtained on clonality in the mouse mammary gland by using more robust 
detection systems, a basic limitation of all " X-inactivation two-marker" detection 
systems is the relatively large patch sizes. All of the data on the mouse mammary 
gland, including ours, is in broad agreement in that it indicates that all mammary 
ducts and at least 60% of TEBs are polyclonal. One would predict that a large 
amount of additional experimentation might only reap small amounts of 
new information. 
However, one approach that could bring considerably more power to the analyses 
would be to extend the method of Kissenberth and Sandgren (2004) by using a 
large number of transgenic cell types to create a chimeric mammary gland. In 
principle, it would be relatively simple to set up such experiments if one could 
source a number of congenic transgenic animals that each expressed a distinct 
marker that was detectable immunohistochemically. If four such distinguishable 
cell lines were used in the construction of a chimeric transplantation mammary 
gland, then there is only a 6.25% (0.252x 100) chance that a polyclonal structure 
with a 2-cell origin will stain homogeneously for one of the four cell line specific 
markers. Extending this suggestion further, if a IO cell chimeric gland could be 
produced then the percentage chance of homogenous staining in termini with an 
origin from 2-cells would be reduced to just I% (0.1 2x 100); although constructing 
a gland from so many cell lines would be technically difficult. Accordingly, 
within a transplantation chimeric gland comprised of many different and 
distinguishable lineages, the actual number of cell lines responsible for an 
individual terminus, alveolus or HAN, could be measured with some degree 
of certainty. 
While the power of the mouse mammary gland analyses might be quite 
considerably improved by employing a larger number of marked stem cells, it 
would be somewhat impractical to do such analyses in larger mammals such as 
farm animals, or in humans. In these animals, one is essentially limited to the 
"two-marker" approach based on inactivation of one or the other X-linked allele. 
So, in the immediate future, the main improvements that could be made to the 
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detection and measurement of stem cell clones revolve around better methods of 
detecting and distinguishing the expression of alleles of X-linked genes. Some 
methods of doing this have already been discussed in Chapter 4, and we believe 
that improvements in XIST RNA detection still has considerable potential, given 
that the expression of this gene is a canonical marker of X-inactivation, and that 
32% of cattle are heterozygous for the SNP that we have identified in the RNA. 
Despite the fact that patches may still prove a confounding issue, there are a 
number of issues concerning cellular clonality in the bovine mammary gland that 
could be addressed: 
I) What are the patterns of monoclonality in bovine TDLU? 
2) Are the patterns observed in first lactations similar to those seen in 
subsequent lactations? 
3) Are the patterns similar to those observed in murine studies, and are 
sizes of monoclonal regions, patches etc also similar? 
4) Are there any correlations between regions that are clonal and those 
that do, and do not, express milk protein genes, especially in pregnant 
and/or beef animals? (Molenaar et al., 1992) 
5) Is the bovine gland a more suitable model of human disease than the 
mouse gland? 
Beyond the relatively straightforward questions concerning the clonal origins of 
cells that constitute the mammary gland, there are a number of more complex 
biological issues that concern the interactions between these cells. Some of these 
revolve around the basic biology of the normal gland, such as the nature of the 
cell-to-cell or paracrine communication that is thought to exist between stem cell 
clones within individual termini/alveoli or across the entire gland, and how 
manipulation of such pathways affects mammary growth. Then there are a whole 
series of questions relating to precancerous changes in mammary tissue and the 
actual growth of mammary tumours. That the hyperplasia occurring in HANs 
appears to be polyclonal in origin is intriguing, and may be highly relevant to the 
observation that an appreciable fraction of (human) tumours are not monoclonal. 
And the question of just why a tumour is polyclonal is far from resolved. Could it 
reflect some basic biology of the mammary gland in which adjacent cells 
communicate and interact in some mutually stimulatory fashion, or are there some 
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quite bizarre phenomena taking place in neoplastic tissue, such as cells taking up 
DNA from adjacent apoptosing cells? (Holmgren et al., 1999). Moreover, could 
the vast majority of breast tumours originate from polyclonal growth and it is only 
some type of later clonal evolution within the tumour that lead to the 
predominance of the clone that results in molecular analysis classifying the 
tumour as "monoclonal", whereas a much earlier analysis might have given a 
"polyclonal" result. And is this predominant clonal outgrowth closely related to 
the epithelial stem cells and should it be the main target of anti-cancer therapies? 
Clearly, such future investigations extend well beyond the subject of this thesis, 
but the techniques and results presented here would provide a valuable framework 
for many of these studies. 
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Appendix 1. Electropherogram showing relative 
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Figure A. I. Electropherogram showing the position of the identified polymorphism (SNP2) 
relative to Xist promoter in a heterozygous animal. SNP2 is indicated by a grey box highlighted 
by a yellow bar. The promoter begins upstream of the indicated sequence and terminates close to 
the beginning of the sequence in the electropherogram. 
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Appendix 2: DNA Sequences obtained during study 
A.2.1 AF531754 pG6PD: Bos taurus glucose-6-phosphate 1-
dehydrogenase (G6PD) pseudogene ('exons' 9-13) 
The entire sequenced pG6PD clone insert was submitted for intron/exon boundary 
prediction by Gcncmachine (http://genemachine.nhgri.nih.govD. 
Bos _G6PD 
I I I I I I I I I I I I I I I I I I I I I I I 'I 
1 500 116 
Gene: Genscan 
• Gene : HMMGe ne 
• Gene: Fgenes - -exon e:::-:on -
Figure A.2. 'Gc11c111 :1chine' exon/intron prediction for pG6PD.B analysed on Sequin sequence 
submission software . The exons predicted by GENSCANW approximate those predicted by the 
other software algori1l11ns, such as MZEF, used. Note the predicted repeat regions predicted by 
'REPEAT_maskcr·. 
GENSCAN 
130-365 3rd phase read, 5' GG insertion 
VPFILRCGKALNEHh.-\ EVRLQFRDVAGDIFRQQCKRNELVIRVQPNEA VYTKMMTKKPGMFFNP 
EESELDLTYGNRYK 
2 457-524 151 phase read, 3' TC insertion 
NVKLPDAYERLILD \ .FAGARCT 
3 650-75() 3rd phase read , 5' GT, 3' AG insertion 
DELREAWRIFTPLLI l I IIEREKARPIPYVYGRYVY AE 
4 876-980 3rd phase read, 5' CC, 3' T insertion 
GACGGRRA VKRVG F< /YRGHLQVGEPPQALSRPPS 
HMMGene 
I 130-365 As GENSCAN I 
2 457-524 As GENSCAN 2 
3 650-905 3rd phase read, 5' GT, 3' GA insertions 
MNCGRPGGSSLHc :-:·1·TsNARRPGPSPTCTAGTSMQKVRRTRRGVDRGVTGVEGGRRGTLWLRAP 
SPLPTACPPASRGJ ,\\ ltQTSC 
Appendices 190 
F-Genes 
1 288-366 1st phase read 
MMTKKPGMFFNPEESELDLTYGNRYK 
2 457-532 1st phase read 
NVKLPDA YERLILD\'FAGARCTSCA 
3 650-759 2nd phase read 
DELREA WRIFTPLLI I HIEREKARPIPYVYGRYVYAE 
4 876-905 2nd phase re~d, 3' A insertion 
RGLWRQTSCE 
MZEFexons 
1 130-365 As above 
2 650-742 2nd phase read,, 5' T, 3' GA insertions 
DELREAWRIFTPLLI I HIEREKARPIPYVYG 
The peptides shown are those from the frame of the putative exons that showed 
similarity by simple alignment with published G6PD protein sequences. 
ESTs 
Published ESTs were searched to determine whether the clone sequence 
corresponded to any expressed sequences. A bovine sequence (gi: 17887640) 
showed strong similarity to regions of the clone sequence as shown in the clustalX 
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Figure A.3. A clustalX sequence alignment showing pG6PD clone and the bovine EST 
gi: I 7887640. (from a Nonnalized bovine leucocyte EST library project). Significant similarity is 
found in regions corresponding roughly to the putative coding regions predicted by the 
'Genemachine' suite of exon/intron prediction algorithms. This alignment was considered in a 
description of the clone sequence. 
The EST data supported the presence of frame-shifted exons between positions: 
1. 99-365 (ignoring a less favourable start at 130) to encode: 
PA VSIPRLL TGVPFILRCGKALNERKAEVRLQFRDV AGDIFRQQCKRNEL VIRVQPNEA VYTKMMTKKPG 
MFFNPEESELDLTYGNRYK 
2. 366-532 (ignore 3' G insertion) to encode: 
NVKLPDA YERLILDVFAGARCTSCA 
3. 649-742 to encode: 
DELREA WRIFTPLLHHIEREKARPIPYVYGRY 
Appendices 192 
4. 875-1143 to encode (ignore 5' CC and 3' CT that result in short 'ORF'): 
AGACGGRRA VKRV<; FQYRGHLQVGEPPQALSRPPSCAPWACPPLSLYTPSHQTQLQRTRDHCPQ 
PHIPALGGGHPPPTI 'llPSRIPRPAAL 
The coding regions predicted using EST similarity as a guideline (reading real 
frame portions or the data only) were assembled into putative proteins and 
submitted to BLASTP searching. 
gi I 14579295 I gb LAAK<i~l 185.1 I AF326207 1 
musculus) 
Length= 515 
Score= 248 bits (632). Expect= 6e-65 
(AF326207) glucose-6-phosphate dehydrogenase [Mus 
Identities= 122/155 (78%), Positives= 127/155 (81 %), Gaps= 1/155 (0%) 
Query: 11 GVPFILitCGKALNERKAEVRLQFRDVAGDIFRQQCKRNELVIRVQPNEA VYTKMMTKKPG 
70 
GVPFILRCGK.\l,NERKAEVRLQFRDVAGDIF QQCKRNELVIRVQPNEA VYTKMMTKKPG 
Sbjct: 351 GVPFILI:<:GKALNERKAEVRLQFRDVAGDIFHQQCKRNELVIRVQPNEAVYTKMMTKKPG 
410 
Query: 71 MFFNPEESELDLTYGNRYKNVKLPDA YERLILDVF AGARCTSC-ADELREAWRIFTPLLH 129 
MFFNPEESELDLTYGNRYKNVKLPDAYERLILDVF G++ +DELREAWRIFTPLLH 
Sbjct: 411 MFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQMHFVRSDELREAWRIFTPLLH 
470 
Query: 130 HIEREKARPIPYXXX,'OCXXXXXXXXXXXXQYRG 164 
I+REK +PIPY FQY G 
Sbjct: 471 KIDREKPQI'IPYVYGSRGPTEADELMKRVGFQYEG 505 
The search reve:licd that the regions corresponding to EST regions 1-3 gave 
strong similarity to published G6PD sequences (Mus musculus in the above 
example). Howe\'er the region beyond these, corresponding to EST4 above, had 
no significant similarity to any published sequence. A BLASTX comparison of 
the EST itself shows strong similarity to published G6PD protein sequences only 
for the first 524 or its 684 bp sequence. This may indicate, as is common for EST 
data, that sequence quality is poor. Usually this is because the sequence is 
obtained with only a IX sequencing coverage, and average 3% error, c.f. human 
genome project that boasts an error rate of only 0.01 % (Baxevanis and Ouellette, 
2001). Curiously. sequence alignment of the EST with the pG6PD.B clone gives 
reasonable similarity in the same region. This may be due to the coding bovine 
G6PD protein h,.l\'ing a quite unique C-terminal sequence. Another possibility is 
that the EST is itsclf the expressed (and untranslated) product of a pseudogene 
(supported by the fact that the regions of the EST corresponding to exons of 
G6PD are themsc Ives not represented as sequences of lengths that are multiples of 
three - as one would expect to find for coding exons). 
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BLASTX 
If frameshift aberrations in the predicted exons are ignored, a protein with strong 
similarity to all but the 3'-most of the exons predicted by GENSCAN and F-genes 
(see above) gives significant expect values with a number of published G6PD 
protein sequences. 
Repeatmasker 
A single repeat element was identified m the clone sequence using an online 
repeat searching engine (http:! /ftp.genome. washington.edu/cgi-
bin/RepeatMasker). The repeat was: 
Simple hexanucleotide repeat: (CCCCCT)n, positions 547-604 forward strand 
Bos taurus G6PD-like pseudogene 
;S imple repeat 
(partial_exon9\ (exon_10)\ (ex on_11)\ I f exon12) (exon13) 
~~---1111-.11111--~--1111Ha,---ai!a-~~--•-11-~-----o 
Dt·lA'1 
(1 14 ·1) 
Figure A.4. Showing regions of similarity to published G6PD sequences (at the gene, EST and 
protein level) for the I 141 bp submitted sequence. The brackets around the 'exons' indicate that 
there is lack of evidence for first frame coding for the sequence indicated. This fact alone seems 
sufficient to allow a description of the sequence as a pseudogene (as detailed below). 
Summary of in silico data for pG6PD.B description 
Exon/intron boundary prediction software allowed the description of a number of 
putative exons (Figure A.2). Unfortunately most of these exons (9 from a total of 
13) were not first frame reading exons. Furthermore, the single most relevant 
EST found (from a bovine EST library) did give not evidence for in-frame coding 
from the clone sequence. 
In the absence of experimental confirmatory data (or of a high accuracy sequence) 
it is assumed that the clone pG6PD.B displays elements of an unprocessed 
(duplication-type) pseudo gene that exhibits strong similarity to published glucose-
6-phosphate dehydrogenase sequences at the gene and protein levels (Figure A.4). 
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The sequence was submitted to Genbank where it has the reference gi:AF531754 
LOCUS AF531754 1161 bp DNA linear MAM 16-AUG-2002 






ORGANISM Bos taurus 
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
Mammalia; Eutheria; Cetartiodactyla; Ruminantia; Pecora; Bovoidea; 
Bovidae; Bovinae; Bos. 
REFERENCE 1 (bases 1 to 1161) 
AUTHORS Jacobson,G.M. and Wilkins,R.J. 
TITLE Bovine G6PD fragment from Stratagene genomic library #945701 
JOURNAL Unpublished 
REFERENCE 2 (bases 1 to 1161) 
AUTHORS Jacobson,G.M. and Wilkins,R.J. 
TITLE Direct Submission 
JOURNAL Submitted (22-JUL-2002) Biology, The UniversityofWaikato, 








repeat_region 547 .. 604 
/note="simple repeat" 
/rpt_unit=CCCCCT 
BASE COUNT 194 a 441 c 339 g 187 t 
ORIGIN 
1 gtcctctatg tggaaaatga gcgctgggac ggtaggtggc gccgccatcc cgtggggatg 
61 ggagccggcc cctgcagcca gccaagcgct ccccaaagcc tgctgtgtcc atcccccgtc 
121 tcctcacagg ggtgcccttc atcctgcgct gcggcaaagc cctgaacgag cgcaaggccg 
181 aggtgcgcct gcagtttcgt gacgtggccg gggacatctt ccggcagcag tgcaagcgca 
241 acgagctggt aatccgcgtg cagcccaacg aggccgtgta caccaagatg atgaccaaga 
301 agcctggcat gttcttcaac cccgaggagt cggagcttga cctgacctat ggcaaccgat 
361 acaaggtggg cactcgcccg ccccctgggc aggggctggc agcccagggc tccacagggc 
421 tcagcacctt ggtgacaccc tgtggcccgc ccacagaacg tgaagctccc tgacgcctac 
481 gagcgcctca tcctggacgt ttttgcggga gccagatgca cttcgtgcgc aggtgaggag 
541 aggcaccccc ctcgccctcc ctcctccccc gccccctctc catccccctc ttcgtccccc 
601 tccctccgtg gtcacactgg gcctcccatc cccacccctg tcccttcagt gatgaactgc 
661 gggaggcctg gcggatcttc actccactgc tccaccacat cgaacgcgag aaggcccggc 
721 ccatccccta cgtgtacggc aggtacgtct atgcagaagg tgcggcggac aagacggggt 
781 gtggatcggg gggtgacggg agtggagggg gggcgaaggg ggaccctgtg gctcagggct 
841 ccctcaccgc tccccactgc ctgtccccct gccagccggg gcctgtggag gcagacgagc 
901 tgtgaagcgt gtgggcttcc agtaccgagg gcacctacaa gtgggtgaac ccccacaagc 
961 tctgagccgg cccccctcct gtgcgccctg ggcctgccca cctctctcgc tctacacccc 
1021 ctcccaccag acccagctcc agaggactcg ggaccactgc ccccagcccc acattcctgc 
1081 cctgggcggg ggccaccccc cacccactcc tcggcccagt cgcattcctc ggccagcagc 
1141 actgtgaccc cacccgtacc c 
A.2.2 pBHAP: Bos taurus Huntingtin-Associated Protein-1 
(HAP1) like pseudogene 
A suite of exon/intron boundary prediction software, including GENSCANW (as 
above) HMM, F-genes and the exon likelihood assessment predictor algorithm 
MZEF, was applied to the sequence by submission to Genemachine 
(http://genemachinc.nhgri.nih.gov/) Figure A.5. 
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Figure A.5 . 'Gcncmachine' exon/intron prediction analysed on Sequin sequence submission 
software. The cxons predicted by GENSCANW approximate those predicted by the other 
software algorithms, such as MZEF, used. Note the repeat regions predicted by 
'REPEAT _maskcr ' . 
The above prediction corresponds to potential exons occurring at: 
GENSCAN: 
1 849-979 Frameshift (5'C, 3'G) 
2 1715-1870 Codes for 52 aa peptide 
SLWAGSQLQDLQEKYSECGDMLMEAQEKVKTLRQQAPA 
SAGSVTHYTYTVPL 
3 3145-3514 Frameshift 
HMMGene: 
1 849-979 Frameshift (5'C, 3'G) 
2 1715-1870 Codes for a 74 aa peptide 
ASRPLWERVGKASRLGVPGSHQSLWAGSQLQDLQEKYSE 
CGDMLMEAQEKVKTLRQQAPASAGSVTHYTYTVPL 




899-979 Codes for a 27 aa peptide 
MENYEQQQREVAQLQGQVTKLQRCCRS 



















And the following repeat regions: 
SINE/MIR I 172-1098 on the minus strand 
LINE/L2 1486-1564 on the plus strand 
SINE/MIR 2685-2779 also on the plus strand 
The pBHAP clone was submitted for BLASTN and BLASTX searching (that is, a 
query of 'nr' collected databases by the raw DNA sequences and by protein query 
from a translated nucleotide submission). Significant similarity (here defined as 
expect values of less than 1) was required of the search. The submitted sequence 
gave significant hits against a number of published human and rodent Huntingtin 
Associated Protein (HAP 1) sequences. These sequences were considered with 
special attention to published human HAPl gene and protein (AJ012824 and 
P54256 respectively). 
Rationale for annotation of the pBHAP clone 
Weigh BLASTN (nr and EST) data 
The first predicted exon (849-979) was supported by genscan, hmm, mzpz and 
partially by Fgenes predictions, and corresponds to exon 7 of the HAP gene. This 
region, while showing strong similarity to HAPl exon 7 when read in the 3rd 
phase (that is, starting from position 3) was only 131 bp in length and seems to be 
frame-shifted (by the insertion of a 'C' at the 5' and a 'G' at the 3' end of the 
exon). 
BLASTN shows some similarity between pBHAP position 1355-1453 and exon 8 
(position 9325 to 9399) of the human HAPl gene (AJ012824). This similarity 
was supported by back-translation of the exon 8 portion of the human HAPl 
protein, which produced the DNA sequence: 
ATGTACGGAGCYGARACYGARAAGYTBCARAAGCARYTBGCYTCY 
GARAAGGARATYCARATGCARYTBCARGARGAR 
This sequence was shown to be 74% similar to 1354-1432 bp of the submitted 
bovine sequence. Although corresponding to the approximate position of human 
exon 8, the pBHAP sequence has a TTA stop codon at the putative centre of the 
exon (whereas the human protein has a TTC codon for serine) and lacks a splice 
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donor (AG) site immediately 5' to the putative exon. It is suspected that if the 
sequence has coding potential then it is likely that exon 8 is not transcribed. 
Moreover, it should be noted that this region was not predicted by exon boundary 
identification software. 
Another putative coding exon was predicted by HMM (1649-1870) Fgenes (1736-
1870) and Genscan ( 1715-1870). BLASTX similarity searching supported a 
protein coding region between 1715 and 1870 (by similarity with the protein from 
AJ012824). This region, the only exon with definite coding potential was very 
similar to exon 9 of the human sequence. 
A region with similarity to human exon 10 was predicted by the Fgenes algorithm. 
This region was shown to correspond almost perfectly to exon 10 of the human 
HAP gene AJ012824. Unfortunately, as is characteristic of ancestral 'exons' 
within pseudogenes, this region was shown to be frame-shifted (with a total length 
of 92 bp) and therefore unlikely to be coding. 
An 'exon 11-like' region, a 39 bp 'exon' residing between positions 2386 and 
2424 of the submitted sequence, was predicted using F-genes but none of the 
other algorithms. This region, although at the gene level, exhibiting an adjacent 
consensus slice acceptor site (GT), would encode a protein that was truncated 
relative to published HAPl protein sequences. 
Finally, an exon corresponding to exon 12 in human HAPl sequences, was 
predicted by both Genscan and HMM algorithms. This putative exon sequence 
was partial and truncated by insertion into the cloning vector (therefore no more 
sequence from this exon was obtainable from the clone under study). While the 
incompleteness of the sequence made it impossible to predict potential for valid 
coding from this exon, a 1st phase truncated read from position 3278 of the 
submitted sequence was detected. 
The two putative coding exons (corresponding to exons 9 and 12) that seem 
consistent with known HAPI genes would yield a protein product of 120 residues: 
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SLWAGSQLQDLQEKYSECGDMLMEAQEKVKTLRQQAPASAGSVTHYTYTVPLVPA 
EERVTEEEEL VSEEAEA WEDLEPEVDETTQMNVVTSALEASGLGPLRLDIKYVLQQL 
ANWQDARFRQQLRQKMLQKGECSRGGLPLASLTSC (truncated) 
This predicted protein fragment was submitted for BLASTP similarity searching 
and the following representative result obtained against one high scoring 
homologue: 
gi I 10241694 I emb I CAC09418.l I (AJ012824) huntingtin-associated protein 1 [Homo sapiens) 
Length= 671 
Score= 100 bits (249), Expect= 3e-21 
Identities= 52/68 (76%), Positives= 57/68 (83%) 
Query: 53 VDETTQMNVVTSALEASGLGPLRLDIKYVLQQLANWQDARFRQQLRQKMLQKGECSRGGL 
112 
+DE T+MNVVTSALEASGLGP LD+ YVLQQLANWQDA +R+QLR KMLQKGEC G L 
Sbjct: 599 
LDEATRMNVVTSALEASGLGPSHLDMNYVLQQLANWQDAHYRRQLRWKMLQKGECPHGAL658 
Query: 113 PLASLTSC 120 
PASTSC 
Sbjct: 659 P AASRTSC 666 
Score = 77.0 bits ( 188), Expect= 4e-14 
Identities= 37/52 (71 %), Positives= 43/52 (82%) 
Query: 1 SLWAGSQLQDLQEKYSECGDMLMEAQEKVKTLRQQAPASAGSVTHYTYTVPL 52 
S+W GSQLQDL+EKY +CG ML+E QE+VKTLRQQ PS GS THYY+VPL 
Sbjct: 426 SVWVGSQLQDLREKYMDCGGMLIEMQEEVKTLRQQPPVSTGSATHYPYSVPL 4 77 
The product of these exons showed good similarity to human HAPl. As noted 
above, exons IO and 11 in the clone sequence are frame-shifted; if they were 
coding they would account for around 45 aa of the 122 residue gap in similarity 
with the human sequence under comparison. 
As mentioned above, sequence coverage for most of the material submitted to 
Genbank was I-times only. It is possible that this low coverage resulted in 
frameshift reads seen in exons 7, 8 and IO (and possibly exon 11). However, it is 
more likely that the sequenced clone is a fragment of a pseudogene with strong 
similarity to Huntingtin-associated protein. Such pseudogenes are not unique as a 
human HAP I pseudogene has been previously identified (gb: 
NG_000875; HAPP). 
Repeat identification 
A number of repeat elements were identified in the clone sequence by 
Repeatmasker. The repeats were: 
MIR3 repeat SINE/MIR (class/family) positions 1089-1172 




(a third monotremc type repeat was identified but is not shown). 
The relative positions of these repeats are shown on the pseudogene diagram 
below (Figure A.6): 
···-··----······- - ---------------------------







exon_ 11 _2386-2424) xon_ 12_3278-? 
Figure A.6. Annotated diagram of the pHAPl -like (pseudogene) showing exons with predicted 
coding potential (9 and 12) and the mis-framed exons 7, 8, 10 and 11. 
Summary 
In the absence of either 1) experimental confirmation of expression from the 
putative coding region within the pBHAP clone, 2) of 3-fold or better sequence 
coverage, or 3) of complete '(pseudo)gene' sequence, it is difficult to conclusively 
characterize the clone sequence. 
However, prima facia evidence suggests that the pBHAP clone is most likely to be 
an unprocessed pseudogene with strong similarity to published Huntingtin-
associated protein- I sequences at the DNA and protein levels (Figure A.6). That 
is, due to the frequency of reading frame shifts found within the exons (a few 
miscalled bases may be expected of sequencing misreads) it is thought very 
unlikely that the sequence represents elements of a coding gene. The clone 
sequence was hence described in the submission as a Bos taurus HAPl-
like pseudogene. 
The LINE and SINE repeat family elements predicted by repeatmasker as detailed 
above, were included and the annotated sequence submitted to Genbank where it 
has the accession number gi :AF531755 . 
LOCUS AF53 l 755 3562 bp DNA linear MAM 16-AUG-2002 
DEFINITION Bos taurus huntingtin-associated-like protein (HAPl) pseudogene, 
partial sequence. 
ACCESSION AF!i31755 




ORGANISM Bos taurus 
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
Mammalia; Eutheria; Cetartiodactyla; Ruminantia; Pecora; Bovoidea; 
Bovidae; Bovinae; Bos. 
REFERENCE 1 (bases 1 to 3562) 
AUTHORS Jacobson,G.M. and Wilkins,R.J. 
TITLE Bos taurus HAPl-like partial gene sequence 
JOURNAL Unpublished 
REFERENCE 2 (bases 1 to 3562) 
AUTHORS Jacobson,G.M. and Wilkins,R.J. 
TITLE Direct Submission 
JOURNAL Submitted (22-JUL-2002) Biology, The University of Waikato, 





gene <1 .. >3562 
/gene="HAPl" 
/note="similar to huntingtin-associated protein" 
/pseudo 








BASE COUNT G77 a 999 c 1043 g 843 t 
ORIGIN 
1 ttgaggtggc aacagtgaac aacagttgaa gtgagggtgc agttgccctc accccaaatt 
61 tggccttcct tccctcaggt tccctgaatg accccctggt cccaggcccc tggagtagga 
121 gtcctcacat tctgttgctt ctgcctcgta ggaaaggctc aagtctcctt cctcttcccc 
181 atcccagcta cctctagcgc tggccacctg ttacatggtc tctctgcctc cttccctgct 
241 cttccaggcc cttctgcaca cagcccaaag gagttttcta aagccagact attggtcctc 
301 tgcctaaacc gcccaagtaa ctccctattg gccaaaggat aaaccctacc ctccctaccc 
361 cagccctagt catctggacg ctgcccactg ctccagcact ctctcctggt gtccggtggt 
421 tccctctggg cccctccaca ctctgcctgg gctctgttgc cacttctgcc tggtgagacc 
481 tccttgccct gtggaggtcc tagctccata gatcttgcca ggctggactg ggtgcggcgg 
541 ctgggaccct ggatgcactc tttacactcg ctgcacctta gttcataatt tgcactgttg 
601 tgatttgttt ttccctcagt ctccacactc gccttgagct cagtgtgggc tggggccggt 
661 cttgctgact gcttgcccag caccctgctc tgtgtcagtc agtaaacgtt tattgaaaag 
721 aagacccgag tgagggatgt taagccctgt ggaaccttgg gtacctggag gggtgcaggc 
781 agacaggggc atctgggaga ctgagggccc tggggagcca gcgctgacct tgccccactc 
841 ctccccagct gaggccagcc agcagatggc caagctgtca gaggtgctgg cgctcaggat 
901 ggagaacta t gaacagcagc agagggaggt cgcccagctg cagggccagg tcacgaagct 
961 acagcggtgt tgccgatcgg tgagtcggga catatgcggg gcttcctcct cctgtcacag 
1021 ccccctggaa tccatgcccc cttctctctg cccccacccc aggagactca gctcagaggc 
1081 ctctctcttg tgtcagagtc agagttggag aagacatcag ggagcctctc atcctgtccc 
1141 cttgtctcaa ~cgggggct gagcctaaag agagacacag ggtgttccca ggaaacaggc 
1201 cacatgactc caccttcttt ggccttttcc catgtgactt ctgttttaaa gagctgctga 
1261 cactcactga cgtgtctggg gagacttgct ggcagcaggg gctgcaggga tgtggggaga 
1321 cctggggtgg gggttcactg gccttaggtc cttccagtat ggggctgaga ctgagaagtt 
1381 gcagaagcag ctggcttagg agaaagaaat ccaggtgaag ctccaggatg aggtgaggct 
1441 tcccctgagc tcccaggacc cttgggtggc tgcctgagtc taaccagctc cttgaacagg 
1501 ggctgacgct gtcctttcca catactcagg ctctggcaca gggcctggca ggtagcagtt 
1561 cagttggggc ctgaatggag tagagtccag gggtcacact gtgtcattat atgggtctag 
1621 agtctgggcc cgttgcctct ttgcccaggc ttcccggccc ctttgggaga gagtgggcaa 
1681 ggcgtccagg ctgggtgtgc ctgggtccca tcagagcctg tgggcgggtt cccagctgca 
1741 ggacctgcag gagaagtact cagagtgtgg ggacatgctg atggaagccc aggagaaggt 
1801 gaagaccctc cgccagcagg ccccggcatc tgctggctct gtcacccact acacatacac 
1861 tgtacctctg gtgaggcccc cggctcctgc ctgttacctc tgtgcgccct gtgtctatct 
1921 gcagtccctt cctgggtctg gaggtgtgtg tgtggggtct tctgctgaac cttctggtaa 
1981 tgtcccccat ctctgtccat aggaggcact tcctgatttc caggagaccc tgactgagga 
2041 gctcagaatg tctataagga gaattatctc agaccctgtg ttttttatgg aaaggtacac 
2101 actgggcccc agtcccttgg ctgccccaca ctcactcttg cctacctggt cacagcagcc 
2161 tttctggtaa tgggaggggt ttgctcgatc aatcttctcc cctgccgtgg tgtctttcct 
2221 cctgcctcat cggtccccgg cccttccact caacaccagt cctgtgtcca cgttctgggt 
2281 ctgtcacttc tccctgggat ttttctgcac cgtgggtccc cagggatttc acactttcag 
2341 cttcccattg ccttgggaca ccaaaggccc ttttctcttt tgaaggaatt atgaagtgac 




2461 acttttaagc atccagacaa ccccctgcca ctggctttgt gacctgcagc cccggagaag 
2521 ttctggctct cgggctgact ggctgagatg tactgggagg gatactctct aaccctttgc 
2581 cttcaaattt tgccccatgg gtggccctct gattagaggc ctctccaagc aggtactgaa 
2641 gcctttgctt ctcccaacca gtgcctaaga ggcaaatggg tgctggccta ggagccagga 
2701 atgctgggac taagtcccag cttgagccct ttactggctg tgtgtccttg gacaagtcac 
2761 ttgacctgtc tgagccttac taaaatggat ttgttcctat ggcaactaga cctgggatgg 
2821 gttatgaaag ttgaataatg aaggagtggg gcagaggaga tgttattgct agtctgttct 
2881 atgaagcaga gtgaagttac tgggggaagg tggggcttgt gcagtgttgg tgaccgttct 
2941 tctttttgcc agggccatgg gctgggtgtt tgaggccttg agacttgtac ccagctgcct 
3001 cctcccctgg ctgggacaga acttgggagt aatcatcagg ttgagtggga gccctggtgg 
3061 ctggagcccc gggctgcaga tgaagggaga ggctctggct tagagcgggt aggaaaagac 
3121 tttcctgtct gcctgcccag ataggagctt cgctacagag aggagcgagc acaggagcag 
3181 gggctcgagg ctggggaggg gctgacgccg accgaggatt ttgtgcctgt ggaagagttg 
3241 gtgcctgagg agcagctggg ggtcatagaa gaggcagtgc cagctgagga gagggtaaca 
3301 gaagaggagg aactggtgtc tgaggaagct gaggcctggg aggacctaga gccggaggtg 
3361 gatgaaacaa ctcagatgaa cgtggtgacc tcagccctgg aggccagcgg cttgggcccc 
3421 ttgcgcctgg acataaagta tgtcctccag cagctggcca actggcagga tgcccgtttc 
3481 aggcagcagc tgaggcagaa aatgctccag aaaggtgagt gttcccgtgg gggcctccct 
3541 ctggccagcc tgacaagctg ca 
Discussion of sequence annotation 
201 
If the sequences described above are indeed true pseudogenes (and not merely the 
result of sequencing error) then they seem most likely to have arisen by gene 
duplication (c.f. 'processed pseudogenes' that characteristically lack intron 
regions due to their origin from retrotransposition of mRNA molecules) (Vanin, 
1985). It seems that both types of these pseudogenes are not uncommon. A 
recent survey of human chromosomes 21 and 22 has described some 189 
pseudogenes with an approximate ratio of 1: 1 for processed to unprocessed 
pseudo gene. and a genome wide estimate of around 7,000 and 9000 for each type 
respectively (relative to total gene number of around 25,000) (Balasubramanian et 
al., 2002). 
After gene duplication, a new copy of a gene may: be maintained unchanged, 
acquire new functions, or it may become neutralised to give rise to a pseudogene 
(a gene-like region that is non-functional because of either: a dramatically altered 
'frame-shifted· protein coding potential, or due to failure of transcription or 
translation) (Vanin, 1985). Most of the predicted exons (by splice consensus 
sequences) in the sequences under discussion have undergone frame-shift 
changes, presumably after insertion or deletion mutations. Furthermore as the 
sequenced region does not include potential promoter sites, or earlier exons, it is 
difficult to judge conclusively whether other portions of the gene have better 
potential for coding. Hence, these factors combine to make it difficult to 
conclusively determine the likelihood of the production of mature coding RNA 
from either sequence. 
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It is predicted that the described g6pd pseudogene is located on the bovine X 
chromosome as it is common for such products of gene duplication to reside close 
to the genes original loci (Mighell et al., 2000). 
Future classification of the region may include re-sequencing of the region and 
RT-PCR with primers on flanking 'exons' to determine whether the predicted 
exons are found in any expressed gene product (presumably a brain cDNA library 
would provide the best template DNA for such an experiment). 
Appendix 3. Other sequences obtained 
A.3.1 AF181665 Bos taurus SINE sequence [gi:6003528) 
A 432 bp fragment that gave significant similarity to other SINE on Genbank. 
This sequence was produced from a spurious band that was gel eluted after it co-
amplified with a smaller (desired) product. 
LOCUS AF181665 432 bp DNA linear MAM 30-JUL-2002 
DEFINITION Bos taurus Bov-tA2 sequence. 
ACCESSION AF181665 
VERSION AF181665.l GI:6003528 
KEYWORDS . 
SOURCE cow. 
ORGANISM Bos taurus 
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
Mammalia; Eutheria; Cetartiodactyla; Ruminantia; Pecora; Bovoidea; 
Bovidac; Bovinae; Bos. 
REFERENCE 1 (bases 1 to 432) 
AUTHORS ,Jacobson,G.M. and Wilkins,R.J. 
TITLE Direct Submission 
JOURNAL Submitted (29-AUG-1999) Biology, University of Waikato, Hillcrest 





repeat region 102 .. 306 
BASE COUNT 122 a 91 c 111 g 108 t 
ORIGIN 
II 
1 aggttcaaag taagggcttt tgtaaagtct ggttaccaga cccagagtcc aagctcagaa 
61 catgtctgaa gtgtttttta gtcaaataat gtgctaaatt tgagcttccc tggcggcttt 
121 catggtaaag agtctgcctg caactcagga gacccaggtt cgatccctgg gtcaggaaga 
181 tctcctggag aaggaaatgg catccagctc cagtattctt gcctggaaaa tcccatggac 
241 agaagagcct ggcgagtccc agtccatgca atcacaagga gtcggacacg actgagtgac 
301 taacacttca atgtgctaaa tttagggtcc ttaaagtgtt ttctacttag gaagcaactg 
361 gtcccaggat attgaataag ctgaagcttt gcttggagag tcagacagtc acagctgttg 
421 gcagaagagg aa 
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A.3.2 AF104906 Bos taurus X-inactive specific transcript (Xist) 
gene, partial sequence. [gi:10181229] 24-AUG-1999 
This sequence represents the product of amplification directly from a bovine 
genomic DNA template using universal primers. 
LOCUS AF104906 2182 bp DNA linear MAM 19-SEP-2000 
DEFINITION Bos taurus X-inactive specific transcript (XIST) gene, partial 
sequence. 
ACCESSION AF104906 
VERSION AF104906.5 GI:10181229 
KEYWORDS . 
SOURCE Bos taurus. 
ORGANISM Bos taurus 
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
Mammalia; Eutheria; Cetartiodactyla; Ruminantia; Pecora; Bovoidea; 
Bovidae; Bovinae; Bos. 
REFERENCE 1 (bases 1 to 2182) 
AUTHORS Jacobson,G.M. and Wilkins,R.J. 
TITLE Bos taurus partial (exon 1) XIST sequence 
JOURNAL Unpublished 
REFERENCE 2 (bases 1187 to 1740) 
AUTHORS Jacobson,G.M. and Wilkins,R.J. 
TITLE Direct Submission 
JOURNAL Submitted (05-NOV-1998) Dept. of Biology, University of Waikato, 
Hillcrest Rd, Hamilton 2001, New Zealand 
REFERENCE 3 (bases 1 to 2182) 
AUTHORS Jacobson,G.M. and Wilkins,R.J. 
TITLE Direct Submission 
JOURNAL Submitted (03-JUN-1999) Dept. of Biology, University of Waikato, 
Hillcrest Rd, Hamilton 2001, New Zealand 
REMARK Sequence update by submitter 
REFERENCE 4 (bases 1 to 2182) 
AUTHORS Jacobson,G.M. and Wilkins,R.J. 
TITLE Direct Submission 
JOURNAL Submitted (14-JUL-1999) Dept. of Biology, University of Waikato, 
Hillcrest Rd, Hamilton 2001, New Zealand 
REMARK Sequence update by submitter 
REFERENCE 5 (bases 1 to 2182) 
AUTHORS Jacobson,G.M. and Wilkins,R.J. 
TITLE Direct Submission 
JOURNAL Submitted (24-MAR-2000) Dept. of Biology, University of Waikato, 
Hillcrest Rd, Hamilton 2001, New Zealand 
REMARK Sequence update by submitter 
REFERENCE 6 (bases 1 to 2182) 
AUTHORS Jacobson,G.M. and Wilkins,R.J. 
TITLE Direct Submission 
JOURNAL Submitted (18-SEP-2000) Dept. of Biology, University of Waikato, 
Hillcrest Rd, Hamilton 2001, New Zealand 
REMARK Sequence update by submitter 
COMMENT On Sep 18, 2000 this sequence version replaced gi:7322074. 
FEATURES Location/Qualifiers 








mRNA 33 .. >2182 
/gene="XIST" 
exon 33 .. >2182 
Appendices 
lgene="XIST" 
BASE COUNT 457 a 4 73 c 533 g 719 t 
ORIGIN 
II 
1 ttcttaaagc gctgcaattt gctgcgaccg ccatatttct tcttttcccg agatggaagc 
61 ttattaatat tggatttctt tgcctgtgtg gttctttctg gaacattttc cagaccccaa 
121 ccatgcctta tggcatattt cttggaaaaa attacaccaa aaattcataa aatattttta 
181 aaaacctgaa ctttcttcta gtattttctt gacaccttct cagtatttta cagatacttg 
241 gggatatttt taggcaattt tccattttaa aggacgtttt ctttggaatg atttttggtt 
301 gcctcctctg ggttttttgt ggtttctttt tctttttctc ctccttttct atattatttg 
361 cccatcgcgg ctgtggatac ctggttttag tgtgtatata gataggtaga tagatatatt 
421 attattgtat tattttttac ccaacggggt catggatacc tgccttttat tttatttttt 
481 tttaatttgc ccatcggggc cacggatacc tgcttttaat tttttttttc ccccttagcc 
541 catcggggcc tcggatacct gctgtgtacc ccctctctcc ctaacctggc ccatcggggc 
601 aatggatacc tgcctctttt ttaaatgtgt tgtttttttt tttttttcct tgcccatcgg 
661 ggcctcggat acctgcttta attttttttt tcttgcccat cggggcctcg gatacctact 
721 ttaatttttt ttccttgccc atcgggaccg cggacacctg cttagatttt tgttttacac 
781 cacccatcgg ggctttatat ggttggaaaa gtgttgggtt ttgtggttcg ttgtactatc 
841 tggaatgtct acaaaatttt gctgctaatc gtttgtgttg tgtgagtgga cctacggctt 
901 tggctgggag atgactttgc agttaggcta gagggttggt taggctgggg aggaaagatg 
961 gcggccactt cagatttgcc gcccagcttg gctgaggggt aactgtgcta agtatcacta 
1021 ggaaggtaag atgaataatg cgacaggcaa aggaaatggt atgcattgca tgagttaaat 
1081 gttttgaata agctgacttg gatcatgtta ggagcttggc atgaattgtg gtatcatgag 
1141 gtgggaaaac ataggatcat cctatgtcat attacaaggg tctaatggaa aatgagcggg 
1201 agaagaatta ggcgcagtgt tcaaaatggc gattttgacc ttgcagcatt gcttagcatg 
1261 gctctctgct ttgttagagt gttcaaaatg gcggatccat tttgccgcag tgttccaatg 
1321 gcgggaagcc acatcatggg tgtctttgtt ctagtgtgca gcatggcggt agaaatattc 
1381 tgttacatag taaaagatgg ccgcttaagt acttgccgca gtctaaaaca tggcgggctt 
1441 ttgtctctgc cgtgtgcatt tcctgatagg ttttgctgca gggacaatat ggctgacctt 
1501 gtcatgtgga tatcatggca gtttgtcacg tggatatcgt ggcaggggtg tttgaccgtt 
1561 acattcttgg cgggctttgc atcaggaggg cctgccgcat tgttaaagat ggcgtgcttt 
1621 gccgcggaca aagtgaaagg agggattggc aatgttagat tgccgcgtgt cccacccaat 
1681 cagaaagggt ggtagaatcg gtcacagcca gttagtggag gatggaatta gatgagttag 
1741 catagcacct cgctaccgtc tctattcagc cagtcaggat tggccacatt tgtactaatc 
1801 tcagtgggtg gtaccaaagt ctttccaagg acatttggcc tttccacctc ctccctcccc 
1861 tctcactggc tccctcccct ccctcattgc cacttgcagt gctggatatt aggttgtgca 
1921 ggcagaacct cacgccattc ctctgcattg gtgccgtggc cgaagccctt ccccacttcc 
1981 cccttccccg ccccctgctc ttctgcgttg tggccagggg cagtgcgcca tgcctgctaa 
2041 gtgtgaactt ggcggtgagt cgtggcaagg accagaatgg atcgcagatg atcgttggcc 
2101 aactgttggc agaagaggaa tccctgcctt cctcaagagg aacacctacc ccgtggctaa 
2161 tgctggggtc ggatttttga ta 
A.3.3 AY136819 
LOCUS AY136819 691 bp DNA linear MAM 20-AUG-2002 





ORGANISM Bos taurus 
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata;Euteleostomi; 
Mammalia; Eutheria; Cetartiodactyla; Ruminantia; Pecora; 
Bovoidea; Bovidae; Bovinae; Bos. 
REFERENCE 1 (bases 1 to 691) 
AUTHORS Jacobson,G.M. and Wilkins,R.J. 
TITLE Bos taurus LINE repeat sequence (Bov-B LINEIBovB) 
JOURNAL Unpublished 
REFERENCE 2 (bases 1 to 691) 
AUTHORS Jacobson,G.M. and Wilkins,R.J. 
TITLE Direct Submission 
JOURNAL Submitted (29-,JUL-2002) Biology, The University of Waikato, 












BASE COUNT 239 a 138 c 152 g 162 t 
ORIGIN 
II 
1 gatcactcac ctagagccag acatccttga gtgtgaagtc aagtgggcct taggaagcat 
61 gacaatgaac aaagtgagtg gaggtgatgg aatcccagtt gagctgtttc aaatcctaaa 
121 agaagcagtg gccacaggac tgaaaaaggt cagttttcat tccaatcaca aagaaaggca 
181 atgccaaaga atgctcaaac taccgcacaa ttgctctcat ttgatatgct agcaaagtaa 
241 tgttcaaaat ccttcaagct aggtttcaat agtatgtgaa cttagaactt ccagatgtac 
301 aagctggatt tagaagaggc agaggaacca gagatcaaat tgccaacatc ttttggatca 
361 tagaaaaagc caattcagaa aacatctact tctgcttcat tgactatgct aaagcctctg 
421 cctgtatgga tcacaccaaa ctggaaaatt cttaaagaga tgggaatacc agaccacctg 
481 acctgcctct tgagaaacct gtatgcaggt caggaagcaa cagttagaac tggacatgga 
541 acaacagact ggttccaaat aggaaaagga gtatgtcaag gcagtatgtt gccaccctgc 
601 ttatttaact tatttgcaga gtacatcatg agaaatgcca ggctggatgg atcacaagct 
661 ggaatcaaga ctgctgggag aaatatcaat a 
A.3.4 AV136820 
LOCUS AY136820 2082 bp DNA linear MAM 20-AUG-2002 
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DEFINITION Bos taurus clone pBLS2 Bov-B LINE/BovB and BOV-tA2 SINE/BovA repeat 
sequences. 
ACCESSION A Y 136820 
VERSION A Y 136820 
KEYWORDS 
SOURCE COW. 
ORGANISM Bos taurus 
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
Mammalia; Eutheria; Cetartiodactyla; Ruminantia; Pecora; Bovoidea; 
Bovidae; Bovinae; Bos. 
REFERENCE l (bases 1 to 2082) 
AUTHORS Jacobson,G.M. and Wilkins,R.J. 
TITLE Bos taurus Bov-B LINE/Bov-B and Bov-tA2 SINE/BovA containing 
repetitive region 
JOURNAL Unpublished 
REFERENCE 2 (bases I to 2082) 
AUTHORS Jacobson,G.M. and Wilkins,R.J. 
TITLE Direct Submission 
JOURNAL Submitted (29-JUL-2002) Biology, The University of Waikato, 
Hillcrest Rd., Hamilton 200 I, New Zealand 
FEATURES Location/Qua! i tiers 




/clone_lib="Stratagene lambda library Cat number 945701" 
repeat_region < 1..1464 
/rpt_family="Bov-B LINE/BovB" 
/rpt_type=disperscd 
repeat_region 2018 .. 2082 
/rpt_family="B0V-tA2 SINE/BovA" 
/rpt_type=dispcrscd 
BASE COUNT 616 a 467 c 504 g 495 t 
ORIGIN 
1 gatcactcac ctagagccag acatccttga gtgtgaagtc aagtgggcct taggaagcat 
61 gacaatgaac aaagtgagtg gaggtgatgg aatcccagtt gagctgtttc aaatcctaaa 
Appendices 
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121 agaagcagtg gccacaggac tgaaaaaggt cagttttcat tccaatcaca aagaaaggca 
181 atgccaaaga atgctcaaac taccgcacaa ttgctctcat ttgatatgct agcaaagtaa 
241 tgttcaaaat ccttcaagct aggtttcaat agtatgtgaa cttagaactt ccagatgtac 
301 aagctggatt tagaagaggc agaggaacca gagatcaaat tgccaacatc ttttggatca 
361 tagaaaaagc caattcagaa aaacatctac ttctgcttca ttgactatgc taaagcctct 
421 gactgttgga tcacaacaaa ctggaaaatt cttaaagaga tgggaatacc aaccacctga 
481 cctgcctctt gagaaacctg tatgcaggtc aggaagcaac agttagaact ggacatggaa 
541 caacagactg gttccaaata ggaaaaggag tatgtcaagg cagtatgttg ccaccctgct 
601 tatttaactt atttgcagag tacatcatga gaaatgccag gctggatgga tcacaagctg 
661 gaatcaagac tgctgggaga aatatcaata acctagatat gcagatgaca ccactcttat 
721 ggcaggaaga gaagaggaac taaagagcct cttgatgagg ctggaagaga agagtgaaaa 
781 agctggctta aaacacattc aaaaaactaa gatcatggta tctggtccca tcacttcatg 
841 gcaaatggat ggggaaacaa tgcaaacagg gaccaacagt tttcttgggc tccacaatca 
901 ctacagatgg tgcctgcagc catgaagtta aaagacgctt gctctttgga agaaaagcta 
961 tgacaaaact aaacagagta ttaaaaagca gagacatcac tttgctgact aagttctatc 
1021 tagtcaaagc tatggttttt gcagtaatca tgtacagatg tgagacttgg acaataacaa 
1081 aggctgagtg ccaaagaatt gatgctttca aactgtggtg ctggagaaca ctcttgagaa 
1141 tcccttggac agcaaggaga tcaaagcagt gcatcctaaa ggaaatcaac cctgaatact 
1201 cattggaagg actcatgctg aagctgaagc tccaatactt tggccacctg atgcaaagag 
1261 ccttttctca ttggaaaaga ccctgatgct aggatagact gaggacagga gaaggggacg 
1321 acagaggatg agatgcttgg atggcatcac cgactcaatg gacacgagtt tgagtaaact 
1381 ccgggagatg gtgaaggaca gggaagcctg gcgtgctgca gtccatgcat tctcaaggag 
1441 ttgggcatgc ctgagtgaat gaacaacaac caggacctca tgcctctttt gcattgcaag 
1501 ctcctagagc tgagattaca gctactgtcc ttctcaggtc cttcatgtct gtccttcatt 
1561 ttcattgcac tgggcatccg gtgatagttg agcatcctca ccagggccct ctcatctctg 
1621 tcacagggta gcaccaagat ctgagctgtg cactaacttc tctagcctgg gccctctgtc 
1681 atggtgggga cactcagaga ggatcagctt gggggttccc accctgccct ccctgctccc 
1741 acgtagtcat cacatgttgg gagtccagga agagcttagt ctctcctcca tttccggttc 
1801 ctggccctac atggatcctc cacgctgtta agtgtcccac tcagtgatgc catgccagaa 
1861 ggctttccaa ggggcttggg atgactctcc ccagaactca gctctactgg gtcccccaaa 
1921 gtctgtaggt gtctgtggag ctgtgtgagg ggtccctgag cacaaagacc ccagcagggt 
1981 caagaaaggc tcttttgttt ctttgctttt tctcctgagg gcttccctgg tggctcagat 




/acZ staining in mouse intestine and skin 
A 




Figure A.7. Showing A) Samples of histochemically stained intestinal tissue and B) skin, from a 
homozygous Tam-lacZ animal. The images are of whole-mount tissues and were taken via a 
compound microscope using a Nikon 'Coolpix' camera. Magnification is indicated on the plates. 
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Appendix 5. Recipes 
Neutralizing solution 
0.5 M Tris-HCL (pH 7.4) 
1.5 M NaCl 
SX TBE buffer 
108 g Tris base (final 890 mM) 
55 g boric acid (final 890 mM) 
40 ml 0.5 M EDT A, pH 8.0 (final 20 mM) 
Adjust volume to l 1 
TE buffer 
IO mM Tris-HCI (as recipe below) 
1 mM EDT A, pH 8.0 
Adjust to required pH (usually 7.4, 7.5, or 8.0) 
lM Tris-HCI 
Dissolve 121 g Tris base in 800 ml H20 
Adjust pH (between pH 7 .2-9) with IO M HCl 
Add H20 to 1 l with mixing 
SOX TAE buffer 
242 g Tris base 
57 .1 ml glacial acetic acid 
37 .2 g N a2EDT A.2H20 
H20 to 1 I 
Sodium acetate, 3 M (500 ml) 
Dissolve 204 g sodium acetate.3H20 in 400 ml H20 
Adjust pH with 3 M acetic acid (usually to pH 4.8 or 5.2) 
Add H20 to 0.5 I 
lOMNaOH 
Dissolve 400 g NaOH in 450 ml of H20 
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lM MgCli (100 ml) 
Dissolve 20.3 g MgC12.6H20 in 80 ml of H20 
H20 to 100 ml 
Ethidium bromide (10 mg/ml) 
Dissolve 0.1 g ethidium bromide in 10 ml of H20 
Store at RT in an amber bottle. 
0.5 M EDTA 
Dissolve 186.1 g Na2EDTA.2H20 in 700 ml H20 
Adjust to pH 8.0 using 10 M NaOH 
Add H20 to 11 
Lambda top agarose 
10 g Tryptone 
8 g NaCl 
6 g Agarose 
add H20 to 1 I, mix well and autoclave 
Luria-Bertani (LB) medium (broth/agar) (11) 
10 g Bacto-tryptone 
5 g LB base 
10 g NaCl 
(add 15 g/1 agar before autoclaving if LB agar is required) 
Bring to 1 I and autoclave for 20 min 
Suspension medium (SM) (11) 
5.8 g NaCl 
2 g MgS04.7H20 
50 ml 1 M Tris.HCI (pH 7.5) 
0.01 % gelatin 




0.1 g LB 
1 ml of 40% PEG 8000 
100 µl 2M MgS04 
Bring to 4 ml with deionised water 
10 X MOPS buffer 
0.2M MOPS (pH 7) 
35 mM Sodium Acetate 
10 mM EDTA (pH 8) 
0.5 M EGTA (250 ml) 
190.2 gEGTA 
Bring to 250 ml with H20 
Bring to pH 7.5 by addition of 1 M NaOH to dissolve 
LacZFix#l 
0.2% Glutaraldehyde 
5 mM EDT A (pH 7 .35) 
O.lM MgCl 2 
1 XPBS 
Lacz wash buffer 
2mMMgC1 2 
0.01 % desoxycholic acid (Sodium salt) 
0.02% Nonidet-P40 
1 X PBS, adjust pH to 7 .5 
Lacz stain 
1 mg/ml X-gal (initially dissolved in dimethylformamide) 
5 mM Ferrocyanide 
5 mM Ferricyanide 
1 XPBS 
Adjust to pH 7 .8 before use 
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(may be supplemented with 20-100 mM Tris-HCI as a pH buffer) 
LacZfix#2 
Dissolve 2 g of paraformaldehyde in ddHp at 60° with stirring by adding a few 
drops of 2 M NaOH, add a 1/10 V of IO X PBS and adjust pH to 7.3. Add 
glutaraldehyde to a final concentration of 0.25%. 
Bis-acrylamide/ Acrylamide stock solution: 
For JOO ml - 0.81 g bis-acrylamide 
30 g Acrylamide 
(bis-/acrylamide cross-linking ratio= 2.7). 
Diethylpyrocarbonate (DEPC) treatment 
Solutions used for RNA work were pre-treated by the addition of 1 ml of DEPC 
per litre of solution (0.1 % ). The solution was then mixed vigorously and 
autoclaved before use. 
15 % non-denaturing Acrylamide gel 
For 20 ml total (that is 2 JO cm X JO cni gels, 0.75 mm thick) 
IO ml 30% bis-/ Acrylamide. 
4 ml 5X TBE buffer 
6 ml High quality ultra-filtered water 
160 µI IO% ammonium persulphate 
16µ1 TEMED stock solution. 
10 X PBS (with or without DEPC) 
80 g of NaCl, 2 g of KCI, 2 g KH2P04 and 11.5 g of Na2HPQ4·7H20 was 
dissolved in high quality water. Then solution was immediately autoclaved or, if 
the PBS was intended for RNA work. autoclaved 6 h after the addition of 1 ml/I 
ofDEPC. 
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Proteinase K buff er 
20 mM Tris pH 8.0 
25mMKCI 
1.5 mMMgCh 
0.5% Tween 20 
Supplemented with 400 ng/µl of Proteinase K 
Church and Gilbert hybridization buffer 
212 
1. Dissolve 44.5 g of Na2HP04.2H20 in 500 ml of H20. Adjust pH to 7.2 with 
H3P04 and autoclave. 
2. Dissolve 50 g of SDS in 500 ml of H20 and dissolve at 37°. Add 1 ml of 
0.5 MEDTA. 
Mix 1 and 2 and store at 37° before use 
20X MOPS buffer 
To make 400 ml, dissolve 16.75 g of MOPS, 2.7 g Na0Ac.3H20 and 1.4 g of free 
acid EDTA in 390 ml of DEPC-H20. After adjusting pH to 7.4 with NaOH, filter 
through a 0.4 µm filter and store at 4°. 







Quantity of bovine DNA extracted from 1 I of retail milk product; 
How many cells does this equate to? 
DNA from a 50 µI resuspension of total DNA from 240 ml of milk was quantified 
at of 1880 ng/µI. Hence, assuming no DNA loss during the extraction, there was 
94 µg of DNA per 240 ml, or 390 ng/ml. A diploid bovine genome is equivalent 
to 6 pg of DNA, so, in l µI of milk there are 65 cells, in 1 ml of milk there are 
390/0.006 (6.5 X 104) cells and in a litre of milk - from healthy animals - 6.5 X 
107 mammary gland cells. 
